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ABSTRACT
Diabetes  is  a  chronic  condition  that  occurs  when the  pancreas  does  not  produce
enough insulin or the body cannot effectively use the insulin it produced by hyperglycemia
and other related disorders in the body’s metabolism can lead to serious damage to many of
the  body  systems  especially  of  nerves  and  blood  vessels.  Diabetic  complications  are
classified in to two major categories like acute and chronic. The acute complications of
diabetes  include  diabetic  ketoacidosis,  hyperosmolar  hyperglycemic  syndrome,
hypoglycemia. The chronic complications of diabetes again classified in to micro vascular
and  macro  vascular  complications.  The  micro  vascular  complications  include  diabetic
retinopathy, diabetic nephropathy, diabetic neuropathy. Macro vascular complications are
stroke, hypertension, insulin resistance syndrome. Diabetic peripheral neuropathy is nerve
damage  that  occurs  because  of  the  metabolic  degenerations  associated  with  diabetes
mellitus. The  most  common  symptoms  of  diabetic  peripheral  neuropathy  include  pain,
burning, tingling, or numbness in the toes or feet, and extreme sensitivity to light touch. The
pain may be worst at rest and improve with activity, such as walking. Some people initially
have intensely  painful  feet  while  others  have few or  no symptoms.  Diabetic  peripheral
neuropathy usually affects both sides of the body. Diabetic peripheral neuropathy treated
with main three components that is , tight control of blood sugar levels  , care for the feet to
prevent  complications  and  Control  of  pain  caused  by  neuropathy.  Diabetic  patients  are
encouraged to follow a daily leg exercises , foot care regimens like washing , and inspecting
the foot proper fitting shoes can prevent major complications. 
           A study was done to evaluate the effectiveness of exercises on pain and sleep among
patients with diabetic peripheral neuropathy in selected hospitals, Erode.
      An Evaluative approach was used for this study. The research design used was Quasi
experimental  non equivalent pre test  and post test  control group design. The conceptual
framework of the study was based on the “Modified Ludwig Von Bertlanffy System theory
(1968). Non probability purposive sampling method was used to select 60 samples for the
study. 30 samples were in experimental group was selected from S.R.C diabetes care centre
Erode and 30 samples were in control group was selected from Monika diabetes care centre
Erode.  The  tool  used  for  this  study  was  Leeds  Assessment  of  Neuropathic  Signs  and
Symptoms Scale to assess the level of pain and Sleep Scale from medical outcome of study
to assess the level of sleep,  exercises was given to the patients with diabetic peripheral
neuropathy  for 30 minutes once in a day for a period of 15 days in experimental group.
The data gathered were analyzed by using descriptive and inferential statistics. The
mean post test level of pain in experimental group 9.6(SD±3.15) was significantly lower
than the mean posttest level of pain in control group 15.9(SD±2.99) The mean difference
was 6.3.The Independent‘t’ value was 8.51which was significant at p<0.05 level. The mean
post test scores of sleep in experimental group 47.7 (SD±5.56) was significantly higher than
the mean post test scores of sleep in control group 34.2(SD±7.03). The mean difference was
13.5.The independent‘t’  value was 8.88which was significant at p<0.05 level.  The mean
post test scores of pain and sleep among patients with diabetic peripheral neuropathy in
experimental  group  were  9.6(SD±3.15)  and  47.7  (SD±5.56)  respectively.  The  mean
difference  was  38.1.  The  ‘r’  value  was   -0.9  which  showed  that  negative  relationship
between  pain  and  sleep  scores   among  patients  with  diabetic  peripheral  neuropathy  in
experimental group. It reveals that as the pain level decreases sleep pattern was improved. 
The study findings revealed that there was a significant association between post test
level  of  pain  among  patients  with  diabetic  peripheral  neuropathy  with  demographic
variables  of  marital  status(χ2=7.74),  family  monthly  income(χ2=9.65),  and  duration  of
treatment for diabetic peripheral neuropathy(χ2=7.66) at p<0.05 level of significance and no
significant association between post test level of sleep score in experimental group. There is
a decreased level of pain and improvement in the level of sleep pattern among patients with
diabetic peripheral neuropathy after exercises. The study findings revealed that practicing
exercises is beneficial for patients with diabetic peripheral neuropathy for decreasing pain
and improving sleep pattern.
CHAPTER-I
i) INTRODUCTION
BACKGROUND OF THE STUDY:
“Live simply, eat wisely, exercise regularly and live happily-away from diabetes”
                                        World diabetes day .,(2014)
            Health is a state of complete physical, mental, and social well being, and not merely
the absence of disease or infirmity. .Health is a dynamic condition resulting from a body's
constant adjustment and adaptation in response to stresses and changes in the environment
for maintaining an inner equilibrium called homeostasis.
                                                                                Medical dictionary., (2013)
Wellness  is  "an  integrated  method  of  functioning  which  is  oriented  toward
maximizing the potential of which the individual is capable. It requires that the individual
maintain a continuum of balance and purposeful direction within the environment where  is
functioning.  "wellness  is  a  direction  in  progress  toward  an  ever-higher  potential  of
functioning"
                                                                                 HalbertDunn M.D., (2006)
          Illness is a subjective state in a human marked by feelings of deviation from the 
normal healthy state 
                                                                                 Medical dictionary., (2013)
        Disease may be caused by factors originally from an external source, such as infectious
disease,  or  it  may  be  caused  by  internal  dysfunctions,  such  as autoimmune  diseases.
Diseases usually affect people not only physically, but also emotionally, as contracting and
living with many diseases can alter one's perspective on life, and their personality.
                                                                                                   John D., (2010)
The endocrine system and the nervous system are two of the primary communicating
and coordinating systems in the body. The nervous system communicates through nerve
impulses;  the  endocrine  system  communicates  through  chemical  substances  known  as
hormones, and it plays a role in reproduction, growth and development and regulation of
energy. The endocrine system is composed of glands and glandular tissues that produce,
store, and secrete hormones that travels through the blood to specific target cells throughout
the body.
                                                                                                    Lewis., (2007)
           Diabetes is a chronic condition that occurs when the pancreas does not produce
enough insulin or the body cannot effectively use the insulin it produced by hyperglycemia
and other related disorders in the body’s metabolism can lead to serious damage to many of
the body systems especially of nerves and blood vessels.
                                                                                               WHO.,(2005)
         Diabetes mellitus is  a chronic  multisystem disease related to  abnormal insulin
production, impaired insulin utilization or both.
                                                                                              Lewis., (2007)
          Diabetic complications are classified in to two major categories like acute and
chronic. The acute complications of diabetes include diabetic ketoacidosis, hyperosmolar
hyperglycemic  syndrome,  hypoglycemia.  The  chronic  complications  of  diabetes  again
classified  in  to  microvascular  and   macrovascular  complications.  The  microvascular
complications  include  diabetic  retinopathy,  diabetic  nephropathy,  diabetic  neuropathy.
Macrovascular complications are stroke, hypertension,insulin resistance syndrome.
                                                                                                        Lewis., (2007)
                  Over a long period of time, hyperglycemia damages the retina of the eye, the
kidneys, the nerves, and the blood vessel. Damage to the nerves from diabetes (diabetic
neuropathy) is a leading cause of foot ulcers and wounds which frequently lead to foot and
leg amputations.
                                                                                   Robert . J. berry ., (2011)
        Diabetic peripheral neuropathy is nerve damage that occurs because of the metabolic
degenerations associated with diabetes mellitus.
                                                                                              Lewis., (2007)
       
Diabetic Peripheral  neuropathy  or  sensory motor  neuropathy  or  distal  symmetric
neuropathy  is  the  nerve  damage  in  the  arms  and  legs . It leads to loss of   protective
sensation in the toes, which extends to involve the feet and legs in a stocking distribution.
Muscle weakness and loss of reflexes occurs causing changes in the way the person walks.
Numbness develop, blisters and sores may appear resulting in sepsis leading to infection of
bone and the foot.
                                                                                   Stacy. B., (2005)
                 
         The most common type of neuropathy affecting persons with diabetes is sensory
neuropathy. This can lead to the loss of sensation in the lower extremities, and coupled with
other factors, this significantly increases the risk for complications that result in a lower
limb amputation. More than 60% of nontraumatic amputations in the United States occurs in
people with diabetes.
                                                                                                     Lewis., (2007)
          In people with type 1 or type 2 diabetes, the biggest risk factor for developing diabetic
peripheral neuropathy is having high blood sugar levels over time. Other factors can further
increase  the  risk  of  developing diabetic  neuropathy,  including coronary artery  disease  ,
increased triglyceride levels, being overweight (a body mass index >24) , smoking and high
blood pressure   
                                                                      Eva L. Feldman et al., (2012) 
           The most common symptoms of diabetic peripheral neuropathy include pain,
burning, tingling, or numbness in the toes or feet, and extreme sensitivity to light touch. The
pain may be worst at rest and improve with activity, such as walking. Some people initially
have intensely  painful  feet  while  others  have few or  no symptoms.  Diabetic  peripheral
neuropathy usually affects both sides of the body. Symptoms are usually noticed first in the
toes. If the disease progresses, symptoms may gradually move up the legs; if the mid-calves
are affected, symptoms may develop in the hands. Over time, the ability to sense pain may
be lost, which greatly increases the risk of injury.
                                                                          Jeremy M. shfner., (2011)
          Diabetic peripheral neuropathy disrupts the body’s ability to communicate with its
muscles,  organs, and tissues.  Symptoms can include numbness,  tingling,  weakness,  and
pain.  With early diagnosis, it can often be controlled and quality of life restored.  If ignored,
symptoms can intensify to loss of sensation, weakness, unremitting pain, and/or disability.
                                                                                      Stephane zahala.,(2013)
        Pain is an unpleasant sensory and emotional experience associated with actual or
potential tissue damage, or described in terms of such damage.
                              International Association for the Study of Pain., (2011)
             Sleep is defined by a natural periodic state of rest for the mind and body, in which
the eyes usually close and consciousness is completely or partially lost, so that there is a
decrease in bodily movement and responsiveness to external stimuli. During sleep the brain
in humans and other mammals undergoes a characteristic cycle of brain-wave activity that
includes intervals of dreaming.
                                                                                Medical dictionary., (2010)
             Diabetic peripheral Neuropathy can impact sleep in a number of ways. For some,
the symptoms may cause the sleep disturbances e.g., diabetic peripheral neuropathic pain
makes it difficult to fall asleep or stay asleep; abnormal sensations or hypersensitivity to
touch, particularly in the feet and legs makes it difficult to fall asleep. 
      Gardiner.N.J.,(2013) 
             Diabetic peripheral neuropathy is diagnosed based upon a medical history and
physical examination of the feet. During an examination, there may be signs of nerve injury,
including , Loss of the ability to sense vibration and movement in the toes or feet (eg, when
the toe is moved up or down) , Loss of the ability to sense pain, light touch and temperature
in the toes or feet , Loss or reduction of the Achilles tendon reflexMore extensive testing,
other studies like nerve conduction studies, nerve biopsy, or imaging tests (eg, x-ray or CT
scan), is not usually needed to diagnose diabetic neuropathy.
                                                                                         John F. dashe., (2010)
            Diabetic peripheral neuropathy treated with main three components that is, Tight
control of blood sugar levels, Care for the feet to prevent complications and Control of pain
caused by neuropathy.
                                                                                                     Soulis., (2006)
           Lifestyle modification included advice on physical activity (30 min of brisk walking
per day) and reduction in total calories, refined carbohydrates and fats, avoidance of sugar,
and increase in fiber-rich foods are used as an effective management of diabetic peripheral
neuropathy.
 Andrews athams., (2005)
            Begonia roxburghii, Calamus tenuis, Callicarpa arborea, Cuscuta reflexa, Dillenia
indica  are  the  plants  used  to  control  the  glucose  level  and  help  to  prevent  diabetic
complications.
Ethnopharmacol., (2012)
           Allium sativum is more commonly known as garlic,  and is thought  to offer
antioxidant properties and micro-circulatory effects and prevent diabetic micro and macro
vascular problems.
Diabetes .co.uk.,(2012)
          The benefits of exercise in patients with diabetes, may include the reduced heart
disease, prevention of diabetes in those at high risk, improved muscle sensitivity to insulin,
better blood sugar control, better blood cholesterol profiles, better blood pressure control,
potential weight loss, improved general sense of well being
Medicine., (2014)
          Buerger allen exercises is a specific exercises for diabetic peripheral neuropathy.  In
this the legs are elevated for 2 to 3 minutes, down 5 to 10 minutes and then flat on the bed
for 10 minutes. It helps to improve circulation to the feet and legs.  
Arthur. W., (2012)
 
          Exercise that involves being upright and putting pressure on the feet, called weight-
bearing exercise, can increase the chance of injury to the  feet. But simple foot exercises like
foot massage, foot rolling foot bending, marching and walking is helpful to prevent diabetic
nerve complications and help to promote circulation to the lower extremities.
Madline vann., (2011)
         The nursing care of patients those with diabetic peripheral neuropathy are difficult to
manage because of their range of pain symptoms and their need for higher levels of pain
medication.  Enhancing a  solid  knowledge base for  the various causes  of  nerve  damage
leading to nerve pain can help the advanced practice nurse to choose effective therapeutic
options. With so many medications to treat a wide variety of symptoms, it can be hard for
nurse practitioners to prescribe the best medication. By dividing the medications into tiers
based on efficacy, Nurse Practitioners will be able to effectively treat Diabetic Peripheral
Neuropathy. Effectively treating patient’s pain will optimize health care resources. 
Carol Wamboldt., (2012)
            Diabetic complications such as poor circulation and nerve damage can result in loss
of sensation and slower wound healing in  the lower extremities,  which can lead to  the
formation  of  diabetic  foot  ulcer.  Diabetic  patients  are  encourage  to  follow a  daily  leg
exercises , foot care regimens like washing , and inspecting the foot proper fitting shoes can
prevent major complications. 
                                                                       Juliehumpton., (2010)            
        The World Diabetes Day 2014 campaign marks the first of a three-year (2014-16)
focus on “healthy living and diabetes”. This year's activities and materials will specifically
address the topic  of healthy eating and its  importance both in  the prevention of type 2
diabetes and the effective management of diabetes to avoid complications. All campaign
activities will be continue to be informed by the slogan "Diabetes: protect our future."The
campaign will continue to promote the importance of immediate action to protect the health
and well-being of  future  generations  and achieve meaningful  outcomes for  people  with
diabetes and those at risk.
 International diabetes federation.,(2014)
            Based on these alarming figures Government of India started National Diabetes
Control Program on pilot basis during 7th Five year plan in 1987, but due to paucity of
funds in subsequent years this program could not be expanded further in remaining years.
The main objectives are, Prevention of diabetes through identification of high risk subjects
and  early  intervention  in  the  form of  health  education,  Early  diagnosis  of  disease  and
appropriate treatment morbidity and mortality with reference to high risk group, Prevention
of acute and chronic metabolic, cardiovascular, renal and ocular complication of the disease,
Provision of equal opportunity for physical attainment and scholastic achievement for the
diabetic patients, Rehabilitation of those partially or totally handicapped diabetes people. 
National Institute of Health and Family Welfare.,(2009)
           The Ministry of Health spearheaded a national consultation in 2005 to "identify
action pathways and partnerships for implementing the Global Strategy in the context of
India".  To  contain  the  increasing  burden  of  Non-Communicable  Diseases,  Ministry  of
Health and Family welfare, Government of India, has launched the National Program on
Prevention and Control of Diabetes, Cardiovascular diseases and Stroke on 8th January 2008
with  the  following  objectives:  Prevention  and  control  of  Non  Communicable  Diseases
Awareness generation on lifestyle changes, Early detection of Non Communicable Diseases,
Capacity building of health systems to tackle Non Communicable Diseases.
Ramesh varma., (2012)
NEED FOR THE STUDY:
             Diabetic Peripheral neuropathy is nerve damage caused by chronically high blood
sugar and diabetes. About 60% to 70% of all people with diabetes will eventually develop
painful  diabetic  peripheral  neuropathy,  people  with  diabetes  can  reduce  their  risk  of
developing nerve damage by keeping their blood sugar levels as close to normal as possible.
Webmed.,(2014)
In worldwide diabetes mellitus  is rapidly emerging as a global health problem that
threatens to assume a pandemic level by 2030.The total number of  persons with diabetes
and its complications is projected to rise from 170 million in 2000 to 366 million by 2025.
Diabetes is a silent epidemic , there are 246 million people in the world living with diabetes.
This is almost 6% of the world's adult population.
                                                           Andrew. J.M. boulton .,(2013) 
Annual  incidence  of  54  per  100,000  has  been  reported  for  diabetic  peripheral
neuropathy in an urban general population in the UnitedKingdom.  prevalence estimates
within the diabetes population ranged from 16.3% to 50% This variability in prevalence is
likely due to differences in definition, method of assessment, and patient selection, 28.5% of
individuals with diabetes were estimated to have peripheral neuropathy defined as at least
one insensate area upon monofilament testing of both feet.
National Health and Nutrition Examination Survey., (2013)
According  to  American  diabetic  association  criteria,  the  prevalence  of  diabetic
neuropathy was 4.7% in the urban and 1.9% in the rural areas. The prevalence of diabetic
peripheral neuropathy according to WHO criteria was 5.6% and 2.7% among urban and
rural areas respectively.
                                                                               Fatima .,(2010)
          Diabetes in Asians is five times the rate of the white population.
                                                                                                Med India .,(2014)
          In India an overall prevalence of diabetic peripheral neuropathy was 2.1% in urban
areas and 1.5% in rural areas. From the available region wise population based studies it is
clear that in the last two decades, there has been a marked increase in the prevalence of
diabetic peripheral neuropathy among both urban as well as the rural Indians, with southern
India having the sharpest increase.
                                                                                    Mohan Pradeepa .,(2007)
           The world wide incidence rate for diabetic peripheral neuropathy in men was 5.5%;
and women 5.9% The incidence rate of impaired fasting glycaemia was 4.5% among the
men and 3.5% among the women whereas the incidence rate of impaired glucose tolerance
was 7.3% among the men and 8.5%  among the women. 
Hiroshi.et.al., (2014) 
           In North India prevalence studies in the rural areas were conducted in which reported
that the prevalence of diabetic neuropathy in a rural locality near Delhi was 1.5 %. The
prevalence has been reported to vary between 1.5 % in Delhi  and 3.7% in Nagpur in rural
areas. A prevalence of 4.6% was reported  from Pohir, a rural area in Punjab, which was
relatively higher compared to earlier surveys done in different cities.
                                                                                           John., (2008)
             In Kolkata the earliest documented study on prevalence of diabetic peripheral
neuropathy was done Out of the 96,300 medical records checked, 38% was found to have
diabetic neuropathy was diagnosed.
                                                                                                   Raymen., (2007) 
Recently a National control of disease risk factor surveillance was conducted in six
different geographical locations in India. There was a geographical difference in the overall
prevalence of  self-reported diabetes,  with the centres in  southern states having a higher
prevalence  [Trivandrum  (9.2%);  Chennai  (6.4%)]  compared  with  north  [Delhi  (6.0%);
Ballabgarh  (2.7%)],  east  [Dibrugargh  (2.4%)]  and  west/central  India  [Nagpur  (1.5%)].
Similar trends were observed even when categorized based on residential areas as urban,
periurban/slum and rural areas, except for urban areas where Delhi had higher rates (10.3%)
than Chennai (8.7%) and Dibrugarh (5.5%) had higher rates than Ballabgarh (4.8%)
                                                                          Michele .,(2014)
            In South India 60-70% of people with diabetes have some form of neuropathy and
75% peripheral neuropathy. The highest rates of neuropathy are among people who had
diabetes for the past 25 year.  Any organ of the body can be affected by diabetes and among
the micro vascular complications of diabetes, neuropathy results in significant disability and
morbidity.           
                                                              Matsuo .et.al., (2013)
In  Bangalore  the prevalence of  peripheral  neuropathy was 64.1%, of  which only
35.8% had adequate knowledge about peripheral neuropathy and its prevention. The study
concluded  that  there  is  a  need  for  educating  the  people  with  diabetes  regarding  early
assessment  of  peripheral  neuropathy  and  must  be  motivated  to  perform  the  clinical
assessment annually on physician consultation.
                                                                     Stevens .M.J .et.al., (2011)
    
           In Kerala prevalence of diabetes is very high. A study from central Kerala reported a
prevalence of diabetes at 20% and prediabetes at 11%. Another study from southern Kerala,
showed a wide urban-rural gradient in age-standardized (30-64 years) prevalence of diabetes
indicating an important role of lifestyle factors. The prevalence was 17% in urban, 10% in
the midland, 7% in the highland, and 4% in the coastal regions
Reddy K.S., (2014)
           The study showed that the age standardized prevalence of diabetic peripheral
neuropathy  was  12.1%.  The  prevalence  in  Chennai  (13.5%),  it  was  the  highest  rate  of
incidence in Tamil Nadu.
                                                                                                    Gerry .,(2012)
          The prevalence of diabetes in Chennai increased by 39.8 percent (8.3 to 11.6%);
between 1995 to 2000 by 16.3 percent (11.6 to 13.5%) and between 2000 to 2004, by 6.0
per  cent  (13.5  to  14.3%).  Thus  within  a  span  of  14  years,  the  prevalence  of  diabetes
increased significantly by 72.3 per cent.        
                                             Mohan.,(2009) 
           The prevalence of diabetic peripheral neuropathy in coimbatore was 48.1%, of which
was relatively higher compared to earlier surveys.
       Stephenson.et.al., (2013)
              The prevalence of diabetic peripheral neuropathy in erode was 67.1%, of which
only 28.6% had adequate knowledge about peripheral neuropathy and its prevention and
19.98%  people  had  foot  ulceration  due  to  improper  awareness  of  diabetic  peripheral
neuropathy. 
Thomas.P.K., (2013)
Steenkiste.et.al.,(2011) conducted a study on effects of diabetic leg exercises on pain
and sleep, patients with diabetic peripheral neuropathy in pensylvania. Quasi experimental
design  was  used.48  patients  from  diabetic  clinic  were  randomly  selected  and  before
exercises the pain and sleep level was assessed. The exercises consisted of walking, foot
massage, foot rolling, calf muscle exercises and marching. Significant improvement was
shown  in  on  sleep  scale  from  medical  outcome  of  study  (n =  40)  from  67.1 to
72.4, neurological  symptom  score  was  improved  from  6.5(2.3)  to  3.9(0.65)
(p=0.007),sensory and motor impairment score was improved with 17.7(2.15) to 13.5(1.71)
(p=0.003) (t=8.39: p=0.001). 
    
                                  
Stenward.et.al.,(2011) conducted a study to determine the effectiveness of aerobic
diabetic leg exercises on pain and anxiety among diabetic peripheral neuropathy patients in
china .  The sample size was 50.  True experimental  design was used in  this study. The
samples receives 30 minutes of leg exercises. And also the patients encouraged to walk 15
minutes per day. The exercises was continue for 3 weeks. The data were collected using
leeds assessment of neuropathic symptoms and signs scale and hospital anxiety scale. The
result shows that experimental group has significant improvement than the control group
(7.57±2.71pre/4.67±3.71post)  for  pain  and  for  anxiety  (5.50±3.68pre/3.5±2.71post),
(p=0.0073)  (t=10.21) 
Barbosa.et.al.,(2011) conducted  a randamised  control trial to evaluate the effect of
low level foot exercises on pain and sleep among diabetic peripheral neuropathy patients in
hospital  setting  in  united  states.  40  male  and  female  patients  with  painful  diabetic
neuropathy participated in this study. Their ages ranged from 35 to 60 years with a mean of
52.1 ± SD 4.7 years.  Patients  were  randomly  assigned  into  two  equal  groups  of  20,  an
experimental  and  a  control  group.  The  exercises  group  received  foot  exercises  for  40
minutes  per  day  for  a  period  of  20  days.  Pain  intensity  via,  Leeds  Assessment  of
Neuropathic Sign and Symptoms Scale, and Sleep Scale from Medical outcome of Study are
evaluated pre- and post for both groups. Pain was significantly decreased from 10.21 to 5.37
(p ≤ 0.05) and sleep score were significantly improved from 43.2 to 61.9 (p ≤ 0.05) in the
exercise  group  and  it  had  a  negative  relationship  with  pain  and  sleep  in  experimental
group(r=-0.8), while no significant change was obtained in the control group. Low level
exercises and technique could be an effective therapeutic modality in reducing pain and
improving sleep in patients with diabetic peripheral neuropathy.
         The researcher observed during clinical experiences in Erode hospitals that the
patients with diabetic peripheral neuropathy having more pain and they feel insomnia. The
medication  therapy  was  given  out  of  many  side  effects  like  drug  resistance  and  other
complications. The researcher felt to help the patients to use exercises to ease them and to
reduce pain and to improve sleeping pattern.
STATEMENT OF THE PROBLEM:
            A study to evaluate the effectiveness of exercises on pain and sleep among patients
with diabetic peripheral neuropathy in selected hospitals, Erode.
OBJECTIVES:
• To  assess  the  pretest  and  post  test  level  of  pain  among  patients  with  diabetic
peripheral neuropathy in experimental and control group.
• To assess  the  pre  test  and  post  test  level  of  sleep  among  patients  with  diabetic
peripheral neuropathy in experimental and control group.
• To  compare  the  pre  and  post  test  level  of  pain  among  patients  with  diabetic
peripheral neuropathy in experimental group.
• To  compare  the  pre  and  post  test  level  of  sleep  among  patients  with  diabetic
peripheral neuropathy in experimental group.
• To find the effectiveness of exercises on pain among patients with diabetic peripheral
neuropathy between experimental and control group.
• To  find  the  effectiveness  of  exercises  on  sleep  among  patients  with  diabetic
peripheral neuropathy between experimental and control group.
• To find the relationship between the post test level of pain and sleep among patients
with diabetic peripheral neuropathy in experimental group.
• To find the association between post test level of pain among patients with diabetic
peripheral  neuropathy  with  their  selected  demographic  variables  in  experimental
group.
• To find the association between post test level of sleep among patients with diabetic
peripheral  neuropathy  with  their  selected  demographic  variables  in  experimental
group.
OPERATIONAL DEFINITIONS:
Effectiveness: 
“It means producing an intendend result 
                                                    Erlentson.,(2007)
In this study effectiveness refers to extent of exercises has brought out about the
significant difference between pre and post test which is measured in terms of brief pain
inventory scale and sleep scale among patients with diabetic peripheral neuropathy by using
statistical measurements and its score.
Exercise:
It means activity requiring physical effort, carried out to sustain or improve health
and fitness.
                                                                      Medical dictionary.,(2007)
In this study exercises refers to the exercises practiced 30mts of aerobic exercise
technique once in a day. The 30 minutes exercises consist of ten steps. They are,
STEP-I
Foot massage :
Inspect the feet before starting the massage. Look for discoloration such as bluish
purple spots, redness, sores, cracks in the skin, fungus on the toenails , dark spots, cold areas
or  anything  else  that  stands out  as abnormal.  Be sure  to  look in  between the  toes  and
encourage the client to do the same every day. If they cannot reach their feet, have them
place in a mirror on the floor to view their feet carefully. Experiment with light pressure
while inspecting the feet. This should take about two minutes.
Begin with some light compression, using the whole hand. Spend about one minute
on each foot lightly compressing the plantar and dorsal surfaces and all but tissue from the
toes to the knee.
 STEP II
Foot rolling exercises:
         Sit in a chair with back straight, knees together. Lift right foot off the floor,  place a
round thick plastic bottle under the foot. Start to move the bottle front and back. Do this
exercise five times. Lower the right foot to the floor and repeat the exercise with left foot.
STEP-III
Stretching the calf muscles:
         Lean with the palms of the hand against a wall. Keep feet some distance away, the
heels firmly on the floor. Bend arms 10 times, keeping back and legs straight.
STEP-IV
Tiptoe exercise:
        Hold to a chair and raise and lower the body on the toes of one foot then the other.
STEP-V
Leg bends:
         Hold chair. Put one foot forward and lower body straight down, keeping both feet on
floor. Raise and lower 10 times. Change legs.
STEP-VI
Heel Raising:
        Get up on the toes and then down on heels, about 20 times. Also try putting the whole
first on one leg and then the other.
STEP-VII
Leg Sweeps:
          Stand with one leg slightly raised, on a book for example. While holding to a chair or
table swing the other leg back and forth 10 times. Change to the other leg. Repeat  it.
STEP- VIII
Wave your feet:
         Sit down on the floor and lean backwards. Shake the feet until they are relaxed and
warm. 
STEP-IX
Sitting leg pointers
          Sit in a chair with back straight, knees together. Lift the right foot off the floor,
straightening the right knee at the same time. Point the toes into the distance. Holding the
leg out straight. Circle the ankle joint clockwise, then counterclockwise five times. Lower
the right foot to the floor and repeat the exercise with the left foot.
STEP-X
March exercise:
            Stand straight in a place. March in place lifting the knees higher each times.  
           Total duration of the exercises is 30minutes one session per day for 15 days
individually for improving the sleep and reduce the pain.
Pain:
Pain has been defined as “an unpleasant sensory or emotional experience associated
with actual or potential tissue damage”. 
                                                                         Odendal .,(2014)
In this study the pain refers the level of pain in foot among patients with diabetic
peripheral  neuropathy  which  is  measured  by  using  Leeds  Assessment  of  Neuropathic
Symptoms and Signs Scale and their scores.
Sleep:
Sleep is  a  period  of  rest  for  the  body  and  mind,  during  which  volition  and
consciousness are in abeyance and bodily functions are partially suspended; also described
as  a  behavioral  state,  with  characteristic  immobile  posture  and  diminished  but  readily
reversible sensitivity to external stimuli.
                                                                            Medical dictionary .,(2007)
In  this  study  the  sleep  refers  to  the  level  of  sleep  among  patients  with  diabetic
peripheral neuropathy which is measured by using sleep scale from medical outcome of
study and its scores.
Patients with Diabetic peripheral neuropathy:
Diabetic peripheral neuropathy is nerve damage that occurs because of the metabolic
degenerations of nerves associated with diabetes mellitus.
                                                                                              Lewis., (2007)
In this study it refers to the persons diagnosed with diabetic peripheral neuropathy by
using vibrometer with the age group of above 30 years, who are admitted in the ward for
minimum stay of 16 days with underlying treatment. 
HYPOTHESES:
H1 : The mean post test level of pain score is significantly 
lower than the mean pre test level of pain score in experimental group.
H2 : The mean post test level of sleep score is significantly 
higher  than  the  mean  pre  test  level  of  sleep  score  in
experimental group.
H3 : The mean post test level of pain score in experimental 
group is significantly lower than the mean post test level 
of pain score in control group.
H4 : The mean post test level of sleep score in experimental 
group is significantly higher than the mean post test level
of sleep score in control group.
H5 : There will be a significant relationship between post test 
level of pain score and post test level of sleep score among patients
with diabetic peripheral neuropathy in experimental group.
H6 : There will be a significant association between post test 
level of pain score among patients with diabetic peripheral neuropathy
and their selected demographic variables in experimental group.
H7 : There will be a significant association between post test 
level  of  sleep  score  among  patients  with  diabetic
peripheral neuropathy and their selected demographic variables.
ASSUMPTIONS:
¾ Diabetic peripheral neuropathy patients experience pain and  insomnia
¾ Nurses play a vital role in reducing the level of pain and improving sleep pattern
among patients with diabetic peripheral neuropathy.
DELIMITATION:
This study is de limited to,
e) Data collection period was 6 weeks
f) Sample size was limited to 60
PROJECTED OUTCOME:
             Exercises helps to maintain the peripheral blood flow thus it reduce the level pain
and improve sleep pattern. It helps to reduce the cost and duration of treatment. It promotes
comfort and improves the activity of daily living.
ii) CONCEPTUAL FRAME WORK
             Conceptual frame work helps to express about abstract ideas in a more reality,
understandable,  or  precise  form of the original  conceptualization.  The conceptual  frame
work  for  this  study  was  direction  from general  system theory  (Ludwig  von  bertlanffy,
1968).
         According to general system theory system is a set of interacting parts in a boundary
which makes the system work well to achieve its overall objectives.
          General system theory is useful in breaking the whole process into essential task to
assure goal realization. The system is a set of elements which is in constant interaction with
the environment, which is organized for the accomplishment of a goal. The aim of the study
was  to evaluate  the  effectiveness  of  exercises  on  pain  and  sleep  among  patients  with
diabetic peripheral neuropathy.
Bertlanffy explained that the system has 4 major concepts
 Input 
 Through put
 Output 
 Feedback 
INPUT:
        According to  theory,  input  is  the  information  that  enters  into  the  system from
environment through its boundaries.
       In this study, the input includes demographic variables such as Age, sex, marital status,
educational  status,  religion,  occupation,  family monthly income, type of family,  area of
residence,  duration  of  diabetic  peripheral  neuropathy,  duration of  treatment  for  diabetic
peripheral neuropathy, assessing pretest level of pain and sleep by Leeds Assessment of
Neuropathic Symptoms and Signs Scale and Sleep Scale from Medical Outcome of Study in
experimental and control group.
THROUGHPUT:
       According to theory, throughput is the operational phase. It is the process that allows
the input to be transformed to the system.
       In  this  study  it  is  the  exercises  done  with  the  method, Exercises  like Foot
massage ,Foot rolling exercises,  Stretching the calf muscles, Tiptoe exercise, Leg bends,
Heel raising, Leg sweeps, Wave your feet, Sitting leg pointers, March exercise given to the
patients with diabetic peripheral neuropathy for 30 minutes a day for a period of 15 days in
experimental group.
 OUTPUT:
        According to  theory,  output  is  the  product  of  the  system which results  from the
process of throughput.
In this study, it is the assessment of the posttest level of pain by Leeds Assessment of
Neuropathic Symptoms and Signs Scale in experimental and control group. The  pain level
was interpreted as non neuropathic pain, Mild neuropathic pain, Moderate neuropathic pain,
Severe  neuropathic  pain.  And  the  posttest  level  of  sleep  by  sleep  scale  from  medical
outcome of study in experimental and control group. The sleep score was interpreted as
Good sleep, Poor sleep, Very poor sleep
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INPUT THROUGH PUT OUTPUT
DEMOGRAPHIC
VARIABLE: 
Age,  Sex,  Marital
Status, Educational Status,
Occupation,  Religion,
Family  Monthly  Income,
Type Of Family, Area Of
Residence,  Duration  Of
diabetic  peripheral
neuropathy,  Duration  Of
Treatment  For  Diabetic
Peripheral Neuropathy.
PRETEST:
Assessment  of  level  of
pain by Leeds Assessment
of Neuropathic Symptoms
and Signs Scale, and sleep
by  Sleep  Scale  From
Medical  Outcome  of
Study in experimental and
control group
Planned for 
diabetic 
peripheral 
neuropathy 
foot exercises 
in experimental
group
EXERCISES: 
Exercises  like
Foot  massage  ,Foot
rolling  exercises,
Stretching  the  calf
muscles,  Tiptoe
exercise,  Leg  bends,
Heel  raising,  Leg
sweeps,  Wave  your
feet,  Sitting  leg
pointers,  March
exercise given  to  the
patients  with  diabetic
peripheral  neuropathy
for  30  minutes  a  day
individually  for  a
period  of  15  days  in
experimental group. 
POST TEST:
      Assessment of
pain  by  Leeds
Assessment  of
Neuropathic
Symptoms  and
Signs  Scale  in
experimental  and
control group
POST TEST:
        Assessment
of  sleep by Sleep
Scale  From
Medical  Outcome
of  Study  in
experimental  and
control group.
 
• Non neuropathic
pain
• Mild 
neuropathic pain
• Moderate 
neuropathic pain
• Severe 
neuropathic pain
• Good sleep
• Poor sleep
• Very poor sleep
FEEDBACK
Fig:1 CONCEPTUAL FRAME WORK BASED ON MODIFIED LUDWIG VON BERTLANFFY SYSTEM
THEORY(1968)
CHAPTER-II
REVIEW OF LITERATURE
           This chapter deals with the related review of literature. The literatures
are classified under the following headings:
PART-I
       Over view of
F. Diabetic peripheral neuropathy
G. Exercises 
H. Pain 
I. Sleep  
PART-II
Section A :   Studies  related  to  incidence
and prevalence of diabetic Peripheral neuropathy
Section B      :  Studies  related  to  pain  on  diabetic  peripheral
neuropathy
Section C   :  Studies  related  to  sleep  on
diabetic peripheral neuropathy 
Section D : Studies related to effectiveness
of exercises on pain and sleep among patients with
diabetic peripheral neuropathy  
Section E   :  Studies related to nurses role in exercises on pain
and sleep among patients with diabetic peripheral
neuropathy. 
PART-I
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a)  DIABETIC PERIPHERAL NEUROPATHY
INTRODUCTION:
Diabetes can cause a  number of problems that  creep up slowly.  The
most common of these is nerve damage in the feet and hands. This kind of
nerve damage can lead to different kinds of symptoms, such as numbness or
lack  of  muscle  control.  But  the  most  common  and  troublesome   problem
caused by nerve damage is a burning or tingling pain.
American academy of neurology foundation.,(2011)
DEFINITION:
Diabetic peripheral neuropathy is a  non-inflammatory disease process
associated with diabetes mellitus and characterized by  sensory and/or motor
disturbances in  the peripheral nervous system. Patients commonly experience
degeneration of sensory nerves and pathways. 
Medical dictionary., (2013)
INCIDENCE:
About  60%-70%  of  patients  with  diabetes  have  some  degree  of
neuropathy, with neurological complications occurring equally in type 1 and
type 2 diabetes. The  most common type of neuropathy affecting persons with
diabetes is sensory neuropathy. This can lead to the loss of sensation in the
lower extremities., and  coupled with other factors, this significantly increases
the risk for complications that result in a lower limb amputation. More than
60% of nontraumatic amputations in the united states occurs in people with
diabetes.                                               
                                                       Lewis.,(2007)
ETIOLOGY / RISK FACTORS:
The risk factors are ,
• Have poor blood sugar control
•  Have had diabetes a long time
• Have high blood pressure
• Smoke
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• Diabetes -  this  is  the  most  common  cause  of  chronic  peripheral
neuropathy in Europe. The high blood sugar (glucose) levels in people
with poorly controlled diabetes lead to the nerve damage. 
• Dietary deficiencies - B12 or folate vitamin deficiencies can cause nerve
damage and peripheral neuropathy.
The ends of the longest nerve fibers are usually the first to be
damaged by high blood sugar levels. That’s why pain is often felt first in
the feet, then in the hands—parts of the body farthest from the brain and
spinal cord. This type of pain is sometimes called the “stocking-glove”
pattern. 
                                                                Raymen ., et.al., (2008)
TYPES OF NEUROPATHY :
SENSORY NEUROPATHY:
The  most  common  form  of  sensory  neuropathy  is  distal  symmetric
neuropathy. Some times referred to as “stocking –glove  neuropathy“.  Loss of
sensation , abnormal sensations, pain and paresthesias present. The patient may
report a feeling of walking on pillows or numb feet. It cause atropy of the small
muscles of the hands feet causing deformity and limiting fine movements.   
AUTONOMIC NEUROPATHY:
It  can  affect  nearly  all  body  system  and  lead  to  hypoglycemic
unawareness , bowel incontinence and diarrhea and urinary retention. Delayed
emptying  is  the  complication.  Postural  hypotention,  resting  tachycardia,
painless myocardial infarction will occur. 
                                                                                     Lewis.,(2007)
TYPES OF DIABETIC PERIPHERAL NEUROPATHY:
Acute Peripheral Neuropathy:
• Often abrupt onset and not related to duration of diabetes.
• Can resolve completely.
• Burning foot pain, often worse at night.
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• Associated with poor glycaemic control but sometimes initially follows
establishing good glycaemic control.
• Examination may be normal apart from hyperaesthesia.
Chronic Peripheral Neuropathy:
• Sensory nerves are affected more than motor.
• Touch,  pain  and  temperature  sensation  and  proprioception  in  lower
limbs in a glove and stocking distribution.
• Loss of ankle jerks and, later knee jerks.
• Hands are only affected in severe long-standing neuropathy.
• Equal prevalence in types 1 and 2.
Classification of diabetic peripheral neuropathy according to the number
of nerves affected:
Mononeuropathy:
Where only one nerve is damaged, the term used is mononeuropathy. 
Poly neuropathy:
When multiple nerves are damaged, the term used is polyneuropathy. 
Webmed.,(2013)
PATHOPHYSIOLOGY:
The pathophysiologic process of diabetic peripheral neuropathy are not
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well  understood.  Several  theories exist  ,  including metabolic ,  vascular  and
autoimmune elements.
 
Wedmed.,(2011)
CLINICAL MANIFESTATION:
The pain caused by nerve damage can be more intense than other types
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HYPERGLYCEMIA
• Direct neuronal injury
• Oxidative stress/free 
radicals
• Advanced glycation 
products
• Sorbitol pathway
• Poor myelinization
• Genetic polymorphisms
• Protein kinase C 
activation
• Mitochondrial injury
• Expression stress genes
• Altered neuroleptic 
factors
• Lipid peroxidation
• Apoptosis 
Microvascular disease 
• Microthrombosis
• Thrombomodulin 
deficiency
• Basement membrane 
changes
• Loss of nitric oxide 
vasodilation 
• Lipid peroxidation 
• Nerve hypoxia
Life style 
environment
DIABETIC PERIPHERAL NEUROPATHY
of long term pain. The pain can take many forms, including:
¾ Tingling
¾ Burning
¾ Prickling
¾ Cramping
¾ Extreme sensitivity to touch
 
Diabetic  nerve  pain  is  often  worse  at  night.  This  can  disrupt  sleep,
leading  to  difficulty  with  thinking  and  memory,  mood  changes,  and  lower
quality of life.
OTHERS 
¾ Complete or partial loss of sensation  and temperature
¾ Foot injury and ulceration
¾ Hypoglycemic unawareness 
¾ Bowel incontinence
¾ Diarrhea 
¾ Urinary retention
¾ Anorexia
¾ Nausea
¾ Vomiting
¾ Gastro esophageal reflex disease
¾ Fullness feeling
¾ Postural hypotension
¾ Resting tachycardia
¾ Painless myocardial infarction
¾ Sexual function disturbances 
¾ Erectile dysfunction
¾ Restless leg syndrome
                                                                          Jeremy ., (2011)
Definition of restless leg syndrome:        
Restless legs syndrome (RLS) is a condition in which patient have an
uncontrollable urge to move the legs, usually due to leg discomfort.  It typically
happens in the evenings or nights while sitting or lying down. Moving eases the
unpleasant feeling temporarily. Restless legs syndrome, now known as restless
legs syndrome/Willis-Ekbom disease (RLS/WED). It can disrupt sleep leading
to daytime drowsiness  and make traveling difficult.
                                                                              Jeremy ., (2011)
Causes of Restless Legs Syndrome:
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In most cases, doctors do not know the cause of restless legs syndrome;
however, they suspect that genes play a role. Nearly half of people with RLS
also have a family member with the condition.
Other factors associated with the development or worsening of restless
legs syndrome include:
• Chronic  diseases. Certain  chronic  diseases  and  medical  conditions,
including iron deficiency, Parkinson’s disease, kidney failure, diabetes,
and  peripheral  neuropathy often  include  symptoms  of  RLS.  Treating
these conditions often gives some relief from RLS symptoms.
• Medications.Over-the-counter sleeping pills, Antihistamines (found in
many cold and allergy pills such as Benadryl, NyQuil, and Dimetapp),
Anti-nausea  medications  (such  as  Antivert,  Compazine,  and
Dramamine),  Calcium channel  blockers  (used for  high blood pressure
and  heart  problems),   Antidepressants  (such  as  Prozac,  Effexor,  and
Lexapro),  Antipsychotics (used for bipolar disorder and schizophrenia)
• Pregnancy. Some women experience RLS during pregnancy, especially
in the last trimester. Symptoms usually go away within a month after
delivery.
• Other factors, including alcohol use and sleep deprivation, may trigger
symptoms or make them worse. Improving sleep or eliminating alcohol
use in these cases may relieve symptoms.
Webmed .,(2014)
 
Symptoms of Restless Legs Syndrome:
People with restless  legs syndrome have uncomfortable  sensations in
their legs (and sometimes arms or other parts of the body) and an irresistible
urge  to  move  their  legs  to  relieve  the  sensations.  The  condition  causes  an
uncomfortable, "itchy," "pins and needles," or "creepy crawly" feeling in the
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legs. The sensations are usually worse at rest, especially when lying or sitting. 
 The  severity  of  RLS  symptoms  ranges  from  mild  to  intolerable.
Symptoms can come and go and severity can also vary.  The symptoms are
generally worse in the evening and at night and less severe in the morning. For
some people,  symptoms may cause severe nightly sleep disruption that  can
significantly impair a person's quality of life. 
Webmed., (2014)
Diagnosis of Restless Legs Syndrome:
There is no medical test to diagnose restless legs syndrome; however,
doctors may use blood tests and other exams to rule out other conditions. The
diagnosis  of  restless  legs  syndrome  is  based  on  a  patient’s  symptoms  and
answers  to  questions  concerning  family  history  of  similar  symptoms,
medication  use,  the  presence  of  other  symptoms  or  medical  conditions,  or
problems with daytime sleepiness.
Neil .et.al., (2013)
Treatment for Restless Legs Syndrome:
Treatment for RLS is targeted at easing symptoms. In people with mild
to  moderate  restless  legs  syndrome,  lifestyle  changes,  such  as  beginning  a
regular exercise program, establishing regular sleep patterns, and eliminating or
decreasing the use of caffeine, alcohol, and tobacco, may be helpful. Treatment
of an RLS-associated condition also may provide relief of symptoms.
Other non-drug RLS treatments may include:
• Leg massages
• Hot baths or heating pads or ice packs applied to the legs
• Good sleep habits
• A vibrating pad called Relaxis
Medications may be helpful as RLS treatments, but the same drugs are
not helpful for everyone. In fact, a drug that relieves symptoms in one person
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may worsen them in another. In other cases, a drug that works for a while may
lose its effectiveness over time.
Drugs used to treat RLS include:
• Dopaminergic drugs, which act on the neurotransmitter dopamine in the
brain. Mirapex, Neupro, and Requip are FDA approved for treatment of
moderate  to  severe  RLS.  Others,  such  as  levodopa,  may  also  be
prescribed.
• Benzodiazepines, a class of sedative medications, may be used to help
with sleep, but they can cause daytime drowsiness.
• Narcotic pain relievers may be used for severe pain.
• Anticonvulsants,  or  antiseizure  drugs,  such  as  Tegretol,  Lyrica,
Neurontin, and Horizant.
• Although there is no cure for restless legs syndrome, current treatments
can help control the condition, decrease symptoms, and improve sleep  
Webmed .,(2014)
Medications: 
Sleep  quality  is  also  influenced  by  certain  drugs.  The  drugs  which
decrease REM sleep are barbiturates, amphetamines and antidepressants. Short-
acting benzodiazepines are used to  initiate  and maintain sleep.  These drugs
may  act  by  stimulating  an  inhibitory  neurotransmitter  called  gamma-amino
butyric acid (GABA) and induce the rapid onset of sleep but they suppress
deep sleep as well as REM sleep.
Lippincott., (2009)
DIAGNOSTIC  STUDIES  FOR  DIABETIC  PERIPHERAL
NEUROPATHY:
Diabetic  peripheral  neuropathy  is  diagnosed  based  upon  a  medical
history and physical examination of the feet. During an examination, there may
be signs of nerve injury, including:
¾ Loss of the ability to sense vibration and movement in the toes or feet
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(eg, when the toe is moved up or down)(vibrometer assessment)
¾ Loss of the ability to sense pain, light touch and temperature in the toes
or feet
¾ Loss or reduction of the Achilles tendon reflex
¾ Michigan neuropathy screening tool
                                                                                      Margeret .,(2010)
GRADING OF DIABETIC PERIPHERAL NEURPATHY:
An alternative approach to estimating severity is to indicate severity by
grades. Dyck described the stages of severity: 
• Grade 0 = no abnormality of Nerve Conduction, 
• Grade 1a = abnormality of Nerve Conduction,
• Grade 1b = Nerve Conduction abnormality of stage 1a plus neurologic
signs typical of diabetic neuropathy but without neuropathy symptoms
• Grade 2a = Nerve Conduction abnormality of stage 1a with or without
signs (but if present, <2b) and with typical neuropathic symptoms
• Grade  2b  = Nerve  Conduction  abnormality  of  stage  1a,  a  moderate
degree of weakness (i.e.,  50%) of ankle dorsiflexion with or  without
neuropathy symptoms.
Salomon tesfaye.,(2013)
INSTRUMENTS USED TO DIAGNOSE THE NEUROPATHIC SIGNS 
AND SYMPTOMS:
Monofilaments-5.07/10gm:
Monofilament 10gm is a sensory testing tool that is used to detect the
level of insensate foot. 10gm Monofilament offered by us is designed as per the
recommendation  of  World  Health  Organization  and  International  Diabetes
Federation.  This  device is  ideal  for  early detection of  neuropathy allowing
secondary prevention measures to check non-traumatic lower-limb amputation.
It is designed to buckle when a 10gm of force is applied to it when it is in
contact with the body.  (fig: 1)
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Fig 1: Monofilament
VIBRATIP:
It  is a  wipe-clean,  pocket-sized  device  for  testing  vibration  sense.
Vibration sense is typically one of the first sensory modalities to be impaired as
peripheral neuropathy develops.
 Graduated tuning forks (e.g. Reidel-Seiffer) and calibrated electronic
devices (e.g. Digital Biothesiometer (Vibrometer) are recommended to quantify
the integrity of vibration sensation.
VibraTip is a wipe-clean, disposable, key fob-sized device that provides
a constant and reproducible source of vibration. The spherical head facilitates
application from any angle and its pocket size means that it is easy to carry and
therefore likely to be available at the point of use. 
This  Validated  point  of  care  device  for  mass  screening  purpose  is
vibrating at 128Hz and voltage equivalent of 25Volts of a Biothesiometer.By
gently  touching  the  patient's  intact  skin  twice  with  the  rounded  tip  of
VibraTip™, each time for about half a second, explaining that 'this is touch
one' and 'this is touch two' whilst randomly activating VibraTip™ on either the
first or second touch, a sensitive and specific assessment vibration perception is
obtained. (fig:2)
46
Fig 2: Vibratip
VIBROTEST:
Sensory neuropathy increases the risk of foot ulcerations by seven folds
and peripheral arterial disease (PAD) by three folds in people with diabetes.
Peripheral neuropathy is the major causal factors in the development of foot
ulcerations among diabetic subjects.
Diabetics  with  neuropathy  have  seven  fold  increased  risk  of  foot
ulcerations. Diabetics are also exposed to 15 fold higher risk of amputation of
lower extremities compared to the general population. Vibration perception has
been shown to be strongly associated with foot ulceration. Vibration perception
threshold determination by using a Biothesiometer has been used to identify
peripheral sensory neuropathy and subjects at risk of foot ulcerations.
The  Digital  Biothesiometer  VIBROTEST is  an  electronic  instrument
designed  to  measure  the  threshold  of  appreciation  of  vibration  in  human
subjects simply and accurately.(fig:3)
Features :
• Full solid state Design
• Digital 0 to 50 Volts output indicator
• Electronic Tuning Fork
• Easy tool to quantify Neuropathy
• Cost effective Biothesiometer
• Weighs less than 3 Kg
47
Fig 3: Digital Biothesiometer
DIGITAL-BIOTHESIOMETER-VIBROMETER: 
            Digital Biothesiometer is a non-invasive tool to detect the occurrence of
neuropathy.  It  is  an  electronic  research  device  that  helps  in  detecting
neurological  diseases  on  the  threshold  of  losing  or  already  lost  sensation.
Biothesiometer  Vibrometer  is  equipped  with  a  turning  fork  which  works
electronically and has vibration strength that is slowly increased till a patient
can  feel  the  vibratory  sensation.  This  helps  to  detect  the  level  of  loss  of
sensation in the part of body.
         Biothesiometer is digital with the integrated software system, which is
compatible with the computer. The software is designed to store the patient
data and later print it according to the requirement. The tracking and storage
function of the software can be customized as per the need. (fig:4)
Features of Digital Biothesiometer:
• Digital 0 to 50 Volts output indicator
• Electronic Tuning Fork
• Easy tool to quantify Neuropathy
• Full solid state Design
• Interpretation rules can be changed by user
• Modular design makes servicing easy
• Over voltage indicate alarm
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• PC enabled
• PC reporting software is simple
• Record Key transfer the data to PC
• Serial RS232/ USB Data transfer facility
• Supplied with padded bag for easy carry
• Weighs less than 3 Kg
Fig 4: Digital Biothesiometer vibrometer
THERMOMETRY-HCP: 
           An Instrument to assess damage to the small nerve endings, which
detect changes in temperature.
          Thermometry - HCP offers an accurate measure of warm, cool and heat-
pain  thermal  sensory  thresholds,  all  clinically  useful  determinants  in  the
evaluation  of  neuropathic  pain,  diabetic  neuropathy  and  other  small-fiber
neuropathies. 
             Research has shown that diabetic neuropathy affects the peripheral
nerves, typically both small and large fibers, though this can be at different
time  intervals.  Quantitative  assessment  of  thermal  sensitivity  (small-fiber
testing) may be of value in the detection of early diabetic neuropathy, even in
patients  without  symptoms  or  signs  of  a  clinical  neuropathy.  Since  small
caliber fibers are affected before large fibers, testing the small fibers helps to
detect small fiber diabetic neuropathy two to three years earlier than possible
with traditional Electro MyoGraphic tests. (fig:5)
Features:
• Full Solid State design
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• Easy tool to quantify Polyneuropathy
• Temperature ranges from 1 to 50 oC
• Rate of change of temperature 1 oC per second
• Single probe delivers Cold and Hot sensation
• Patient safety limit beyond range
• Computer compatible
• Storage and patient report from Computer
Fig 5:Thermometry-Hcp
NEUROPATHY-ANALYZER-VIBROTHERM-DX:
        Neuropathy Analyzer model Vibrotherm Dx is an excellent tool used to
track and measure the loss of vibration and thermal perception in the part of
body. Vibrotherm Dx helps in tracking Cool, Warm, Hot and Cold Perception
Thresholds and detecting Diabetic Polyneuropathy at an early stage.(fig:6) 
• Digital 0 to 50 Volts output indicator for vibration
• Easy tool to quantify Neuropathy
• Full solid state Design Personal Computer enabled
• Offers Glycemic control to diabetic patients 
• Non-invasive tool for testing of pain thresholds
• Range: 1˚C to 50˚C (Restricted for the purpose of safety)
• Rate of change: 1˚C per second for Hot/Cold 
• Date storage on Personal Computer
• Universal Serial Bus/ Serial Right Selection232 Data Transfer
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• Easy operation with hand remote
Fig 6: Neuropathy-Analyzer-Vibrotherm-Dx
CARDIAC-AUTONOMIC-NEUROPATHY-SYSTEM-ANALYZER-
CANS-504:
              One of our most sought after devices is the Cardiac Autonomic
Neuropathy  System  Analyzer--  CANS  504  which  investigates  both
Sympathetic and Parasympathetic autonomic nervous system response of the
patient. The system is provided with ECG Cardio - Tachogram(R-R interval)
and innovative automatic NIBP (Non-Invasive Blood Pressure) module to run a
succession of Resting ECG, Deep Breathing ECG, Valsalya manoeuvre ECG,
BP response to standing ad BP response to hand grip  tests. These tests are
carried out with patients support and the PC onscreen panel aids in successful
operation.(fig(7))
Fig (7): Cardiac-Autonomic-Neuropathy-System-Analyzer-Cans-504
          All vibrometer had a total scoring of 30. That is 30 volts. In that <9volts
(0-30%) considered as normal. 9-15 (31-50%) consider as mild neuropathy, 16-
21  (51-70%)  considered  as  moderate  neuropathy  and  22-30  considered  as
severe  neuropathy  and  the  patient  had  a  chance  of  internal  infections  or
problems with there.
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MANAGEMENT:
¾ Tight control of blood sugar levels
¾ Care for the feet to prevent complications
¾ Control of pain caused by neuropathy
          
Control blood sugar levels — One of the most important treatments for
diabetic neuropathy is to control  blood sugar levels.  Symptoms of pain and
burning may improve when blood glucose sugar improves. 
                                                                  Eve L. Feldman., (2013)
MEDICAL MANAGEMENT:
 Offer  a  choice  of  amitriptyline,  duloxetine,  gabapentin  or  pregabalin  as
initial treatment for neuropathic pain.
 If the initial treatment is not effective or is not tolerated, offer one of the
remaining three drugs, and consider switching again if the second and third
drugs tried are also not effective or not tolerated.
 Consider tramadol only if acute rescue therapy is needed.
 Consider capsaicin cream for people with localised neuropathic pain who
wish to avoid, or who cannot tolerate, oral treatments.
 Opioids other than tramadol should be avoided unless part of shared-care
arrangements after specialist assessment.
 Patients on drug treatment should be reviewed early when starting treatment
for dosage titration, or when changing dose to monitor for adverse effects
and tolerability.
 Regular reviews (National institute for health and care excellence does not
specify a time interval) should also be arranged to check progress, adverse
effects, mood, quality of sleep and any problems with daily activities.
                     National institute for health and care excellence., (2014)
OTHER MANAGEMENT:
Non pharmacological Pain Treatments:
A variety  of  devices  and  techniques may help  relieve diabetic  nerve
pain.  For  example,  electric  nerve stimulators  have been shown to  work for
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some patients. Other methods, such as physical therapy or the use of cold-water
treatments, may also be helpful. A device called a bed cradle can keep sheets
and blankets from touching sensitive feet and legs.
                           American academy of neurology foundation., (2011)
Alternative and Complementary Approaches to Pain Relief:
Roughly  40% of  Americans  have tried  alternative  or  complementary
approaches for relieving chronic conditions such as pain. Only a few of these
techniques, however, have been scientifically studied for their ability to relieve
nerve pain. Studies show that some diabetic leg exercises may help to relieve
nerve pain. 
                           American academy of neurology foundation., (2011)
Many people assume that because herbs and other plants are natural,
they’re safe, but that’s not necessarily true. Be cautious before taking any herb,
plant,  or  supplement  suggested  for  diabetic  peripheral  neuropaty,  even  if
someone the patient know has taken it. It may contain substances that could
interfere with medicine the patient do take, and some can lower blood sugar to
dangerous levels.
Neither the American Diabetes Association nor the National Center for
Complementary  and  Alternative  Medicine  (NCCAM)  endorses  using
Complimentary  Alternative  Medicine  treatments  in  place  of  traditional
treatment. The NCCAM notes that there is not yet enough scientific evidence
to suggest complementary medicine will help people with diabetic peripheral
neuropathy. Here  are  some  therapies  that  are  being  studied.  They  show
potential,  but  they  are  a  long way from being  cleared  for  use.  Those  with
promise include:
• Alpha-lipoic acid:
This is an antioxidant made by the body. It’s also found in organ
meats like liver and in dark vegetables like spinach and broccoli. In some
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people, it can  lower blood sugar and help prevent the nerve damage that
often accompanies diabetes.
• Chromium:
Chromium is a trace mineral, meaning one that is needed in small
amounts in daily diet. It’s found in whole-grain bread and some vegetables.
Sold as chromium picolinate, chromium chloride, or chromium nicotinate, it
appears to be safe when taken in low doses and for short periods. Some
studies show chromium may be safe in doses of 1,000 micrograms a day for
up to six years, but doses over that amount could harm the kidneys. Because
chromium seems to  help  glucose metabolism,  research is  looking at  the
right amount to help manage diabetes.
• Polyphenols:
These are antioxidants found in green tea and dark chocolate, among
many other  foods.  Scientists  are  trying  to  see  if  polyphenols  can  lower
blood sugar and cholesterol. Although some lab studies had good results,
those from studies done on people are mixed.
• Ginseng:
Practitioners have used this herb for centuries for different illnesses,
including headaches, fatigue, diabetes, and fever. Some studies have shown
that it can reduce blood sugar. But it can also have the same negative effects
as drinking too much coffee, causing anxiety, diarrhea, high blood pressure,
and sleeplessness.
           Some cultures have been using a variety of plants to lower blood sugar
for  hundreds of  years  because the plants  contain chemicals  that  can  reduce
blood  sugar.  For  this  reason,  diabetes  researchers  are  currently  studying
botanicals  such  as  fenugreek  and  milk  thistle,  a  flowering  herb  from  the
Mediterranean. Some researchers are also looking at bitter melon, a vine grown
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in  many  Asian  gardens.  Be  careful  when  using  any  herb  or  supplement,
because it can affect the way diabetes medications and other medicines work.
Talk  with  the  doctor  before  taking  any  herbal  supplements  and  don’t  stop
taking the prescribed medications. 
Sohrabi Farrokh., (2014)
Exercise:
Exercise is one natural treatment that does work for diabetic peripheral
neuropathy.  It  can control  weight  and lower  blood sugar  and it’s  free.  Just
about any exercise is helpful, but particularly foot exercises are easy to work
out and prevent from fall, injury and improve peripheral circulation to the feet.
Exercise intervention and peripheral neuropathy relationship:
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Hereditary  diseases 
(e.g charcot-marie-
tooth, refsum)
Acquired causes 
(trauma, toxins, 
diseases)
Idiopathic 
neuropathy 
(unknown causes)
Peripheral neuropathy
Sensory dysfunction Inflammation 
(+) (+) (+)
Here are a few tips before starting a exercise routine:
• Monitor blood sugar level:   The blood sugar may fall too low when
exercise.
• Get the right gear and shoes for the exercise:  Helps to prevent injury
and damage to the foot.
• Bring water with the patient: Sip water to avoid dehydration.
• Take along something to  eat: If  blood sugar  falls  dramatically,  the
patient may need a quick snack.
• Watch for injuries,  and stop if  the patient  feel  discomfort: If  the
patient get an injury, it may take longer for the patient to recover than it
would someone without diabetes.
• Check the feet every day:  The patient may need to be sure that they
don’t get any blisters or small cuts that could get infected.
Joselin diabetes center harvard medical school., (2013)
NURSING MANAGEMENT:
 Nurses are health care providers who actively involved in prevention
and early detection of diabetes and its complications. 
 The nurses’ role could be in health care, health, community education,
health systems management, patient care and improving the quality of
life.
 Diabetic peripheral neuropathy nurses play their educating role in the
field of prevention of diabetic foot like leg exercises, walking , staircase
exercises  ,   foot  care  and preventing from foot  injury,  controlling of
glucose level. 
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Motor dysfunction
Pain 
Exercise intervention 
(-)
(-)
(-)
(-)
 In care dimension, nurses responsible for early detection of any changes
in  skin  and  foot  sensation,  foot  care,  dressing  and  apply  novel
technology.  
Berry Judith., (2013)
PREVENTION:
           Be guided by the doctor, but general suggestions to reduce the risk of
diabetic neuropathy include: 
• Maintain blood glucose levels within the target ranges. 
• Exercise regularly. 
• Maintain a healthy weight for your height. 
• Stop smoking. 
• Reduce the blood pressure and lipid levels  through diet  and lifestyle
changes, and medication where appropriate 
• Consult with the doctor promptly if may have the symptoms including
pain, numbness or tingling in your hands or feet. 
• Feet  checked  at  least  yearly  by  the  doctor,  podiatrist  or  diabetes
educator, or more often if have signs of problems with the feet or other
complications of diabetes.
Baker IDI heart and diabetes institute.,(2014)
COMPLICATION : 
¾ Hypoglycemia (due to decreased renal clearance of insulin)
¾ Rapidly progressing chronic kidney failure
¾ End-stage kidney disease
¾ Hyperkalemia
¾ Severe hypertension
¾ Complications of hemodialysis
¾ Coexistence of other diabetes complications
¾ Peritonitis (If Peritoneal Dialysis Used)
                                                                                     Milarakis., (2009)
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CONCLUSION:
            Because the changes are subtle and happen as people get older, people
tend to ignore the signs of nerve damage, thinking it's just part of getting older.
But the treatments that can help slow the progression of this condition and limit
the damage.
 Webmed .,(2012)
B)EXERCISES
           People with diabetic neuropathy are more likely to develop problems in
the legs and feet. Daily exercises and not smoking can help to prevent serious
damage. 
BENEFITS OF EXERCISES:
Short term and long term benefits:
          Life style interventions, including exercises, are the first line in diabetic
management.  Actually, exercises reduces blood glucose levels via uptake of
glucose in to active muscles. Exercises also stimulates glucose transporter type
4 (GLUT4) translocation  ,  enhancing  glucose  uptake  into  muscle  cells  and
compensating  for  impaired  insulin  sensitivity  associated  with  diabetes.
Although both aerobic and resistance exercises offer benefits to the patient with
diabetes. 
          Exercises over the long term reduces low density lipoprotein cholesterol
levels  and  systolic  blood  pressure  in  diabetic  patients.  It  also  ameliorates
symptoms of depression and improves health related quality of life. Given  its
effects  on blood glucose regulation and the role that  tight glycemic control
plays  in  preventing  diabetic  peripheral  neuropathy.   Exercises  should  be
consider a mainstay of treatment for this complication of diabetes. Simple and
functional  exercises are remarkably  effective and can done by anyone with
little or no equipment required.
                                                                               John whyte ., (2013)
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STEP I:
FOOT MASSAGE :
         Inspect the feet before start the massage.  Looking for discoloration such
as bluish purple spots,  redness,  sores,  cracks in the skin, fungus on the toe
nails, dark spots, cold areas or anything else that stands out as abnormal. Be
sure to look in between the toes and encourage the client to do the same every
day. If they cannot reach their feet, have them place in a mirror on the floor to
view their feet carefully. Experiment with light pressure while inspecting the
feet. This should take about two minutes.
         Begin with some light compression, using the whole hand. Spend about
one minute on each foot lightly compressing the plantar and dorsal surfaces and
all but tissue from the toes to the knee.
STEP II:
FOOT ROLLING EXERCISES:
       Sit in a chair with back straight, knees together. Lift right foot off the floor,
place a round thick plastic bottle under the foot. Start to move the bottle front
and back. Do this exercise five times. Lower the right foot to the floor and
repeat the exercise with left foot.
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STEP III:
STRETCHING THE CALF MUSCLES:
        Lean with the palms of the hand against a wall. Keep feet some distance
away, the heels firmly on the floor. Bend arms 10 times, keeping back and legs
straight.
STEP IV:
SITTING LEG POINTERS:
            Sit in a chair with back straight, knees together. Lift right foot off the
floor,  straightening the right  knee at  the same time.  Point  the toes into the
distance. Holding the leg out straight. Circle the ankle joint clockwise, then
counterclockwise five times. Lower the right foot to the floor and repeat the
exercise with the left foot.
 STEP V
TIPTOE EXERCISE:
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       Hold to a chair and raise and lower the body on the toes of one foot then
the other.
STEP VI:
LEG BENDS:
         Hold chair. Put one foot forward and lower body straight down, keeping
both feet on floor. Raise and lower 10 times. Change legs.
STEP VII:
HEEL RAISING:
          Get up on the toes and then down on heels, about 20 times. Also try
putting the whole first on one leg and then the other. 
STEP VIII:
LEG SWEEPS:
         Stand with one leg slightly raised , on a book for  example. While holding
to a chair or table swing the other leg back and forth 10 times. Change to the
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other leg. Repeat  it.
STEP IX:
WAVE YOUR FEET:
             Sit down on the floor and lean backwards. Shake the feet until they are
relaxed and warm. 
STEP X:
 MARCH EXERCISE:
                  Stand straight in a place. March in place lifting the knees higher
each times.
Webmed.,(2013)
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CONCLUSION :
                 Practicing these exercises are benefit to improving the peripheral
circulation to the legs. Thus it will relieve the pain, burning sensation, color
changes in the skin, improve the confidence level of the person, reduce anxiety
and improve sleep pattern to the diabetic peripheral neuropathy patients. 
Webmed., (2012)
C) PAIN
INTRODUCTION : 
          Acute pain is informative and serves as a warning against impending or
current tissue damage, whereas chronic pain is itself a pathological condition
that serves no beneficial function. Chronic neuropathic pain is characterized by
exaggerated  responses  to  painful  stimuli  (hyperalgesia),  pain  resulting  from
stimuli that would not normally provoke pain (allodynia) and by abnormal pins
and needles sensations. The transition from acute pain to chronic neuropathic
pain is a highly complicated process that results in dysfunction throughout the
pain transmission pathway, from the nociceptors to the dorsal root ganglion and
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spinal cord to the thalamus and, finally, the cerebral cortex. 
Fischer and Waxman., (2010)
DEFINITION:
           Pain is an unpleasant sensory and emotional experience associated with
actual or potential tissue damage. 
                                                            Merskey & Bogduk.,(2007)
DEFINITION OF PERIPHERAL NEUROPATHIC PAIN:
          Peripheral neuropathy pain is a result of damage to the peripheral nerves,
usually in hands and feet. It can also affect other areas of the body. The
patient may experience pricking, cramping or burning pain.
Mayo clinic.,(2013)
Nature of diabetic peripheral neuropathic pain:
Related to the pain there may also be:
• Allodynia.  This means that the pain comes on, or gets worse, with a
touch or  stimulus that  would not  normally cause pain.  For example,  or the
pressure of the bedclothes may trigger pain in diabetic peripheral neuropathy.
• Hyperalgesia. This means that you get severe pain from a stimulus or
touch that would normally cause only slight discomfort. For example, a mild
prod on the painful area may cause intense pain.
• Paraesthesia. This means that get unpleasant or painful feelings even
when there is nothing touching, and no stimulus. For example, painful pins and
needles, or electric shock-like sensations
Colin tidy., (2014)
PHYSIOLOGY OF PAIN:
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                                                         Medscape., (2013)
CHARECTERISTICS  OF  DIABETIC  PERIPHERAL  NEUROPATHY
PAIN:
¾ The discomfort is usually of a chronic nature and may be described by
the patient as a burning sensation, a sharp, stabbing or shooting pain, or
'like an electric shock'.
¾ Other features may include:
 Allodynia - seemingly harmless stimuli, such as light touch, provoking
pain.
 Hyperpathia - a short episode of discomfort causing prolonged severe
pain.
 Hyperalgesia - discomfort, which would otherwise be mild, being felt as
severe pain. The IASP states that hyperalgesia is a psychophysical term;
it  is  has  been  suggested  as  the  umbrella  term  for  all  conditions  of
increased  pain  sensitivity.  Its  definition  parallels  that  of  the
physiological term 'sensitisation'
Brufen brunner.,(2013)
LEVELS OF PAIN:
The four levels of pain are as follows: 
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¾ Sensory-Motor
¾ Affective
¾ Imaginative
¾ Linguistic Narrative. 
DIABETIC  PERIPHERAL  NEUROPATHIC  PAIN  ASSESSMENT
TOOLS/ SCALES:
¾ Douleur Neuropathique en 4 Questions (DN4): A tool (“the French”)
using seven interview questions and three physical tests 
¾ Intra-epidermal nerve fibre (IENF) density: Measured from punch
skin biopsy
¾ Leeds Assessment of Neuropathic Symptoms and Signs (LANSS): A
tool (“the British”) using five interview questions and two physical tests
¾ Laser-evoked potentials (LEPs): Scalp signals evoked by laser stimuli
¾ Nerve Conduction Study (NCS): The standard electrodiagnostic tool
for assessing peripheral nerve fibre function
¾ Neuropathic Pain Questionnaire (NPQ): A tool based on 12 interview
questions
¾ PainDETECT: A tool (“the German”) based on nine items, including a
drawing
¾ Quantitative sensory testing (QST): A method of assessing sensory
function with graded stimuli
¾ Somatosensory-evoked  potentials  (SEPs): Scalp  signals  evoked  by
electrical  stimuli;  the  standard  electrodiagnostic  tool  for  assessing
central somatosensory pathways
¾ Standardized Evaluation of Pain (StEP): A new pain assessment tool
that uses six interview questions and ten physical tests
MEDICAL MANAGEMENT: 
Medications  are  used  to  control  the  pain  associated  with  peripheral
diabetic neuropathy. Unfortunately, at this time, there aren’t any medications to
treat and  prevent diabetic nerve pain (another name for diabetic neuropathy);
the only way to do that is through careful control of blood glucose levels. There
are many medication options to relieve pain associated with  peripheral nerve
damage.
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Methyl cobalamin: 
It is a cobalamine used in diabetic peripheral neuropathy and all types of
neuropathy and anemia. It is the form of vitamin B12. This vitamin is one of two
active  coenzymes  used  by  5-  ethyltetrahydrofolate-homocystine
methyltransferase (MTR), also known as methionine synthase.
♣ Pharmacokinetics : 
             Methyl cobalamin is the neurologically active form of vitamin B12 and
occurs as a water-soluble vitamin in the body. It is a cofactor in the enzyme
methionine synthase, which functions to transfer methyl group for regeneration
of  methionine  from  homocystine.  In  anaemia  it  increases  erythrocyte
production by promoting nucleic acid synthesis in the bone marrow and by
promoting maturation and division of erythrocytes.
♣ Absorption : 
Peak plasma concentrations after 3 hour( oral) 0-9 hour (IM) 3 minutes 
(IV)
♣ Excretion : 
Via urine
♣ Adverse reactions :
Oral: Anorexia,  Nausea ,  Vomiting,  Diarrhoea ;  Parenteral  :  Rash,   Head
ache,  Hot  sensation,  Diaphoresis , Pain ,  Potentially  fatal;  anaphylactoid
reactions:  Others:  Decreased   GI  tract  absorption  with  neomycin,
Aminosalicylic   acid,   H2-  blockers  and  colchicines,  Reduced  effects  in
anaemia with parenteral chloramphenicol.
♣ Dosage: 
       Oral for diabetic peripheral neuropathy  adult:1500mcg/day in 3 divided
dose. Parenteral for diabetic peripheral neuropathy adult: 500 mcg daily IM/IV
3 times/ wk. It can be administer with or without taken food.
♣ Storage:
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      Store at room temperature. Protect from moisture and light. Parenteral store
at room temperature. Do not expose direct to light.
Endocrine web.,(2013)
Medication Warning:
Because  of  the  possible  interactions  and side  effects,  always  discuss
medications with the doctor—even if they’re “just” over-the-counter. 
Over-the-counter Medications for Diabetic Peripheral Neuropathy
For people in the early stages of diabetic peripheral neuropathy, when
the pain isn’t severe, over-the-counter medications may be enough to relieve
the pain. However,  people with more advanced nerve damage may not find
over-the-counter medications helpful.
For diabetic peripheral  neuropathy, the patient may want to try:
• Acetaminophen: 
         This is a painkiller, also known as an analgesic. Tylenol is an example of
acetaminophen,  and  it  works  by  blocking  pain  messages  to  the  brain. In
essence, acetaminophen makes it harder for the “pain” signal to travel through
the nerves and to the brain, and therefore, the brain doesn’t know that it should
be feeling pain. 
           Possible side effects include liver damage, but that’s after taking large
quantities for a long period of time.
• Non-steroidal anti-inflammatory drugs (NSAIDs):
           NSAIDs have a two-fold effect—they work as painkillers and they fight
inflammation. They work by blocking the body from creating prostaglandins,
which are chemicals that cause inflammation and pain. By taking an NSAID,
you  prevent  your  body  from  making  as  many  prostaglandins,  thereby
decreasing inflammation and pain.  Some common over-the-counter NSAIDs
are Advil, Aleve, and Motrin.
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          Possible side effects include stomach ulcers, diarrhea, nausea, and
fatigue.
• Topical Medication: 
            There are several medications available that the patient can apply
directly to your skin; these are called topical medications.
           One option is capsaicin cream. Capsaicin is what makes chili peppers
hot, and it can also relieve the pain. It just temporarily reduces the pain, though,
so will need to keep re-applying. 
Typically, these topical medications are used by people who have foot
pain (common in diabetic peripheral neuropathy).
Prescription Medications for Diabetic Peripheral Neuropathy:
        Most  people  with  peripheral  diabetic  nerve  pain  need  something
stronger a prescription medication to treat the pain. It may need a combination
of  these  to  deal  with  the  various  effects  of  nerve  damage. The  FDA has
approved two medications  for diabetic  peripheral  neuropathy: Cymbalta
and Lyrica. Talk with the doctor to find out if these medications may be right
for  the  nerve  pain;  however,  many  other  medications  are  commonly  used
successfully to treat diabetic neuropathy. 
Side effects include insomnia, headache, and nausea.
• Anti-depressants:
It’s  not  required  to  be  depressed  in  order  to  take  an  anti-
depressant. Anti-depressants work by blocking pain messages on their way to
the brain, and it’s also thought that anti-depressants stimulate the release of
endorphins, which are the body’s natural painkillers. 
There are  several  types of  anti-depressants  available  to  treat  diabetic
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neuropathy:
¾ Tricyclicanti-depressants: 
By raising levels of calming neurotransmitters in your brain, tricyclic
anti-depressants  can,  most  importantly,  reduce  pain. They can also  improve
mood and help you deal with sleep issues (it can be difficult to sleep when have
severe nerve pain). 
For  diabetic  nerve  pain,  amitriptyline  (eg,  Elavil,  Tryptanol),
desipramine (eg, Norpramin and Pertofrane), and imipramine (eg, Antideprin
and Deprinol) are commonly prescribed. They’re called “first line” medications
because  they  are  among  the  first  medications  doctors  will  try  to  relieve
neuropathy because they are usually effective and safe.
Possible side effects include dizziness, drowsiness, dry mouth and eyes,
and constipation.
¾ Serotonin-norepinephrine reuptake inhibitors (SNRIs): 
Commonly  called  SNRIs,  these  anti-depressants  increase  how  much
serotonin  and  norepinephrine  you  have  in  your  system. They  do  this  by
blocking  them  from  being  reabsorbed  by  brain  cells;  they  inhibit  their
reuptake. With  more  serotonin  and  norepinephrine,  you  should  have  better
mental balance and reduced pain.
Doctors commonly prescribe the SNRI duloxetine (Cymbalta) to treat
diabetic  neuropathy. It  is  FDA-approved  to  treat  the  pain  associated  with
diabetic neuropathy  Side effects include dizziness, drowsiness, and insomnia.
¾ Selective serotonin reuptake inhibitors (SSRIs): 
      Selective serotonin reuptake inhibitors—abbreviated to SSRI—increase
how much serotonin  you have. They are  different  from SNRIs  in  that  they
focus on serotonin. SSRIs block serotonin reuptake so that your serotonin level
is increased. If you have more serotonin, you have less pain perception.
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       Some  examples  of  SSRIs  are: paroxetine  (Paxil)  and  citalopram
(Celexa).
• Anti-seizures (also called anti-convulsants or anti-epileptics): 
       As the name implies,  these medications were—and still  are—used to
treat  seizures. They  work  on  diabetic  neuropathy  by  slowing  down  nerve
signals so that the pain message isn’t transmitted as effectively. 
       Some  examples  of  anti-seizures  and  anti-convulsants  are: pregabalin
(Lyrica) and gabapentin (Gabarone and Neurontin). Lyrica is FDA-approved to
treat diabetic neuropathy. 
       There are possible side effects to take into consideration: drowsiness,
weight gain, dizziness, and nausea.
• Opioids (Narcotics):
Opioids,  also  called  narcotics,  are  very  serious,  heavy-duty
painkillers. They can be used to provide immediate relief for severe pain, but
because they can be addictive, you must exercise extreme caution and prudence
when  using  them;  use  them  only  under  a  doctor’s  careful  supervision.
Tramadol  (Ultram  or  Ultracet)  is  an  example  of  an  opioid. Oxycodone
(OxyContin) is another example that has proven useful in relieving diabetic
neuropathy pain.
Possible  side  effects  with  opioids  include  drowsiness,  nausea,  and
constipation.
Topical Medication: 
In addition to capsaicin cream, which is available without a prescription,
another topical medication is a lidocaine patch. You must have a prescription to
use a lidocaine patch. Lidoderm is an example of a lidocaine patch.
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ALTERNATIVE TREATMENT:
There are a number of alternative treatments that may help relieve the
pain of diabetic peripheral neuropathy, such as: 
Capsaicin: This is the chemical that gives hot peppers their bite. When
applied to the skin, capsaicin creams (ArthriCare, Zostrix, others) can reduce
pain sensations in some people. Side effects may include a burning feeling and
skin irritation. 
Alpha-lipoic acid. One of the most  interesting developments in  pain
research is the discovery that alpha-lipoic acid, a powerful antioxidant found in
food, may be effective at relieving the symptoms of peripheral neuropathy. 
Transcutaneous electrical nerve stimulation (TENS). The doctor may
prescribe this therapy, which can help prevent pain signals from reaching the
brain.  TENS  delivers  tiny  electrical  impulses  to  specific  nerve  pathways
through small electrodes placed on the skin. Although safe and painless, TENS
doesn't work for everyone or for all types of pain. TENS may be prescribed in
addition to other treatments. 
Acupuncture. Acupuncture may help relieve the pain of neuropathy,
and generally doesn't have any side effects. Keep in mind that patient may not
get immediate relief with acupuncture and will likely require more than one
session. Traditional Chinese medicine teaches that Peripheral neuropathy is due
to dampness moving to the limbs, where it obstructs the flow of energy and
Blood within them. The treatment is twofold, to treat the underlying factor that
is causing this dampness to accumulate and to directly facilitate the circulation
of energy and Blood in the affected area. By improving the circulation, the
nerve tissues of the affected area can be nourished to repair the nerve functions
and  reduce  pain.  Peripheral  neuropathy  is  a  symptom  for  many  different
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patterns of disharmony within the body. Oriental Medicine aims to treat each
individual  uniquely  depending  on  what  caused  the  neuropathy  and  how  it
manifests
Biofeedback. This  therapy  uses  a  special  machine  to  teach  how  to
control  certain  body responses  that  reduce pain.  Then learn  how to  control
these  same  responses  themself.  Biofeedback  techniques  are  often  taught  in
medical centers and hospitals.
• Acupressure for diabetic peripheral neuropathy:
         Acupressure may relieve peripheral neuropathy symptoms. Patients with
peripheral neuropathy experience chronic pain and tingling, and acupressure
may provide some relief.  Peripheral  Neuropathy results  from nerve damage
associated  with  a  traumatic  accident,  infection,  metabolic  disorder,  such  as
diabetes or exposure to toxins. Acupressure is a type of massage that targets
strategic points which may give pain relief. Discuss symptoms with the doctor
before trying acupressure, which is not a substitute for medical treatment.
Considerations:
         Symptoms  of  neuropathy  frequently  affect  the  hands  and  feet,  and
include  unusual  sensations,  such  as  heat  or  tingling,  over-sensitivity  and
burning or stabbing pain. Acupressure may help with peripheral neuropathy,
most  of  clinics  which  recommends  massage  to  improve  circulation,  and
acupuncture  to  relieve  pain.  Acupressure  stimulates  the  same  points  as
acupuncture, but uses finger pressure instead of needles. Search the location of
an acupressure point until feel a small indentation or tender spot, then apply
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steady pressure with the thumb or index finger. Press tender areas gently and
avoid causing pain.
Kristin dorman., (2013)
Hot application:
      Warmth provides the body with a pleasant, comfortable sensation that
might  just  be  enough  to  provide  some  relief  from  neuropathic  pain.  Can
purchase the plug-in heating pad in almost any pharmacy. Many pads have
temperature controls to make them adjustable to the needs. Leave the heat on
the painful area for a maximum 10 minutes,  remove it earlier if it  becomes
uncomfortable.
        If spa like treatment means purchase a paraffin wax warmer. This device
is slightly messier and hoter than a heating pad, but using it can feel comfort.
Use a  candy thermometer  to  ensure  the wax temperature  is  no higher than
1000F, and continuous monitoring is needed. 
          Another method and the least expensive is simply to use warm water.
Again make sure the temperature of the water is no higher than 1000 F. 
Ice application:
          In general, ice is not as soothing as heat. However, it does have the
advantage of being an analgesic. It can provide a mild numbing effect, which
can  relieve  pain.  Ice  is  also  anti  inflammatory,  meaning  it  helps  reduce
swelling. This can useful for the feet to reduce pain.
          Fill a large freezer bag about half way with ice cubes and seal it. Place a
doubled-up towel over the feet, mold the bag of ice to the area and keep it in a
place for no more 10 minutes. Different sizes of cold bags – filled with gel or
pellets- at a drugstore and keep them in freezer. 
Contrast application:
        Contrast application are little messy, but it may offer some relief from
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pain. Start with two basins: one filled with ice water and other filled with warm
water.  Starting with the ice water,  submerge the feet  for 30 seconds if  can
tolerate and then immediately switch to the warm water for a 2 minutes. Repeat
it about 5 times.
Erica K. Jacques., (2014)
Benefits Of Exercise Intervention In Reducing Neuropathic Pain:
Foot  exercising  to  relieve  diabetic  peripheral  neuropathy  pain  offers
benefits for both mind and body. Foot exercise stimulates blood flow, which
can  help  to  reduce  cramping in  affected  areas  and  strengthen  nerve  tissue.
Regular  foot  exercise  increases  muscle  strength,  which  prevents  muscle
wasting  and  increases  stability.  In  Diabetic  Peripheral  neuropathy,  foot
exercises also can help to relieve stress and promote sleep for healthy living. 
Rachel nall.,(2013)
CONCLUSION:
The toxic effects of high blood sugar are what cause nerve damage and
nerve  pain  in  the  first  place.  Continued  high  sugar  "only  lets  the  process
continue "Most people with painful diabetic neuropathy need a combination of
both medicines and self-care strategies," But keeping sugars close to normal
and regular exercise can stop ongoing damage and decrease the pain of diabetic
neuropathy, studies show. And because some diabetic nerve damage might be
reversible, reducing sugar may have even more benefits.   
Webmed., (2013)
DIABETIC FOOT CARE:
DIABETIC FOOT PROBLEMS:
• Breakdown of the skin of the foot. Sores may develop. 
• Damage to blood vessels and impairment of the immune system from
diabetes make it difficult to heal these wounds. 
• Bacterial infection of the skin, connective tissues, muscles, and bones
can then occur. 
• People  with  diabetes  must  be  fully  aware  of  how  to  prevent  foot
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problems before they occur, to recognize problems early, and to seek the
right treatment when problems do occur. Although treatment for diabetic
foot  problems  has  improved,  prevention  -  including  good  control  of
blood  sugar  level  -  remains  the  best  way  to  prevent  diabetic
complications. 
Webmed., (2012)
 DIABETIC FOOT CARE CAUSES:
         Several risk factors increase a person with diabetes chances of developing
foot problems and diabetic infections in the legs and feet.
• Poor footwear
• Nerve damage
• Poor circulation
• Trauma to the foot
• Infections 
• Smoking
American diabetes association.,(2013)
 
DIABETIC FOOT CARE SYMPTOMS:
• Persistent  pain  can  be  a  symptom of  sprain,  strain,  bruise,  overuse,
improperly fitting shoes, or underlying infection.
• Redness  can  be  a  sign  of  infection,  especially  when  surrounding  a
wound, or of abnormal rubbing of shoes or socks.
• Swelling of the feet or legs can be a sign of underlying inflammation or
infection, improperly fitting shoes, or poor venous circulation. 
• Other signs of poor circulation include the following: 
9 Pain in the legs or buttocks that increases with walking but improves
with rest (claudication) 
9 Hair no longer growing on the lower legs and feet
9 Hard shiny skin on the legs
• Localized warmth can be a sign of infection or inflammation, perhaps
from wounds that won't heal or that heal slowly.
• Any break in the skin is serious and can result from abnormal wear and
tear, injury, or infection. Calluses and corns may be a sign of chronic
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trauma to the foot. Toenail fungus, athlete's foot, and ingrown toenails
may lead to more serious bacterial infections.
• Drainage of pus from a wound is usually a sign of infection. Persistent
bloody drainage is also a sign of a potentially serious foot problem.
• A limp  or  difficulty  walking  can  be  sign  of  joint  problems,  serious
infection, or improperly fitting shoes.
• Fever or chills in association with a wound on the foot can be a sign of a
limb-threatening or life-threatening infection.
• New or  lasting numbness in  the feet  or  legs  can be a  sign of  nerve
damage from diabetes, which increases a persons risk for leg and foot
problems.
Webmed.,(2013)
 TIME FOR SEEKING MEDICAL CARE:
• Severe pain in the feet or legs is often a sign of acute loss of circulation
to  the leg,  serious  infection,  or  may be due to  severe nerve damage
(neuropathy).
• Any cut to the feet or legs that bleeds significantly and goes all the way
through the skin needs proper cleaning and repair to aid healing.
• Any significant puncture wounds to the feet (for example, stepping on a
nail  or  being bitten  by  a  dog or  cat)  carry  a  high  risk  of  becoming
infected.
• Wounds or ulcers that are more than about 1 inch across on the feet or
legs are frequently associated with limb-threatening infections.
• Redness or red streaks spreading away from a wound or ulcer on the feet
or legs are a sign of infection spreading through the tissues.
• Fever  higher  than  101.5°F  (38.6°C)  in  association  with  redness,
swelling, warmth, or any wound or ulcer on the legs may be a sign of a
limb-threatening or life-threatening infection. If you are a person with
diabetes and you simply have a fever more than 101.5°F (38.6°C), and
no other symptoms, seek immediate care to determine the source of the
fever and to initiate a plan of care. Because the degree of fever does not
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always correlate with the seriousness of the illness, people with diabetes
should  take  even  low-grade  fevers  [less  than101.5°F  (38.6°C)]  very
seriously and seek medical attention. The patient's doctor may or may
not prescribe antibiotics, since fevers are often due to viral infections,
which typically do not require antibiotics.
• Alteration in mental status (confusion) may be a sign of life-threatening
infection that could lead to loss of a leg or foot, when associated with a
leg wound or foot ulcer. Confusion may also be a sign of either very
high or very low blood sugars, which are more common when infection
is present.
Shahil Rio.,(2012)
 EXAMS AND TESTS:
• History and physical examination
• Laboratory tests 
• X-rays 
• Ultrasound 
• Consultation 
• Angiogram (if needed)
Webmed.,(2012)
MEDICAL TREATMENT:
• Antibiotics
• Referral to wound care center 
• Referral to podiatrist or orthopedic surgeon 
• Home health care 
Webmed., (2013)
SELF-CARE AT HOME:
A person with diabetes should do the following:
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• Foot examination: Examine the feet daily and also after any trauma, no
matter how minor, to the feet. Report any abnormalities to  physician.
Use a water-based moisturizer every day (but not between your toes) to
prevent dry skin and cracking. Wear cotton or wool socks. Avoid elastic
socks and hosiery because they may impair circulation.
• Eliminate obstacles: Move or remove any items  likely to trip over or
bump the feet on. Keep clutter on the floor picked up. Light the pathways
used at night - indoors and outdoors.
• Toenail trimming:  Always cut the nails with a safety clipper, never a
scissors. Cut them straight across and leave plenty of room out from the
nailbed or quick. If the patients  have difficulty with the vision or using
your hands, let the doctor do it for patient or train a family member how to
do it safely.
• Footwear: Wear sturdy, comfortable shoes whenever feasible to protect
the feet. To be sure the shoes fit properly, see a podiatrist (foot doctor) for
fitting recommendations or shop at shoe stores specializing in fitting people
with diabetes. The  endocrinologist (diabetes specialist) can provide with a
referral to a podiatrist or orthopedist who may also be an excellent resource
for  finding  local  shoe  stores.  If  the  patient  have  flat  feet,  bunions,  or
hammertoes, may need prescription shoes or shoe inserts.
• Exercise: Regular leg exercise will improve bone and joint health in the
feet and legs, improve circulation to the legs, and will also help to stabilize
the blood sugar levels. Consult physician prior to beginning any exercise
program.
• Smoking: If the patient smoke any form of tobacco, quitting can be one
of  the  best  things  can  do  to  prevent  problems  with  the  feet.  Smoking
accelerates damage to blood vessels, especially small blood vessels leading
to  poor  circulation,  which is  a  major  risk  factor  for  foot  infections  and
ultimately amputations.
• Diabetes  control:  Following  a  reasonable  diet,  taking  medications,
checking blood sugar regularly, exercising regularly, and maintaining good
79
communication  with  physician  are  essential  in  keeping  diabetes  under
control. Consistent long-term blood sugar control to near normal levels can
greatly lower the risk of damage to the nerves, kidneys, eyes, and blood
vessels.
American diabetes association.,(2013)
FOLLOW-UP:
• Read any instructions from the doctor while the patient are still in the
emergency department or doctor's office. Ask questions about any instructions
you don't understand. Follow all of your doctor's or nurse's instructions. Let a
doctor  know if  the patient's  condition is  not improving within a reasonable
time.
• Be sure to finish the entire course of antibiotics if  prescribed by the
doctor. Not finishing the entire course can lead to bacteria becoming resistant
to antibiotics.
• Less pain, swelling, redness, warmth, or drainage are generally all signs
of improvement in an infected wound. Shrinkage of the wound or ulcer is a
good sign. Absence of fever is also generally a good sign. Generally,  some
improvement should occur within the first two to three days. Let a doctor know
if the patient is not improving as expected.
• Be especially vigilant about the patient's diabetes care while they are
healing a foot or leg infection. Good glycemic control is good not only for
healing an ulcer the patient already has, but also for preventing future ulcers.
Check blood sugar regularly and let a doctor know the pattern of low and high
levels.
Webmed.,(2013)
PREVENTION:
Prevention of diabetic foot problems involves a combination of factors.
• Good diabetes control
• Regular leg and foot self-examinations
• Knowledge on how to recognize problems
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• Choosing proper footwear
• Regular exercise, if able
• Avoiding injury by keeping footpaths clear
• Having a doctor examine the patient's feet at least once a year using a
monofilament, a device made of nylon string that tests sensation. 
American diabetes association.,(2013)
CONCLUSION:  
          All health care providers of people with diabetes should be able to
conduct a simple screening exam of the neurological, vascular, dermatological,
and musculoskeletal systems. Providers with interest in the foot may choose to
obtain additional training and provide focused management of high-risk foot
conditions. Additional expertise in patient education, footwear modifications,
nail and callus care, and surgical management of the foot may be needed. 
American diabetes association., (2014)
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D)SLEEP
INTRODUCTION: 
One third of human life is spent sleeping. Periods of rest may account
for  major portion of  the  life  span.  Sleep has long been assumed to  have a
restorative function and recently many people believed sleep to be a passive
state of decreased stimulation. . A widely publicized 2003 study performed at
the  University  of  Pennsylvania  School  Of  Medicine  demonstrated  that
cognitive performance declines with fewer than eight hours of sleep. However,
the  purposes  of  sleep  are  only  partly  clear  and  are  the  subject  of  intense
research. 
Webmed .,(2012)
DEFINITION:
Sleep  is  a  naturally  occurring  altered  state  of  consciousness
characterized by decreases in awareness and responsiveness to stimuli. Sleep is
distinguished  from  abnormal  states  of  consciousness  by  being  readily
reversible.
                                Maharban .,(2012)
 
PHYSIOLOGY OF SLEEP:
Two  systems  in  brain  stem,  the  reticular  activating  system  and  the
bulbar synchronizing region are believed to work together to control the cyclic
nature  of  sleep.  The  reticular  formation  is  found  in  the  brain  stem  and
comprises many nerve cells and fibers. The fibers have connections that relay
impulses into the cerebral cortex and into the spinal cord. It facilitates reflex
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and voluntary  movements  as  well  as  cortical  activities  related to  a  state  of
alertness.  Wakefulness  occurs  when  the  reticular  system  is  activated  with
stimuli from the cerebral cortex and from periphery sensory organs and cells.
The hypothalamus has control centers for several involuntary activities of the
body, one of which concerns sleeping and waking. Injury to the hypothalamus
may cause a person to sleep for abnormally long periods. 
Medscape., (2010)
CIRCADIAN RHYTHMS:
Biological  rhythms that  follow a cycle of about 24 hours are termed
circadian rhythms. The word circadian taken from the Latin words circa means
‖ ‖―about  and dies means ―day . The sleep-awake cycle is closely linked with
other circadian rhythms such as body temperature, gastric acid and hormone
secretion. Sleep is one of the body‘s most complex biologic rhythms. Circadian
synchronization  exists  when  an  individual‘s  sleep-wake  patterns  follow the
inner biologic clock. That is, when physiologic and psychological rhythms are
high or most active, the person is awake and when these rhythms are low, the
person  is  sleep.  Problems  of  resynchronizations  occur  when  sleep-wake
patterns are frequently altered and an individual attempts to sleep during high
activity rhythms and to work when the body is physiologically prepared to rest.
                                     Shabeer., (2012)
PHYSIOLOGIC FUNCTION: 
The  physiology  of  sleep  can  be  discussed  in  relation  to  two  basic
research  approaches,  each  of  which  has  provided  building  blocks  for
developing  concepts  relating  to  mechanisms  and  functions  of  sleep.  The
approaches are the electro- physiologic approach and neurotransmitter balance. 
ELECTRO- PHYSIOLOGIC APPROACH:
Polygraph recording of electro-physiologic changes in brain waves, eye
movements,  and  muscles  show five  sleep  stages.  The  first  four  stages  are
classified as non-rapid eye movement (NREM) sleep and the other stage is
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called REM sleep.
SLEEP CYCLE: 
 
Webmed .,(2013)
NEUROTRANSMITTER BALANCE: 
Sleep  is  an  active  process  involving  the  reticular  activating  system
(RAS) and a dynamic interaction of neurotransmitters. The RAS consists of a
network of interconnecting neurons in the medulla, pones and midbrain with
projections to the spinal cord, hypothalamus, cerebellum and cerebral cortex. It
is in a strategic location for stimulation from a wide variety of inputs. The RAS
includes the ascending facilitators area, which is intrinsically active and a less
well understood inhibitory area, which appears to be particularly involved in
decreasing muscle tone during REM sleep. As with other parts of the nervous
system, communication between neurons in the RAS primarily involves the
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release of specific neurotransmitters from axon terminals and their attachment
to  specific  receptors  on  other  cells.  Serotonin  is  a  major  neurotransmitter
associated with sleep. Serotonin is thought to decrease the activity of the RAS,
thereby inducing and sustaining sleep.  Other neurotransmitters  acetylcholine
and nor-epinephrine appear to be required for the REM sleep cycle.
 Samarba., (2009) 
PSYCHOLOGICAL FUNCTION:
 Psychological functions of sleep are thought to include the following:- 
 Sorting and discarding of neurophysiologic data. 
Much short-term memory is filled with inconsequential detail that the
brain  sifts  through  and  discards.  A person  can  usually  remember  what  the
person ate for breakfast that day or how long the bus took to come, but a month
later those data will probably be beyond recall. 
 Character reinforcement and adaptation.
The  REM  stage  of  sleep  appears  to  be  important  for  mental  and
emotional stability. Through REM dreaming, a reprocessing of knowledge and
memories  is  thought  to  occur.  An increased  need  for  REM sleep  has  been
found in people experiencing stress, worry, or new learning situations. 
The National Sleep Foundation in the United States maintains that seven
to nine hours of sleep for adult  humans is optimal and that  sufficient sleep
benefits alertness, memory and problem solving, and overall health, as well as
reducing the risk of accidents. A widely publicized 2003 study performed at the
University Of Pennsylvania School Of Medicine demonstrated that cognitive
performance declines with fewer than eight hours of sleep. 
Hours by Age: 
Children need a greater amount of sleep per day than adults to develop
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and function properly: up to 18 hours for newborn babies, with a declining rate
as a child ages. A newborn baby spends almost 9 hours a day in REM-sleep.
By the age of five or so, only a bit over two hours is spent in REM.
Age and condition
Average amount of
sleep per day
New born Up to 18 hours
1-12 months 14-18 hours
1-3 years 12-15 hours
3-5 years 11-13 hours
5-12 years 9-11 hours
Adolescents 9-10 hours
Adults, including elderly 7-8 (+) hours
Pregnant women 8(+) hours
Papazoglou.,(2013)
FACTORS AFFECTING SLEEP:
 Physical activity: 
           Activity and exercise influence sleep by increasing fatigue. It appears
that physical activity increases both REM and NREM sleep. 
Psycho logic stress: 
                  Illness and situations in daily living that cause Psycho logic stress
tend to disturb sleep. Generally Psycho logic stress affects sleep in two ways. 
1. The person experiencing stress tends to find it  difficult  to obtain the
amount of sleep he or she needs. 
2. REM sleep  decreases  in  amount  which  tends  to  add  to  anxiety  and
stress. 
Motivation: 
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A desire to be wakeful and alert helps overcome sleepiness and sleep.
E.g. a tired person may be wakeful and alert when at a party or when attending
an interesting play and when there is minimal motivation to be awake, sleep
generally follows. 
Diet:
        It has long been believed that the dietary amino acid L-tryptophan acts
to  promote  sleep.  A  small  protein  snack  before  bed  time  was  frequently
recommended for clients with insomnia. Protein may actually increase brain
energy  alertness  and  concentration,  while  carbohydrates  appear  to  have  an
effect on brain serotonin levels and promote feeling of calmness and relaxation.
Alcohol Intake: 
           Alcoholic beverages when used in moderation seem to help induce sleep
in some people. However, large quantities have been found to limit REM and
delta sleep. 
Caffeine-containing Beverages: 
Caffeine  is  a  central  nervous  system  stimulant.  For  many  people,
beverages containing caffeine interfere with the ability to fall asleep e.g. coffee,
tea and chocolate etc.
Smoking:
          Nicotine has a stimulating effect and smokers usually have a more
difficult time falling asleep. They are more easily aroused once asleep and may
describe themselves as light sleepers. The total withdrawal from smoking may
be  associated  with  sleep  disturbances.  Clients  who  stop  smoking  have  an
increase in periods of day time sleepiness and report restlessness at night.
 Environmental Factors:
          Most people sleep best in their usual home environments. Sleeping in a
strange or new environment tends to influence both REM AND NREM sleep.
87
 Lifestyle:
           Various lifestyles affect the ability to sleep well. Alward and Monk
(1995) describe the nurses who work rotating shifts.  Sleep disorders are the
major problem associated with shift  work and developing a sleep pattern is
difficult if the shift changes periodically. 
Illness:
        Illness  act  as  a  physiologic  and  psycho  logic  stressor,  as  a  result
influences sleep. Certain illnesses are more closely related to sleep disturbances
e.g. Gastric secretions increases during REM sleep. Many people with peptic
ulcers  awaken at  night  with  pain  and they find that  eating a snack to  help
neutralize stomach acidity is often helpful to relieve discomfort and promote
sleep.
Common Sleep Disorders: Primary Sleep Disorders:
          Primary sleep disorders are those in which the sleep disturbance is the
main  symptom  or  sign  of  the  problem.  It  includes  insomnia,  hypersonic,
narcolepsy and sleep apnea.
 Insomnia: 
          Insomnia  is  a  perception  of  inadequate  sleep  and  characterized  by
difficulty in initiating sleep and frequent awakening from sleep. Insomnia may
be classified as idiopathic or psycho physiological. Idiopathic insomnia usually
begins in childhood. It may be caused by a neurochemical imbalance of the
sleep-onset  mechanisms  or  the  sleep-maintenance  system.  The  syndrome is
usually  associated  with  a  decreased  feeling  of  wellbeing  during  the  day,  a
deterioration of mood and motivation, decreased attention span, low levels of
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energy and concentration and increased fatigue. Psycho physiological insomnia
can occur from a variety of causes including stress and tension. Individuals
with disorder are usually not sleepy during the day but function poorly in terms
of cognitive skills and also report fatigue. 
Hypersomnia: 
          Hypersomnia  is  a  condition  characterized  by  excessive  sleep,
particularly during the day. Although this may result from medical conditions,
it is frequently used as a coping mechanism when someone has no desire or
energy to face a new day.
Narcolepsy:
Narcolepsy is a condition characterized by an uncontrollable desire to
sleep. The person with narcolepsy can literally fall asleep standing up, while
driving a car or while swimming. This disabling condition should not to be
confused with hyper somnolence, which is excessive sleeping for long periods.
Although  the  diagnosis  of  narcolepsy  generally  requires  a  multiple  sleep
latency test and polysomnography.
Sleep Apnea: 
Sleep apnea refers to periods of no breathing between snoring intervals.
The person may not breathe for periods of 10 to 20 seconds to as long as 2
minutes. Obstructive sleep apnea results when the airway is occluded due to
collapse of the hypo pharynx. During long periods of apnea, there is a drop in
the oxygen level  of  the blood,  the pulse usually  becomes irregular  and the
blood pressure often increases. The accumulation of carbon dioxide and the fall
in oxygen cause brief periods of awakening throughout night. 
Parasomnias: 
Parasomnias are patterns of waking behavior that appear during sleep.
Parasomnias  are  conditions  associated  with  activities  that  cause  arousal  or
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partial arousal usually during transitions in NREM periods of sleep. They are
not life threatening but they disturb others. 
The examples of parasomnias are:- 
¾ Somnambulism: sleep-walking. 
¾ Nocturnal enuresis: bedwetting. 
¾ Sleep-talking. 
¾ Nightmares and night terrors. 
¾ Bruxism: grinding of teeth. 
Sleep Deprivation: 
Sleep deprivation refers to a decrease in the amount, consistency and
quality of sleep. It may result from decreased REM sleep or NREM sleep. The
manifestations progress from irritability and impaired mental abilities to a total
disintegration  of  personality.  Partial  sleep  deprivation  may result  in  loss  of
concentration and pose serious safety risks. The strange environment of the
hospital, physical discomfort and pain, the effects of medications and the need
for  24  hour  nursing  care  may  all  contribute  to  sleep  deprivation  in  the
hospitalized client. 
Hospital-Acquired Sleep Disturbances: 
Clients in the hospital may report difficulty with sleep onset, latency,
awakening frequently with difficulty getting back to sleep and early morning
awakening. 
Sleep Onset Difficulty: 
Sleep onset difficulty is a common problem in hospital because of the
strange  environment  and  the  anxieties  associated  with  illness  and
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hospitalization. A sleep latency time of 20 to 30 minutes is normal range for
most adults. 
Sleep Maintenance Disturbances: 
Sleep maintenance disturbances may be associated with sustained use of
or withdrawal from a variety of medications and related substances. Alcohol
hasten sleep onset but leads to awakening later in the night. Other factors that
contribute to sleep fragmentation include stimuli that tend to awaken people in
the middle of night. 
Early Morning Awakening:
Early  morning  awakening  occurs  frequently  among  older  clients.
Sensitivity to environmental disturbances increases toward morning in people
of all ages but even more so in older adults. Clients who are disturbed by early
more awakening should be screened for depression. This transient cognitive
disorder  may  e  associated  with  acute  illness,  infection  or  admission  to  the
hospital. Sleep is grossly disturbed with frightening dreams, disorientation and
restlessness. 
Sleep Deprivation: 
Sleep  deprivation  is  of  particular  concern  for  clients  in  critical  care
units. Multiple factors contribute to sleep deprivation including noise level, 24-
hour  lighting  and frequency of  caregiver  interruptions.  Studies  have  shown
noise  levels  in  general  surgical  wards  to  be  above  the  World  Health
Organization‘s guidelines for both day and night shifts. 
REM Rebound: 
REM sleep occurs later in the sleep cycle and therefore can be missed
when sleep time is reduced or interrupted. In order to compensate for missing
sleep  a  greater  proportion  of  REM-deprived  clients‘  sleep  will  be  REM.
Withdrawal  of  medications  that  suppress  REM sleep  can  lead  to  an  REM
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rebound  effect  that  is  accompanied  by  nightmares.  Normal  physiologic
occurrences  during  REM  sleep,  such  as  irregular,  elevated  heart  rate  and
elevated  blood pressure  may  place  the  REM rebound client  at  regular  risk
because of longer amount of time spent in REM. 
Lippincott., (2009)
SLEEP ASSESSMENT:
       Many  people  blame  inadequate  sleep  for  daytime  fatigue  or  they
underestimate the actual time they sleep. Nurses can obtain a more accurate
sleep  pattern  assessment  through  sleep  questionnaires,  sleep  diaries,
polysomnographic  evaluation and a  multiple  latency  sleep  test.  (sleep scale
from medical outcome study, sleep likert scale)
Questionnaires: 
       Several  questionnaires  have been  developed to  help  to  identify  sleep
patterns.  They  are  either  designed  to  obtain  specific  information  or  are
unstructured  to  give  the  person  more  freedom  to  respond.  Examples  of
questions for the client include: 
 When you think about your sleep, what kinds of impressions come to
mind? 
 Do you fall asleep at inappropriate times? 
 How long does it take you to fall asleep? 
 Have you been told that you stop breathing while asleep? 
 Do you fall asleep during physical activities? 
‟Questions for the members of the client s house-hold are:- 
♣ Dose the client snore or gasp for air when sleeping? 
♣ Dose the client kick or thrash around while sleeping?
♣ Dose the client sleep-walk? 
Sleep Diary:
 A sleep diary is a daily account of sleeping and walking activities. 
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 The  client  or  personnel  compile  the  information  in  a  sleep  disorder
clinic. 
 The client notes the times he or she is sleep, describes daily activities, 24
hour log of consumed food and beverages and notes when he or she
takes any medications.
 These self kept diaries generally cover a 2-week period.
Nocturnal Polysomnography: 
         Nocturnal Polysomnography is a diagnostic assessment technique in
which a client is monitored for an entire night‘s sleep to obtain physiologic
data. It generally takes place in a sleep disorder clinic but it is now possible to
conduct the study at the client‘s home; a technician monitors a computerized
recording system up to 60 feet away. The sensors are attached to the head and
body record: 
9 Brain waves. 
9 Eye movements. 
9 Muscle tone. 
9 Limb movement. 
9 Body position. 
9 Nasal and oral airflow.
9 Chest and abdominal respiratory effort. 
9 Snoring sounds. 
9 Oxygen level in the blood. 
Multiple Sleep Latency Test:
              A multiple sleep latency test is another helpful study. 
¾ The person undergoing this test is asked to take to a daytime nap at 2-
hour  intervals  while  attached  to  sensors  similar  to  those  used  in
polysomnography. 
¾ The client is allowed to nap for about 20 minutes. 
¾ The nap periods are repeated four or five times throughout the day. 
¾ Clients  who have certain sleep disorders causing day time sleepiness
have  a  short  latency  period-  that  is  they  fall  asleep  in  less  than  5
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minutes. 
¾ Most  well-rested persons take an average of  15 minutes  before  they
experience the onset of daytime sleep. 
                   Shabeer., (2012)
TOOLS / SCALES FOR ASSESSING SLEEP PATTERN:
 Pittsburgh  Sleep  Quality  Index  (PSQI)  scale: It  has  9  items.  For
assessing the quality of sleep.
 Medical Out come of Sleep Scale:  It  has 12 items for assessing the
sleep pattern.
 Sleep  Quality  Scale  (SQS). It  helps  to  assess  the  quality  of  sleep.
Consisting of 28 items, the SQS evaluates six domains of sleep quality:
daytime  symptoms,  restoration  after  sleep,  problems  initiating  and
maintaining sleep, difficulty waking, and sleep satisfaction.
 The Epworth Sleepiness Scale (ESS); It is a scale intended to measure
daytime sleepiness that is measured by use of a very short questionnaire.
This can be helpful in diagnosing  sleep disorders. It was introduced in
1991 by Dr Murray Johns of Epworth Hospital in Melbourne, Australia. 
 The Insomnia Severity Index (ISI): it  is designed to be both a brief
screening  measure  of  insomnia  and  an  outcomes  measure  for  use  in
treatment research.
 Pittsburgh Sleep Diary: The Pittsburgh Sleep Diary (PSD) is designed
to quantify subjectively reported sleep and waking behaviors for use in
research and practise. 
Eun kim.,(2013)
MANAGEMENT:
        Sleep is essential component of well-being. Planning and implementing
client  care  especially  in  a  health  care  facility,  involves  planning  with  the
suitable measures to promote sleep. Usually sleep problems are not the primary
reason for a client‘s interaction with the health care system. Fundamental to the
success of any nursing measure to correct a sleep problem is the client‘s belief
that the nurse cares and is readily available for extra help to promote sleep. 
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Tips  for  Managing  Sleep  Disturbances  with  peripheral  Neuropathy
         People who sleep poorly are also susceptible to depression and other
mood disorders, changes in eating, decrease in physical activity, and an overall
decline in health. Compounded with neuropathy, this becomes a vicious cycle.
Improving Daytime Habits and Bedtime Routines to Improve Sleep:  
When dealing with neuropathy,  you may find yourself  thinking your
insomnia  is  the  least  of  your  problems.  But,  the  compounding  effects  of
neuropathy and sleep disturbances require that you address both head on. Start
by  tracking  your  symptoms  and  sleep  patterns,  and  then  making  healthy
changes to your daytime habits and bedtime routine ( self help techniques):
9 Keep a regular sleep/wake schedule
9 Develop a bedtime ritual (e.g., taking a warm bath, reading light 
material);
9 Limit or eliminate caffeine four to six hours before bed and minimize 
daytime
9 Avoid smoking, especially near bedtime or if awake in the night
9 Avoid alcohol and heavy meals before go to bed;
9 Turn off  TV, smartphone, iPad, and computer a few hours before 
bedtime;
9 Adopt relaxation techniques to help induce sleep (e.g., give an extra 
hour before bed to relax and unwind and time to write down worries and
plans for the following day; meditation ; deep breathing exercises); and
9  Create a comfortable sleeping environment (e.g., make sure bedroom is 
dark, quiet, and well-ventilated; use bed and pillows that are 
comfortable; elevate the bed sheets so that it is not in direct contact with 
legs and feet).
Non-pharmacological treatments
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       These include cognitive behavioral therapy, relaxation techniques, stress
management, and acupuncture that can help improve sleep disturbances. They
are preferred to prescription sleep medications which can lead to sleepiness
during the day, can cause dependency, and come with side effects.
Pharmacological treatments:
These are used as a last resort and should only be used for short periods
of time especially when the insomnia is chronic. Sometimes, medicines used to
reduce pain or aid sleep can affect your sleep.
Over-the-counter pain medications:
       For mild pain, over-the-counter pain medications (e.g., Tylenol, Advil)
may  suffice.  Some  over-the-counter  pain medications  also  have  an
antihistamine to help with sleep (e.g., Advil PM or TylenolPM).
        Nurses also need to be alert to the dangers of withdrawal symptoms that
can accompany the abrupt cessation of barbiturate sedative-hypnotics. 
        
Medications  used  to  induce sleep  may  produce  day-time drowsiness.
The nurse should administer these medications only when indicated and always
with  full  knowledge  of  their  limitations.  Thorough  client  teaching  should
accompany their use.
 Prescription medications:
         For  more  severe  or  chronic  pain,  your  doctor  may  recommend
prescription  pain  medications  (e.g.,  ultram,  opioids  such  as oxycodone,
hydrocodone  bitartrate  and  acetaminophen,  codeine,  and  morphine).  Other
drugs  can  also  help  with  pain,  such  as  some  antidepressants
and anticonvulsants.
Preparing a Restful Environment:
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 Having a comfortable bed helps promote sleep. 
 The bottom line should be tight and clean and upper linen should allow
freedom of movement and should not exert pressure. 
 A  quiet  and  darkened  room,  with  privacy  is  relaxing  for  nearly
everyone. In a strange environment, unfamiliar noises such as people
walking or entering and leaving the room bring complaints from most
hospitalized clients. 
 Although some of these sources are difficult for the nurse to control,
every effort should be made toward reducing disturbances to promote
sleep. 
 The temperature of the room, the amount of ventilation and the quantity
of bed covering are matters of individual choice. 
Promoting Bedtime Rituals: 
 Most people have bedtime rituals to promote sleep. 
 Reading, listening to the radio, watching television, talking to a family
member and praying are common before-sleep activities. 
 Children may search out a favorite doll, stuffed toy or blanket before
going to bed; insist  on a story. Snacks are important elements in the
bedtime rituals of many children and adults.
  The nurse should be alert to the client‘s bedtime rituals and make every
effort to observe them as far as possible to aid in promoting sleep. 
 These rituals should appear in the client‘s plan of care so that all health
personnel can observe them. 
Offering Appropriate Bedtime Snacks and Beverages:
¾ Because  carbohydrates  seem  to  help  promote  sleep,  there  currently
appears  to  be  justification  for  offering  a  snack  or  beverages  high  in
carbohydrates before bed-time.
¾  Beverages containing caffeine should be avoided for  at  least  4 to  5
hours before bedtime. 
¾ It is best the client take fluids during the day and avoid excessive fluid
intake before bedtime to prevent the necessity of using the bathroom
during sleeping hours. 
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Promoting Relaxation: 
¾ One can  relax  without  sleeping,  but  sleep  rarely  occurs  until  one  is
relaxed. 
¾ Stress and anxiety-producing situations tend to interfere with a person‘s
ability to relax and sleep. 
¾ Effective means for dealing with worries include dealing with problems
as they arise; conditioning oneself to worry only during preset times;
teaching  oneself  that  worrying  never  solve  problems  and  giving  the
worries over to another e.g. a trusted family member, friend, caregiver
or  God.  Back  rubs,  warm  baths  and  face  washing  if  the  client  is
bedridden are typical nursing measures to help the client relax. 
Promoting Comfort: 
 One of  the  greatest  deterrents  to  rest  and  sleep  is  pain;  it  is  not  an
uncommon experience when illness is present. 
 Depending  on  the  cause  and  severity  of  the  discomfort  or  pain,
appropriate  nursing  measures  include  remaining  with  a  lonely  and
frightened child or adult, using the simple strategy of caring presence
and touch, offering back massage, positioning, mild exercises to relieve
signs  and  symptoms  obtaining  an  extra  blanket  or  administering  an
analgesic.
 Respecting Normal Sleep-Wake Patterns: 
 Every effort should be made to observe the client‘s normal periods of
sleep.
  It is recommended that a client‘s normal napping habits be followed
when possible. 
 It has been observed that REM sleep is common during morning naps
where as NREM sleep is common during naps later in the day. 
 With this knowledge, the nurse can help the client plan napping periods
that  best  fit  individual  needs  and  that  interfere  least  with  nighttime
sleeping. 
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Scheduling Nursing Care to Avoid Unnecessary Disturbance: 
9 Common client complaints are that they are awakened to take sleeping
pills  and are aroused at early morning hours to prepare for breakfast
long  before  it  is  served.  These  common  observations  should  be
considered when planning care. 
9 Every effort should be made to time care during periods when the client
is normally awake. 
9 When this cannot be done, it is preferable to avoid awakening the client
during REM sleep, when the rapid eye movements can be observed. 
Teaching About Rest and Sleep/ nurse’s role: 
¾ A well-informed person is better able to cope with distressing situations.
¾ Helping clients and their families understand the nature of rest and sleep
and their  importance  to  well  being  through teaching  is  an  important
nursing function.
¾ Teaching should include aspects of normal variations in sleep patterns
and common measures to promote relaxation and sleep(exercises, music
therapy, pleasant environment, proper ventilation). 
¾ Also  the  plan  of  care  should  be  discussed  with  the  client  for
acceptability.
 Webmed .,(2013)
CONCLUSION:
        Sleep is an essential part of living—sleep helps us avoid major health
problems and it is essential to our mental and physical performance.  It affects
our mood and stress and anxiety levels.  Unfortunately,  sleep disturbance or
insomnia is often a side effect of the pain. It is a common complaint among
people  with  living  with  chronic  pain.  Most  experts  recommend a  range  of
seven to nine hours of sleep per night for adults, regardless of age or gender.
This may seem impossible to people with chronic pain .
The foundation for diabetic peripheral neuropathy.,(2014)
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PART –II
SECTION :A
STUDIES  RELATED  TO  INCIDENCE  AND  PREVALENCE  OF
DIABETIC PERIPHERAL NEUROPATHY:
Yadav.et.al.,  (2014) conducted  a  prospective  study  regarding  the
prevalence and risk factors of Diabetic Peripheral Neuropathy in patients with
type 2 Diabetes Mellitus patients in Lucknow. 195 consecutive patients over
age 30 with a duration of diabetes >6 months were selected. The cases had a
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mean age of  47.6  ± 10.2  years  (59% males)  and duration  of  symptoms of
5.9±8.2. The overall prevalence of Diabetic Peripheral Neuropathy was 29.2%
[95% CI 22.8-35.7]. Peripheral Neuropathy among matched control was 10.7%
(95% CI 3.5-17.8). The prevalence of Diabetic Peripheral Neuropathy showed
an increasing trend with  age (trend chi-square 11.8,  P =  0.001).  Abnormal
vibration perception threshold was present  in  43.3% (95% CI 36.3-50.3)  of
cases and had a significant correlation with Neuropathy Disability Score (P =
0.000). Abnormal monofilament testing was present in 6.1% of cases (95% CI
2.7-  9.5).  A  logistic  regression  analysis  showed  that  Diabetic  Peripheral
Neuropathy  was  independently  associated  with  age  (13.7)  (P =  0.002)  and
duration of diabetic peripheral neuropathy (15.9) (P = 0.02) but not with body
mass index, plasma glucose, or HbA1c. The study showed high prevalence of
Peripheral Neuropathy in patients with Type 2 Diabetes mellitus, which was
independently associated with age and duration of symptoms of diabetes prior
to the diagnosis.
Khaldon  al  sarijin.et.al.,  (2013)  conducted  the  descriptive  study
regarding Prevalence of peripheral  neuropathy among patients with diabetes
mellitus  in  Cambridge.  Convenience  sample  of  202  patients  with  Diabetes
Mellitus. Data were collected through face-to-face interview. Data collection
instrument is composed of two parts; the first part assesses the demographic
characteristic,  while  the  second  part  is  a  translated  version  of  Michigan
Neuropathy Screening Instrument (MNSI). The overall prevalence of diabetic
Peripheral  Neuropathy  was  (54.45  ±  49.92).  The  prevalence  of  diabetic
Peripheral Neuropathy was higher in women than men (55 ± 50 VS 53.92 ±
50.09). 
Preeti  pavade.et.al.,  (2013) conducted  the  cross  sectional  study  on
Prevalence and risk factors  of  diabetic  peripheral  neuropathy among type-2
diabetic  patients  in  Kulasekharam.  Study  Period  is  10th  September-  5th
December  2011  & Sample  Size  is  283.  A  stratified  random sampling  and
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convenient sampling was used. The patients were questioned and Examined
using a Pre-tested Questionnaire followed by a symptomatic history taking and
Clinical  Examination.  In  this  Study  the  prevalence  of  Diabetic-related
Neuropathy  is  33.33%.  The  study  also  shows  risk  factors  for  developing
neuropathy such as Increasing duration of Diabetes,  Comorbid diseases and
Low Socio Economic Status.
Caroline  A  abbott.et.al.,(2011) conducted  a  observational  study
regarding Prevalence and Characteristics of Painful Diabetic Neuropathy in a
Large Community-Based Diabetic Population in Ipswich. The sample size was
15692. Neuropathic symptom score and neuropathy disability score was used.
Prevalence of painful symptoms (NSS $5) and peripheral diabetic neuropathy
(NSS  $5  and  NDS  $3)  was  34  and  21%,  respectively.  Painful  symptoms
occurred in 26% of patients without neuropathy (NDS #2) and 60% of patients
with severe neuropathy  (NDS .8). Women had 50% increased adjusted risk of
painful  symptoms  compared  with  men  (OR  =  1.5  [1.4–1.6],  P  ,  0.0001).
Despite  less  neuropathy in  South  Asians  (14%) than  Europeans  (22%) and
African  Caribbeans  (21%)  (P  ,  0.0001),  painful  symptoms  were  greater  in
South Asians (38 vs. 34 vs. 32%, P , 0.0001). South Asians without neuropathy
maintained a 50% increased risk of painful neuropathy symptoms compared
with  other  ethnic  groups  (P  ,  0.0001).  One-third  of  all  community-based
diabetic  patients  have  painful  neuropathy  symptoms,  regardless  of  their
neuropathic  deficit.  Painful  Diabetic  Neuropathy  was  more  prevalent  in
patients with type 2 diabetes, women, and people of South Asian origin.
Jambart.et.al.,(2010) conducted a study to determine the Prevalence of
Painful  Diabetic  Peripheral  Neuropathy  among  Patients  with  type  I  and  II
Diabetes Mellitus in Jordan. The sample size was 4097 . doluleur neuropathic
score  was  used.  The  odds  of  painful  diabetic  peripheralneuropathy   were
highest  among patients  with peripheral  vascular  disease (OR 4.98),  diabetic
retinopathy (OR 3.90) and diabetic nephropathy (OR 3.23). Because of the high
102
prevalence and associated suffering, disability and economic burden of painful
Diabetic  Peripheral  Neuropathy,  it  is  important  that  diabetic  patients  are
periodically  screened,  using  a  simple  instrument  such  as  the  Doleuar
Neuropathic4, and receive appropriate treatment if symptoms develop. 
Booya.et.al.,  (2009) conducted a case control  study on potential  risk
factors for diabetic  peripheral  neuropathy in America.  The sample size was
110. Michigan neuropathy diabetic scoring scale was used for screening and
Leeds Assessment of Neuropathic Symptoms and Signs Scale was used for
assessing pain.  Of the 110 patients, 78% (79) were female and 22% (31) were
male. The mean age was 55.1 ± 13.2 (20–80 years). All but one of the patients
had type II DM. Mean fasting blood glucose and average duration of disease in
the study population were 140.5 ± 8 mg/dl and 12.9 ± 7 years, respectively.
Overall prevalence of peripheral neuropathy is 28% of them. The values was
significantly associated with age (21.8) [14-19], family income (32.3) [14-22],
duration  of  treatment  (23.98)  [14-20],   height  (19.21)  [15,22,23],  smoking
status (27.01) [15,19,24],  low HDL cholesterol level (37.91) [15],(p<0.001).
No other association was detected. The results of the study confirm the reports
regarding the association of neuropathy with age, family income, duration of
treatment, smoking status, low HDL cholesterol level.
Khaled  kasim.et.al.,  (2009)  Conducted  a  cross  sectional  study  to
determine  the  frequency  of  Peripheral  Neuropathy  and  the  risk  factors
associated with its  occurrence in the studied diabetic patients in Egypt. The
sample size was 300 patients with type-II. A clinical neurological examination
was conducted for all patients using the Michigan Neuropathy Diabetic Scoring
(MNDS) criteria for diagnosis of PN.  The frequency of PN among the studied
subjects was 29.7%. Related risk factors were: older age above 60 years (odds
ratio  (OR) = 73.0;  95%  confidence  interval  (CI) = 14.2–377.2),  associated
moderate  to  severe  hypertension  (OR = 10.2;  95%  CI = 2.8–38.0)  and
associated  ischemic  heart  disease  (IHD)  (OR = 3.80;  95%  CI = 1.50–9.80),
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poor control of DM (OR = 9.1; 95% CI = 2.6–32.1), and duration of Diabetes
Mellitus. The risk of PN, however, was significantly reduced among married
patients and those reported high educational and family income levels. Diabetic
Peripheral Neuropathy is a considerable complication of Diabetes Mellitus. The
related risk factors  were old age,  prolonged and poorly controlled Diabetes
Mellitus and associated medical disorders.
Mohsen Janghorbani.et.al.,(2006) conducted a study to estimate the
prevalence and risk factors of peripheral neuropathy (PN) in people with type 2
diabetesmellitus in United Kingdom. 810 patients with type 2 diabetes (289
male and 521 female) from Isfahan Endocrinology and Metabolism Research
Centre  outpatient  clinics,  Iran  ,  were  examined.  Part  of  the  examination
included  an  assessment  of  neurological  function  including  neuropathic
symptoms and physical signs, and nerve conduction velocity. The prevalence
of PN was 75.1% (95% confidence interval (CI) 72.1, 78.0). The age-adjusted
prevalence rate of Peripheral Neuropathy was 78% higher among patients with
Ischemic Heart Disease, 64% higher among patients with any retinopathy, 66%
higher  among  insulin-treated  type  2  diabetes,  and  greater  with  duration  of
diabetes.  Peripheral Neuropathy is a common complication in this population
of  type  2  diabetic  patients.  It  increases  with  age,  duration  of  diabetes  and
proteinuria.
Devies.et.al.,  (2006) conducted the  cross  sectional  descriptive   study
regarding  The prevalence, severity, and impact of painful diabetic peripheral
neuropathy in type 2 diabetes in United Kingdom. The sample size was 1269.
Initial screening questionnaire and Toronto Clinical Scoring System was used.
In phase 1, there was a 92.7% response (n = 326), with 208 (63.8%) subjects
reporting pain. In phase 2, 269 (82.5%) subjects attended and 51 (19.0%) were
found  to  have  Painful  Diabetic  Peripheral  Neuropathy.  99  (36.8%)
nonneuropathic pain, 20 (7.4%) mixed pain, and 99 (36.8%) no pain (Painful
Diabetic  Peripheral  Neuropathy  prevalence  26.4%).  Of  those  with  Painful
Diabetic Peripheral Neuropathy, 80% stated that their pain was moderate or
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severe.  Those  affected  had  poorer  quality  of  life  than  those  with  no  pain
(difference in mean scores 3.6 [95% CI 2.5-4.6%]) compared with those with
nonneuropathic pain (1.7 [0.4-2.9%]).  Both pain and neuropathy score were
independently  associated  with  quality  of  life,  and  subjects  with  Painful
Diabetic  Peripheral  Neuropathy  had  significantly  higher  neuropathy  scores.
The study showed a prevalence of Painful Diabetic Peripheral Neuropathy of
26.4%.  Having  Painful  Diabetic  Peripheral  Neuropathy  has  a  significant
negative effect on quality of life, and increasing neuropathy is associated with
an increasing risk of developing Painful Diabetic Peripheral Neuropathy.
 Agrawal.et.al.,  (2006) A  cross  sectional  study  was  conducted  to
determine the prevalence of microvascular and macrovascular complications in
type 2 diabetes  and to identify the major risk factors for these complications in
Mohit. This cross sectional study was conducted on 4067 patients out of 4400
type 2 diabetic patients attending the diabetic clinic. All patients underwent the
specific  tests  for  retinopathy,  nephropathy,  neuropathy,  peripheral  vascular
diseases (PVD) and cardio-vascular diseases using relevant investigations. The
researcher  observed  evidence  of  retinopathy  in  1176  patients  (28.9%),
nephropathy in 1323 (32.5%), neuropathy in 1225 (30.1%), Coronary Artery
Disease  in  780  (19.2%)  and  Peripheral  Vascular  Disease  in  735  patients
(18.1%). This study highlights the high prevalence of various microvascular
and  macrovascular  complications  especially  nephropathy  and  neuropathy  in
Indian population.
Beunza .et.al.,  (2009) conducted a  case  control  study on association
with some risk factors on pain and sleep for diabetic peripheral neuropathy in
Africa. The sample size was 110.podiascan was used to assess the severity of
the disease and neuropathic symptom score and medical outcome of sleep scale
was used to assess the sleeep  .  Of the 85 patients, 57%  were female and 43%
were male. The mean age was 47.21 ± 16.4 (30–70 years). All but one of the
patients had type II DM. Mean fasting blood glucose and average duration of
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disease  in  the  study population  were 150.5  ±  2 mg/dl  and  15.4  ±  9  years,
respectively.The values was significantly  didn’t  associated with  age (0.8)  [,
family income (0.02) , duration of treatment (0.19), residence (1.13), smoking
status (1.01), low HDL cholesterol level (0.9), (p<0.001).  The results of the
study confirm the reports  regarding the  risk  factor  there  was no significant
association  of  neuropathy  with  age,  family  income,  duration  of  treatment,
smoking status, low HDL cholesterol level.
SECTION: B
STUDIES  RELATED  TO  PAIN  ON  DIABETIC  PERIPHERAL
NEUROPATHY PATIENTS:
Sarah  L.  kerein.et.al.,  (2012) conducted  a  study  to  examine  the
association between the presence and severity of chronic pain and difficulty
with  diabetic  peripheral  neuropathy  self-management,  adjusting  for
sociodemographic  and  other  health  characteristics  including  depression  in
Alexandria.  A cross-sectional  study of  993 patients  with diabetic  peripheral
neuropathy receiving care through the Department of Veterans Affairs (VA).
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Multivariable  regression  techniques  were  used.  Approximately  60%  of
respondents  reported  chronic  pain.  Patients  with  chronic  pain  had  poorer
diabetic peripheral neuropathy self-management overall (P = 0.002) and more
difficulty following a recommended exercise plan (3.0 [95% CI 2.1–4.1]) and
eating  plan  (1.6  [1.2–2.1]).  Individuals  with  severe  or  very  severe  pain,
compared  with  mild  or  moderate,  reported  significantly  poorer  diabetic
peripheral  neuropathy  self-management  (P =  0.003),  including  greater
difficulty with taking diabetes medications (2.0 [1.2–3.4]) and exercise (2.5
[1.3–5.0]). Chronic pain was prevalent in this cohort of patients with diabetic
peripheral neuropathy.
Obrad.W. et.al.,(2012)  Conducted  a  study  to  determine  the
effectiveness of diabetic leg exercises on pain and depression among diabetic
peripheral  neuropathy  patients  in  Sweeden.  The  sample  size  was  48.  True
experimental design was used in this study. The samples receives 35 minutes of
leg exercises. And also the patients encouraged to walk 30 minutes per day.
The exercises was continue for 2days per week for 4 weeks. The data were
collected using Leeds assessment of neuropathic symptoms and signs scale and
hospital  depression  scale.  The  results  showed  that  experimental  group
(7.1±2.9pre/4.71±3.4post,p<0.005)   has  a  significant  improvement  than  the
control  group (9.01±4.9pre/8.53±3.79post  (p<0.005)  for  pain  and  for  the
depression   experimental  group  has  a  significant  improvement
(5.5±2.3pre/3.7±1.9post(p<0.005) than the control group (7.54±5.2pre/5.98post
(p<0.005).
Anil  Bhensal.,(2009)  conducted  a  cross  sectional   study  on
effectiveness of exercises on pain in  Diabetic Peripheral Neuropathy patients
in North America. 110 samples were selected for the study. The patients with
diabetic peripheral neuropathy with the age group of 40-70 years was selected
for  the  study.  Two  group  exercise  group(n=55)  and  the  normal  treatment
group(n=55). Leeds assessment of neuropathic symptoms and signs scale was
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used.   It  reported that  the level of  pain scores is  significantly lower in the
experimental  group(2.56±2.01)  than  the  control  group  (4.50±2.48)  at
(Independent t=5.101) P=0.011 level of significance. And also it was less in
post test (4.31±2.3) than the pre test (7.35±1.32) ( t=13.82) at p=0.005 level of
significance.
Kevin.et.al ., (2007)   conducted a cross sectional  study on Treatment
of Chronic Painful Diabetic peripheral  Neuropathy With exercises in Spain.
The  study  was  of  double-blind,  randomized,  placebo-controlled,  cross-over
design. After a 2-week run-in period, 22 diabetic patients were randomized to
receive exercises or placebo exercises for 4 weeks. The patients administered
the  exercises  to  both  feet  in  morning.  Biweekly  pain  and  other  sensory
symptoms  were  assessed  using  a  visual  analog  scale  (VAS)  and  Leeds
assessment of neuropathic symptoms and signs scale (LANSS) reduced overall
neuropathic  pain  (P =  0.02)  and  burning  sensation  (P =  0.006).  At  study
completion,  11  patients  (50%) reported  benefit  and  wished to  continue  the
exercises, 4 (18%) preferred the placebo exercises and the remaining 7 (32%)
were  undecided.  Exercises  offers  an  alternative  and  effective  option  in
relieving  overall  pain  and  burning  sensation  in  the  management  of  painful
diabetic peripheral neuropathy. 
Joshph S.gimbel.et.al., (2007)  conducted a study on leg exercises for
pain in diabetic peripheral neuropathy in Jordan. This multicenter, randomized,
double-blind,  placebo-controlled,  parallel-group  study  included  159  subjects
with moderate to severe pain due to diabetic peripheral neuropathy. Treatment
began with selected leg exercises (n = 82) or identical placebo (n = 77) every
24 hours. Exercises lasted up to 6 weeks. Overall average daily pain intensity
measured by Leeds Assessment of Neuropathic Symptoms and Signs  Scale
Overall, 80 (96%) of 82 subjects given exercises and 52 (68%) of 77 subjects
who received placebo. The pain level was decreased for the exercise group than
the  placebo  group  (4.31  and  6.53).  In  this  6-week  trial,  leg  exercises  was
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effective for the treatment of moderate to severe pain due to diabetic peripheral
neuropathy. 
SECTION :C
STUDIES  RELATED  TO  SLEEP AMONG  DIABETIC  PERIPHERAL
NEUROPATHY PATIENTS:
Alexandra .D. et.al.,(2011)  conducted a randomized control study on
effect  of   selected leg exercises  intervention on sleep in  diabetic  peripheral
neuropathy patients  in Brisbane. 45 Sedentary individuals with type 2 diabetes
mellitus  between  ages  45-70  with  clinical  diagnosis  of  Diabetic  Peripheral
Neuropathy were selected in a 3-week, 3 days per week supervised exercise
program. The sleep was assessed by using sleep scale from medical outcome of
study. Two group were formulated. Exercise group (n=20), Normal treatment
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group (n=22).  Findings shows that the sleep in exercise group was decreased
in pretest (48.1±5.9) and increased in post test (52.09±4..34). But in normal
treatment  group  there  is  no  marked  changes  of  sleep  level
(34.7±4.9pre/37.65±5.53post).  (t=8.89;p<0.001).These  preliminary  results
shows  improvement  in  sleep  pattern  in  people  with  diabetic  peripheral
neuropathy following an exercise intervention.
Paul.et.al., [2009] Conducted a study to determine the effectiveness of
diabetic leg exercises on sleep among painful diabetic peripheral neuropathy
patients  in  Central  America.72  patients  with  diabetic  peripheral  neuropathy
were  selected  by  randomized  control  cross  over  trial  and  assigned  of  two
groups.  First  group (n=36)  and second group (36).  First  group receives the
exercises 40 minutes 3 days per week for a period of 3 weeks and  the second
group didn’t receive the exercises. The sleep pattern was assessed by the sleep
scale from medical outcome of study. The results shows that the first group
(56.71±7.43post/ 37.89±5.4pre)  has significant improvement than the second
group (43.73±4.39 post/ 25.1±4.9 pre) at p= 0.001 level of significance. The
results  shows  that  there  is  reduction  in  sleep  disturbance  level  for  the
experimental group.
Livia  S  .  lopes.et.al.,  (2008) conducted  a  study  on Restless  Legs
Syndrome and Quality of Sleep in Diabetic peripheral  neuropathy in Ceara.
The sample size was 100. The  sleep was assessed by sleep scale from medical
outcomes study. Rest less leg syndrome was found in 27% of patients. Poor
sleep quality was present in 45% of cases and was associated with age (P =
0.04),  peripheral  neuropathy  (P =  0.001),  and  restless  leg  syndrome  (P =
0.000). Excessive day time sleepiness was found in 26% of patients. Logistic
regression analysis revealed an association between restless leg syndrome and
peripheral  neuropathy (12.85 [95% CI 2.83–58.40],  P = 0.001).  restless leg
syndrome is common in type 2 diabetic peripheral neuropathy patients and can
be a major cause of sleep disruption in these patients. 
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Robin L. kruse.,(2008) conducted a cross sectional  study on Diabetic
peripheral  Neuropathy With exercises on anxiety and sleep in Australia. 85
samples were selected for the study. The type-2 diabetes patients with diabetic
peripheral neuropathy with the age group of 45-65 years was selected for the
study. Two group exercise group(n=43) and the normal treatment group(n=42).
It reported that the level of sleep scores by sleep scale from medical outcome of
study is significantly higher in the experimental group (73.45±8.73) than the
control group (63.75±7.50) at (independent t= 9.8) p<0.01 level of significance.
And the anxiety scores by hospital anxiety scale is significantly lower in the
experimental  group  (3.23±1.13)  than  the  control  group  (5.31±2.8)
at(independent t=7.51) p<0.01 level of significance.
SECTION :D 
STUDIES  RELATED  TO  EFFECTIVENESS  OF  PAIN  AND  SLEEP
AMONG DIADETIC PERIPHERAL NEUROPATHY PATIENTS:
Min yoo.et.al.,(2013)  conducted a study on effect of aerobic exercises
intervention  on  painful  diabetic  peripheral  neuropathy  in  America.  Twelve
Sedentary individuals with type 2 diabetes mellitus between ages 40-70 with
clinical diagnosis of Diabetic Peripheral Neuropathy were enrolled in a 3-week,
3 days per week supervised aerobic exercise program.  Brief Pain Inventory-
Diabetic Peripheral Neuropathy (BPI-DPN) was used to assess pain intensity
(worst,  least,  average,  now)  and  pain  interference  with  daily  life  (activity,
mood, walk, normal work, relationship, sleep, enjoyment of life) pre and post
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the  intervention.  pre  and  post  the  intervention  as  secondary  outcomes  of
interest 10 of 12 (83.3%) (5 males/5 females; age 57 ± 4.59 years; duration of
diabetes 12.2 ± 5.94 years) participants reported pain due to DPN on the BPI-
Diabetic  Peripheral  Neuropathy and were  included in  the  analysis.  In  these
participants,  significant  reductions  in  pain  interference  on  walking
(4.95±2.83pre/2.8±2.74post,0.0073),  sleep  (5.05±2.77pre/3.2±3.12  post,
P=0.0407)  were  observed  following  the  interventional.  The  overall  pain
interference was also reduced (4.50±2.48pre/2.56±2.01post, P=0.0267). These
preliminary results showed reductions in perceived pain interference in people
with painful DPN following an exercise intervention.
Huffman  C.et.al.,(2012),  conducted  a  randomized,  double-blind,
placebo-controlled  study  to  evaluated  efficacy  and  safety  of  exercises  for
treatment  of  pain  and  sleep  in  patients  with  painful  diabetic peripheral
neuropathy (DPN) who experienced pain  in  diabetic  centre  from Stamford.
Two hundred three patients were treated (exercises n=198; placebo, n=186),
with  no  statistically  significant  treatment  difference  for  exercises  versus
placebo,   in  the  co-primary  efficacy  endpoints,  mean  Diabetic  Peripheral
Neuropathy pain (0.0659) and mean Diabetic Peripheral Neuropathy pain on
walking (0.4120) and sleep(0.0213). Analysis of co-primary endpoints showed
significant  treatment  difference  for  Diabetic  Peripheral  Neuropathy  pain
(0.0338) and Diabetic Peripheral Neuropathy pain on exercises (0.0011) sleep
out  come scale (  0.4105).  .  Treatment with exercises  resulted in  significant
improvements  versus  placebo  on  prespecified  patient  global  impression  of
change  (0.0020),  sleep  out  come  scale  (0.0313).  The  exercises  are  most
effective than the treatment for reducing pain and improve sleep for patients
with diabetic peripheral neuropathy.
Nicholas.et.al., (2011) conducted a study to determine the effectiveness
of  aerobic  diabetic  leg  exercises  on  pain  and  depression  among  diabetic
peripheral  neuropathy  patients  in  Korea.  The  sample  size  was  44.  True
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experimental design was used in this study. The samples receives 30 minutes of
leg exercises. And also the patients encouraged to walk 30 minutes per day.
The exercises was continue for 3days per week for 2 weeks. The data were
collected using brief pain inventory scale and hospital depression scale. The
result  shows  that  experimental  group  has  significant  improvement  than  the
control  group  (5.97±3.75pre/  4.87±2.74post,p=0.0073),  for  pain.,  and   for
depression (4.50±2.48pre/2.56±2.01post). 
Chen.Y.C.et.al.,  (2009) Conducted  a  study  to  determine  the
effectiveness of aerobic diabetic leg exercises on sleep among painful diabetic
peripheral neuropathy patients in China. 32 patients with diabetic peripheral
neuropathy were selected by randomized control cross over trial and assigned
of two groups. The sleep scale from medical outcome of study was used to
assess the sleep pattern. Patient in first group were taught aerobic diabetic leg
exercises  and  practiced  daily  in  home  for  three  weeks.  The  results  were
analysed  with  a  variation  in  the  sleep  ,  symptoms  of  neuropathic   pain.
Compared to the control group(19.7) (p=0.01, the sleep scores were increased
(31.2)  (p=0.01)  in  experimental  group  indicating  that  aerobic  diabetic  leg
exercises  had  a  significant  effect  in  sleep.  The  result  reveals  that  there  is
reduction in sleep disturbance level for the experimental group.
Jeffrey  s.  Gonzalez.,(2009)  A  randomized,  placebo-controlled  study
was conducted to evaluate the effectiveness of exercises for treatment of pain
and  sleep  in  patients  with  diabetic peripheral  neuropathy (DPN)  who
experienced  pain  in  Sismut.  150  patients  were  selected  for  the  study  with
purposive sampling and the age group was 40-65 years.  The subjects  were
divided into two groups the exercise group(n=78) and the placebo group(n=72).
The  results  are  the  pain  level  was  significantly  lower  in  the  post  test
(14.32±5.1pre/7.32±4.1 post‘t value10.91: p<0.01) the sleep score was higher
in  the  post  test  (37±7.9pre/54.05±6.3post:’t’  value21.13:p<0.01).  And  the
independent  value  was  checked  for  pain  (17.23±1.31placebo/  10.21±3.7
exercise)  (independent‘t’:9.71:p<0.01)  and  sleep  (27.1±8.1placebo/  52.0±5.3
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exercise) (Independent ’t’ :8.74:p<0.001). And the relationship was find that
reported that pain (8.71±3.7) and sleep (53.29±4.3) had a negative relationship
(r=(-0.9)., p=0.01) it shows that the exercise was effective in reducing pain and
improving  sleep  pattern  and  the  relationship  shows  that  if  the  pain  level
decreased the sleep pattern was improved in  diabetic  peripheral  neuropathy
patients. 
Swenson.M  .et.al.,  (2006)A  cross  sectional  observational  study  was
conducted on glycaemic control and exercises diabetic complications and their
awareness among 200 diabetes patients in Egypt. The subjects were monitored
regarding  the  control  of  diabetes,  examined  for  micro  and  macro  vascular
complications  and  were  interviewed  about  their  awareness  and  education
regarding diabetes and its complications(micro and macro vascular). The result
showed that the overall glycaemic control was very poor with 81% having an
HbA1c of more than 7%. retinopathy was present in 31%, neuropathy in36%
and nephropathy  in  24%.  It  revealed  that  31% had diabetic  foot  problems,
while  only  38%  had  awareness  or  education  about  diabetes  and  its
complications. The study concluded that along with poor glycaemia control, a
high frequency of complications with poor awareness occurs.
SECTION E:-
STUDIES  RELATED  TO  NURSES  ROLE  IN  EXERCISES  ON  PAIN
AND  SLEEP AMONG  PATIENTS  WITH  DIABETIC  PERIPHERAL
NEUROPATHY:
Amanda boyd.et.al.,(2011) conducted a study on Effects of diabetic leg
exercises on pain and sleep, patients with diabetic peripheral neuropathy. Quasi
experimental design was used.45 patients fromNew Jersy diabetic clinic were
randomly selected and before exercises the pain and sleep level was assessed.
The exercises consisted  of  walking.  Foot  massage,  foot  rolling,  calf  muscle
exercises and marching. Significant improvement was shown in on sleep scale
from  medical  outcome  of  study  (n =  40)  from  67.1 to  72.4, neurological
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symptom score was improved from 5.5(2.3) to 4.3(0.65)(p=0.007),sensory and
motor impairment score was improved with 18.8(2.15) to 12.1(1.71) (p=0.003).
Abeer A. Yamany.et.al.,(2011) conducted  a randamised  control trial to
evaluate the effect of low level foot exercises on pain and sleep among diabetic
peripheral neuropathy patients in hospital setting in United Kingdom. 30 male
and female patients with painful diabetic neuropathy participated in this study.
Their ages ranged from 45 to 60 years with a mean of 52.1 ± SD 4.7 years.
Patients were randomly assigned into two equal groups of 15, an active foot
exercises group(experimental) and a placebo exercises group (control group).
The exercises group received foot exercises for 40 minutes per day for a period
of 2 weeks). Pain intensity via, Leeds Assessment of Neuropathic Signs And
Symptoms Scale, and Sleep Scale from Medical outcome of Study  pre- and
post  for  both  groups.  Pain  was  significantly  decreased  from  9.21  to  4.37
(p < 0.05)  and  sleep  score  were  significantly  improved  from  31.2  to  48.9
(p <0.05) in the exercise group, while no significant change was obtained in the
control  group.  Low  level  exercises  and  technique  could  be  an  effective
therapeutic  modality  in  reducing pain  and improving  sleep  in  patients  with
diabetic peripheral neuropathy.
CHAPTER III
METHODOLOGY
This  chapter  includes  research  approach,  research  design,  research
setting, population, sample size, criteria for selection of sample, description of
the tool, scoring procedure, validity, reliability, pilot study, and method of data
collection and plan for data analysis and protecting the human subjects.
RESEARCH APPROACH:
       An evaluative approach was used for this study
RESEARCH DESIGN:
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    The research design was quasi experimental non equivalent pre test and
post test control group design which was adopted to assess the effectiveness of
exercises  on  pain  and  sleep  among  patients  with  diabetic  peripheral
neuropathy.
Schematic representation 
GROUP PRETES
T
INTERVENTION POST TEST
Experimental
group
O1 X O2
Control group O1 - O2
O1- Collection of demographic data, pretest to assess the level of pain
and sleep  among patients with diabetic peripheral neuropathy in
experimental and control group.
X - exercises was given for 30 minutes once in a day for a period of
15 days individually in experimental group
O2- Post test to assess the level of pain and sleep among patients with
diabetic peripheral neuropathy in experimental and control group.
RESEARCH SETTING:
The study was conducted in Saraswathy Ramasamy Changanithi (SRC)
diabetes care centre Erode for experimental group and Monika diabetes centre
Erode for control group. Saraswathy Ramasamy Changanithi (SRC) diabetes
care centre is a 45 bedded diabetic speciality hospital having four floors. The
number  of  average  out  patients  is  about  70  per  day.  In  which  26-30  are
diagnosed  to  have  diabetic  peripheral  neuropathy  and  inpatients  cases  of
diabetic peripheral neuropathy were about 40-45 per month.
The Monika diabetes centre is a 40 bedded diabetic speciality hospital
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having 3 floors. The number of average out patients is about 60 per day. In
which 25 are diagnosed to have diabetic peripheral neuropathy and inpatients
cases  of  diabetic  peripheral  neuropathy  were  about  35-40 per   month.  The
distance between these two hospitals were around 3km.
POPULATION:
The  target  population  selected  for  the  study  was  patients  who  were
diagnosed with diabetic peripheral neuropathy.
SAMPLE:
Patient with diabetic peripheral neuropathy who were admitted in SRC
diabetes care centre, Erode and Monika diabetes centre, Erode.
CRITERIA FOR SELECTION OF SAMPLE:
INCLUSION CRITERIA:
• Patients with age group of 30years and above
• Both male and female patients 
• Patients who were admitted in the inpatient department  for a minimum
stay of 16 days 
• Patients who have type 2 diabetes mellitus 
• Patients who are willing to participate
EXCLUSION CRITERIA:
¾ Patients who are critically ill
¾ Patients who had foot ulcer.
SAMPLE SIZE AND SAMPLING PROCEDURE:
SAMPLE SIZE:
The sample size for the study consists of 60 samples in that 30 were in
experimental group and 30 were in control group.
SAMPLING TECHNIQUE:
Non probability purposive sampling technique was used to select  the
samples for the study. For experimental group 30 samples were selected from
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SRC  diabetes  care  centre,  Erode  and  for  control  group  30  samples  were
selected from Monika diabetes centre, Erode.
INSTRUMENT AND SCORING PROCEDURE:
INSTRUMENT:
  The tool consists of three parts.
PART-I:
     It consists of demographic variable such as the age, sex, marital status,
educational status, occupation, religion, family monthly income, type of family,
area  of  residence,  duration  of  diabetic  peripheral  neuropathy,  duration  of
treatment for diabetic peripheral neuropathy. 
PART-II;
Leeds Assessment of Neuropathic Symptoms and Signs scale was used
to assess the level of pain among patients with diabetic peripheral neuropathy.
The  tool  was  adopted  from  M.I.  Bennett  (2001).  Which  consist  of   7
dichotomus questions. It was rated as, Yes answer for 1st ,2nd and 6th questions
scored as 5marks, 3rd and 7th questions scored as 3marks, 4th question scored as
2marks, 5th question scored as 1mark. No answer scored as ‘0’ mark. The total
score was 24. 
PART-III:
Sleep scale from medical outcomes study was used to assess the level of
sleep  among  patients  with  diabetic  peripheral  neuropathy.  This  tool  was
adopted from Hays.R.D., and Stewart.A.L. (1992). Which consist of 12 items
1st question scored as, more than 60 minutes 1 mark, 46-60 minutes 2 mark, 31-
45 minutes 3 mark 16-30minutes 4 mark, 0-15 minutes 5 marks and the 2nd
question scored as 0-2 hours 1 mark, 3-4 hours 2 marks, 5-6 hours 3 marks, 7-8
hours 4 marks. Question number 3-12 was rated as all of the time-1, most of
the time-2, a good bit of the time-3, some of the time-4, a little of the time-5,
none of the time-6. Total score was 69. 
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SCORING PROCEDURE:
Part II:
Leeds Assessment of neuropathic Symptoms and Signs scale was used
to assess the pain level of the patient.
The score is interpreted as follows,
Leeds Assessment of 
Neuropathic Symptoms and 
Signs scale
Score
Percentage
(%)
Non neuropathic pain
Mild neuropathic pain
Moderate neuropathic pain
Severe neuropathic pain
0-12
13-16
17-20
21-24
0-50
51-66
67-83
84-100
Part III:
Sleep scale from medical outcome of study was used to assess the sleep
level of the patient.
The score was interpreted as follows, 
Sleep scale from medical
outcome of study
Score Percentage (%)
Good sleep
Poor sleep
Very poor sleep
51-69
32-50
12-31
73-100
45-72
0-44
VALIDITY AND RELIABILITY OF THE TOOL:
VALIDITY:
The validity of the tool was established in consultation with four nursing
experts and one diabetalogist. It was modified according to the suggestions and
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recommendation of the experts.
RELIABILITY:
The  reliability  of  the  Leeds  assessment  of  neuropathic  signs  and
symptoms  scale  was  established  by  testing  the  internal  consistency  using
cronbach’s alpha formula was used and found to be reliable (r=0.9). Reliability
0f  the sleep  scale  was  established  by testing the internal  consistency  using
cronbach’s alpha formula was used and found to be reliable(r=0.9).
PILOT STUDY:
Pilot study was conducted in selected diabetic centers in erode.  The
researcher  selected  S.R.C  diabetic  centre  and  Monika  diabetic  centre  for
experimental  and control  group.  The researcher obtained written permission
from the institution and oral permission from the participants, prior to the study
the purpose of the exercises was explained to the subjects. The pilot study was
conducted for a period of 15 days. The data was collected from 10 samples, 5
samples in experimental group and 5 samples in control group. On the first day
pre test questionnaire such as Leeds Assessment of Neuropathic Symptoms and
Signs scale to assess the level of pain and sleep scale from medical outcome of
study to  assess  the level  of  sleep was administered.  Exercises  given  to  the
subjects individually for 15 days in experimental group. Each session lasts for
about  30 minutes per day.  On the 16th day post  test  was conducted for the
experimental group, where as in control group pre test was conducted on the 1st
day and on the 16th day post test was conducted by using same tool.            
Findings of the pilot study showed that in experimental group the mean
post test scores of level of pain [6.8 (SD±3.11)] was significantly lower than
the mean pre test scores of level of pain [19(SD±3.8)]. The paired ‘t’ value was
5.41(table value=2.78) which was significant at p<0.05 level. In experimental
group  the  mean  post  test  level  of  sleep  scores  [49.4(SD±4.67)]  was
significantly higher than the mean pretest  level of sleep scores [35.2(SD±5.4)].
Paired ‘t’ value was 10.2 (table value=2.78) which was significant at p<0.05
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level.  The  mean  post  test  level  of  pain  scores  in  experimental  group  [6.8
(SD±3.11)] was significantly lower than the mean post test level of pain scores
in control group [17.2(SD±1.3)].  The independent ‘t’ value was 6.91 (table
value=2.31) which was significant at p<0.05 level. The mean post test level of
sleep scores in experimental group [49.4(SD±4.67)] was significantly higher
than the mean posttest level of sleep scores in control group [27.8(SD±6.27)].
Independent  ‘t’  value was 6.17 (table value=2.31)  which was significant  at
p<0.05  level.  The  pilot  study  revealed  that  the  study  was  feasible  and
practicable to conduct main study.
DATACOLLECTION PROCEDURE:
The main study was conducted in SRC diabetes care centre and Monika
diabetes centre Erode. Data collection was done for a period of 5 weeks. The
investigator obtained written permission from the hospital. The oral permission
was obtained from each participants prior to the study. Based on the inclusion
criteria  60  samples  were  selected  by  using  purposive  sampling  technique.
Every day 2-3 samples were selected for each group.                                
On 1st day in experimental  group data pertaining to the demographic
variables was collected by interview and then pre test was conducted to the
participants by using Leeds Assessment of Neuropathic Symptoms and Signs
scale to assess the level of pain, and sleep scale from medical outcome of study
to  assess  sleep pattern.  Exercises  was taught  to  the participants  as  a  single
session of 30 minutes per day individually and made them to practice for 15
days.  During each session the patients were supervised by the investigator.
After  the intervention post  test  was conducted on the 16th day.  For  control
group the demographic variables was collected by interview then the pretest
was conducted on the 1st day and on the 16th day post test was conducted by
using Leeds Assessment of Neuropathic Symptoms and Signs scale to assess
the level of pain and sleep scale from medical outcome of study to assess sleep
status. The same procedure was followed for the remaining 30 samples and
data were collected. The collected data were analysed by using descriptive and
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inferential statistics.
PLAN FOR DATA ANALYSIS
                 Descriptive and inferential statistics were used for data analysis. 
DATA
ANALYSIS
METHOD PURPOSE
Descriptive
statistics 
Inferential
statistics 
Frequency,
percentage
Mean,
Standard
deviation 
Paired ’t’  test
Independent
‘t’ test 
 
KarlPearson
correlation(r)
‘Chi  square’
test
 
¾ To describe the demographic variables of patients
with diabetic peripheral neuropathy
¾ To assess the pre test  and post  test  level  of pain
among patients with diabetic peripheral neuropathy
in experimental group and control group.
¾ To assess the pre test and post test level of sleep
among patients with diabetic peripheral neuropathy
in experimental group and control group.
¾ Comparison between the pre test and post test level
of  pain  among  patients  with  diabetic  peripheral
neuropathy in experimental  group.
¾ Comparison between the pre test and post test level
of  sleep  among  patients  with  diabetic  peripheral
neuropathy in experimental  group.
¾ To  find  the  effectiveness  of  exercises  on  pain
among patients with diabetic peripheral neuropathy
between experimental and control group. 
¾ To  find  the  effectiveness  of  exercises  on  sleep
among patients with diabetic peripheral neuropathy
between experimental and control group.
¾  To find out the relationship between the post test
level of pain and sleep in experimental group.
¾ To find the association between the post test  level
of  pain  among patients  with diabetic peripheral
neuropathy  with  their  selected  demographic
variables in experimental group.
¾ To find the association between the post test  level
of   sleep among patients  with diabetic  peripheral
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neuropathy  with  their  selected  demographic
variables in experimental group. 
PROTECTING THE HUMAN SUBJECTS:
The research proposal was approved by the dissertation committee prior
to the conduction of the study. The written permission was obtained from the
managing director of SRC diabetes care centre and Monika diabetes centre.
Oral consent was obtained from each sample before starting the data collection
and collected data were kept in confidential.
CHAPTER IV
DATA ANALYSIS AND INTERPRETATION
This  chapter  deals  with  the  analysis  and  interpretation  of  the  data
collected  to  assess  the  effectiveness  of  exercises  on  pain  and  sleep  among
patients with diabetic peripheral neuropathy in selected diabetic centers, Erode.
ORGANIZATION OF DATA
The data has been tabulated and organized as follows,
SECTION A:  
Distribution  of  demographic  variables  of  patients with  diabetic
peripheral neuropathy in experimental and control group.
SECTION B:    
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Assess  the  pretest  and  post  test  level  of  pain  among  patients  with
diabetic peripheral neuropathy in experimental and control group.
SECTION C:  
Assess  the  pretest  and  post  test  level  of  sleep  among  patients  with
diabetic peripheral neuropathy in experimental and control group.
SECTION D:    
Comparison  between  the  pre  test  and  posttest  level  of  pain  among
patients with diabetic peripheral neuropathy in experimental and control group.
SECTION E:     
Comparison  between  the  pretest  and  posttest  level  of  sleep  among
patients with diabetic peripheral neuropathy in experimental and control group.
SECTION F:     
Find the effectiveness of exercises on pain among patients with diabetic
peripheral neuropathy between experimental and control group.
SECTION G:   
 Find  the  effectiveness  of  exercises  on  sleep  among  patients  with
diabetic peripheral neuropathy between experimental and control group.
SECTION H:       
Find the relationship between the posttest level of pain and sleep among
patients with diabetic peripheral neuropathy in experimental group.
SECTION I:       
Find the association between posttest level of pain among patients with
diabetic  peripheral  neuropathy  and  their  selected  demographic  variables  in
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experimental group.
SECTION J :       
 Find the association between posttest level of sleep among patients with
diabetic  peripheral  neuropathy  and  their  selected  demographic  variables  in
experimental group.
SECTION A:  DISTRIBUTION OF DEMOGRAPHIC VARIABLES
OF  PATIENTS  WITH  DIABETIC  PERIPHERAL
NEUROPATHY  IN  EXPERIMENTAL  AND
CONTROL GROUP.
TABLE I:    Frequency and percentage distribution of demographic
variables   among  patients  with  diabetic  peripheral
neuropathy in experimental and control group:
                                                                                n1=30; n2=30
S.
NO DEMOGRAPHICVARIABLES
Experimental
Group
Control
Group
F % F %
1 Age in years
a) 30-40 years
b) 41-50 years
c) 51-55 years
d) Above 55 years
6
12
7
5
20
40
23.3
16.7
4
14
7
5
13.3
46.7
23.3
16.7
125
2 Sex
a) Male
b) Female 
18
12
60
40
16
14
53.3
46.7
3 Marital status
a) Married
b) Unmarried
c) Others 
27
-
3
90
-
10
30
-
-
100
-
-
4 Educational status
a) No formal education
b) Primary education
c) Higher secondary education
d) Graduate 
7
11
7
5
23.3
36.7
23.3
16.7
7
12
10
1
23.3
40
33.3
3.4
    
S.
NO DEMOGRAPHICVARIABLES
EXPERIMEN
TAL GROUP
CONTROL
GROUP
F % F %
5 Religion 
a) Hindu
b) Muslim
c) Christian
d) Others 
17
5
8
-
56.7
16.7
26.6
-
16
3
11
-
53.3
10
36.7
-
6 Occupation
a) Coolie
b) Private employee
c) Government employee
d) Self employee
10
7
5
8
33.3
23.3
16.7
26.7
10
5
8
7
33.3
16.7
26.7
23.3
7 Family monthly income 
a) Rs.2000-4000
b) Rs.4001-6000
c) Rs.6001-8000
d) Above Rs.8001
4
10
10
6
13.4
33.3
33.3
20
9
7
8
6
30
23.3
26.7
20
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8 Type of family
a) Nuclear family
b) Joint family
22
8
73.3
26.7
22
8
73.3
26.7
9 Area of residence
a) Urban
b) Rural 
16
14
53.3
46.7
15
15
50
50
10 Duration of diabetic 
peripheral neuropathy
a) 1-3 years
b) 3-5 years
c) >5 years
20
8
2
66.7
26.7
6.6
11
6
13
36.7
20
43.3
S.
NO DEMOGRAPHICVARIABLES
EXPERIMEN
TAL GROUP
CONTROL
GROUP
F % F %
11 Duration  of  treatment  for
diabetic peripheral neuropathy
a) 1-3 years
b) 3-5 years
c) >5 years
28
1
1
93.3
3.3
3.4
13
12
5
43.3
40
16.7
       Table  1 showed  that Regarding  age  in  experimental  group,
majority12(40%) belonged to the age group of 41-50 years,7(23.3%) belonged
to  51-55  years,  6(20%)  belonged  to  30-40  years  and  remaining   5(16.7%)
belonged to above 55 years. In control group majority 14(46.7%) belonged to
41-50 years, 7(23.3%) belonged to 51-55 years, 5(16.7%) belonged to above 55
years and remaining 4 (13.3%) belonged to 30-40 years.(fig:2) 
         Regarding to sex, in experimental group, 18(60%) were males and
12(40%) were females. In control group, 16(53.3%) were males and 14(46.7%)
were females. (fig:3)
         Regarding marital status in experimental group 27(90%) were married
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and 3(10%) were widow. In control group 30(100%) were married.(fig:4)
Regarding  educational  status  in  experimental  group,  majority  of  the
patients 11(36.7%)  had  primary education, 7(23.3%)  had no formal education
and 7(23.3%) had higher secondary education and 5 (16.7%) were graduates. In
control group, majority of the  patients 12(40%)  had  primary education and
10(33.3%)  had higher secondary education,7(23.3%) had no formal education,
and 1(3.4%) were  graduates .(fig:5)
Regarding religion in experimental group, majority 17(56.7%) belonged
to  Hindu  religion,  8(26.6%)  belonged  to  Christian  religion  and  5(16.7%)
belonged to Muslim religion. In control group majority 16(53.3%) belonged to
Hindu religion, 11(36.7%) belonged to Christian religion, and 3(10%) belonged
to Muslim religion. (fig:6) 
Regarding occupation in experimental group, majority 10(33.3%) were
coolie workers, 8(26.7%) were self employee, 7(23.3%) were private employee
and 5(16.7%) was government employee. In control group majority 10(33.3%)
were coolie workers, 8(26.7%) were government employee ,7(23,3%) were self
employee,5(1316.7%) were private employee.(fig:7)
Regarding  family  monthly  income,  in  experimental  group  majority
10(33.3%) were in between Rs 4001-Rs.6000, 10(33.3%) were in between Rs
6001-Rs.8000, 6 (20%) were in between above Rs.8001 and 4 (13.4%) were
Rs.2000-Rs.4000. In control group majority 9(30%) were in between Rs 2000-
Rs.4000,  8(26.7%)  were  in  between  Rs  6001-Rs.8000,  7  (23.3%)  were
Rs.4001-Rs.6000 and 6(20%) were above Rs.8001. (fig:8)
Regarding type of family in experimental group 22 (73.3%) were from
nuclear  family  and  8(26.7%)  were  from joint  family.  In  control  group  the
patients 22(73.3%) were from nuclear family and 8(26.7%) were from joint
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family.(fig:9)
Regarding area of residence in experimental group, majority 16(53.3%)
were  in  urban  area  and  14(46.7%)  were  in  rural  area.  In  control  group
majority15(50%) were in urban area and 15(50%) were in rural area. (fig:10)
Regarding duration of diabetic peripheral neuropathy, in experimental
group 20(66.7%) had duration of illness for 1-3 years, 8(26.7%) had duration
of  3-5  years  and  2(6.6%)  had  above  5  years.  In  control  group  majority
13(43.4%) had above 5 years, 11(36.7%) had the illness for 1- 3 years had,
6(20%) had duration of illness for 3-5 years. (fig:11)
Regarding duration of treatment, in experimental group 28(93.3%) had
duration of treatment for a period of 1-3year ,1(3.3%) had duration of treatment
for a period of 3-5 years,1(3.4%) had a duration of treatment for a period of
above 5 years,. In control group majority 13(43.3%) had duration of treatment
for a period of 1-3 years, 12(40%) had duration of treatment for a period of 3-5
years, 5(16.7%) had duration of treatment for a period of above 5 years.(fig12)
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AGE IN YEARS
Figure 2:  Percentage distribution of patients with diabetic peripheral neuropathy according to their age in years  in 
experimental and control group.
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Figure 5:  Percentage distribution of patients with diabetic peripheral neuropathy according to their educational satus 
in experimental and control group.
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OCCUPATION
Figure 7:  Percentage distribution of patients with diabetic peripheral neuropathy according to their occupation in 
experimental and control group.
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FAMILY MONTHLY INCOME
Figure 8:  Percentage distribution of patients with diabetic peripheral neuropathy according to their family monthly 
income in experimental and control group.
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Figure 9:  Percentage distribution of patients with diabetic peripheral neuropathy according to their type of family in 
experimental and control group.
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Figure 10:  Percentage distribution of patients with diabetic peripheral neuropathy according to their area of residence
in experimental and control group.
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Figure 11:  Percentage distribution of patients with diabetic peripheral neuropathy according to their duration of 
diabetic peripheral neuropathy in experimental and control group.

SECTION B : ASSESS  THE  PRETEST  AND  POST  TEST  LEVEL OF PAIN
AMONG  PATIENTS  WITH  DIABETIC  PERIPHERAL  NEUROPATHY  IN
EXPERIMENTAL AND CONTROL GROUP.
TABLE 2 :   Frequency and percentage distribution of pre test and post test level
of  pain  among patients  with diabetic  peripheral  neuropathy in experimental  and control
group
                                                                                                      n1 =30    n2 =30
S. 
No LEVEL OF PAIN
PRETEST POSTTEST
Experime
ntal 
group
Control 
group
Experime
ntal group
Control 
group
F % F % F % F %
1 Non neuropathic pain - - - - 24 80 1 3.3
2 Mild neuropathic pain 6 20 10 33.3 6 20 14 46.7
3 Moderate neuropathic 
pain
16 53.3 13 43.3 - - 13 43.3
4 Severe neuropathic pain 8 26.7 7 23.4 - - 2 6.7
           
 Table 2 shows that in pretest 6(20%) had mild neuropathic pain, 16(53.3%) had moderate neuropathic pain, 8 (26.7%)
had severe neuropathic pain in experimental group. In control group 10 (33.3%) had mild neuropathic pain, 13(43.3%) had
moderate neuropathic pain and 7 (23.4%) had severe neuropathic pain. In post test 24(80%) had non neuropathic pain, 6(20%)
had mild neuropathic pain in experimental group. In control group, 1(3.3%) had non neuropathic pain, 14(46.7%) had mild
neuropathic pain, 13(43.3%) had moderate neuropathic pain and 2(6.7%) had severe neuropathic pain. (fig:13)

SECTION   C :    ASSESS THE PRE TEST AND POST TEST LEVEL OF SLEEP
AMONG  PATIENTS  WITH  DIABETIC  PERIPHERAL  NEUROPATHY  IN
EXPERIMENTAL AND CONTROL GROUP.
TABLE 3 :    Frequency and percentage distribution of pre test and post test level
of sleep among patients with diabetic peripheral neuropathy in experimental and control
group
                                                                                        n1 =30      n2 =30
S. 
No
LEVEL OF 
SLEEP
PRE TEST POST TEST
Experimen
tal group
Control 
group
Experimenta
l group
Control 
group
F % F % F % F %
1 Good sleep - - - - 16 53.3 - -
2 Poor sleep 4 13.3 2 6.7 14 46.7 18 60
3 Very poor sleep 26 86.7 28 93.3 - - 12 40
                     
Table 3   shows that in pre test 4(13.3%) had poor sleep, 26(86.7%) had very poor sleep in experimental group. In
control group 2(6.7%) had poor sleep, 28(93.3%) had very poor sleep. In post test 16(53.3%) had good sleep, 14(46.7%) had
poor sleep in experimental group. In control group 18(60%) had poor sleep, 12(40%)had very poor sleep.(fig 14) 


SECTION   D:    COMPARISON  BETWEEN  THE  PRE  AND
POST  TEST  LEVEL  OF  PAIN  AMONG
PATIENTS  WITH  DIABETIC  PERIPHERAL
NEUROPATHY IN EXPERIMENTAL GROUP
TABLE 4:    Comparison of mean score, standard deviation,
mean difference and paired ‘t’ value of pretest
and post test level of pain among patients with
diabetic peripheral neuropathy in experimental
group
n=30
S.
No Variable
Mea
n
Standar
d
deviatio
n
Mean
differenc
e
Paired
‘t’
value
Table
value
In
fe
re
nc
e
1
2
Pre test
Post test
18.3
9.6
2.67
3.15 7 12.82 2.045 S
    df= 29         S-significance                              p<0.05
Table 4 shows that the mean pretest and post test scores of level of pain
in experimental group is 18.3 (SD+ 2.67) and 9.6 (SD+3.15) respectively. The
mean difference is 8.7. the paired  ‘t’ value was 12.87 which was significant at
p<0.05 level. The findings revealed that the exercises was effective in reducing
the pain level among patients with diabetic peripheral neuropathy. Therefore
the  research  hypotheses  H1  that, the  mean  post  test  level  of  pain  score  is
significantly lower than the mean pre test level of pain score in experimental
group, was accepted.
 
SECTION   E: COMPARISON  BETWEEN  THE  PRE  AND
POST  TEST  LEVEL  OF  SLEEP  AMONG
PATIENTS  WITH  DIABETIC  PERIPHERAL
NEUROPATHY IN EXPERIMENTAL GROUP.
TABLE 5:    Comparison  of  mean
score,  standard  deviation,  mean  difference  and
paired ‘t’ value of pretest and post test level of
sleep  among  patients  with  diabetic  peripheral
neuropathy in experimental group
n=30       
S.  
No Variable
Mea
n
Standar
d 
deviation
Mean 
difference
Paired 
‘t’ 
value
Table 
value
In
fe
re
nc
e
1
2
Pre test
Post test
29.1
47.7
3.23
5.56
18.6 16.39 2.045 S
df= 29 S =significance      p<0.05
                  
 Table 5 shows that the mean pretest and post test scores of level of
sleep  in  experimental  group  is  29.1  (SD+ 3.23)  and  47.7  (SD+5.56)
respectively. The mean difference is 18.6. the ‘t’ value was 16.39 which was
significant  at  p<0.05  level.  The  finding  revealed  that  the  exercises  was
effective  in  improving  the  level  of  sleep  among  patients  with  diabetic
peripheral neuropathy. Therefore the research hypotheses H2 that, the mean post
test level of sleep score is significantly higher than the mean pre test level of
sleep score in experimental group , was accepted 
 
SECTION  F:   FIND THE EFFECTIVENESS OF EXERCISES
ON  PAIN  AMONG  PATIENTS  WITH
DIABETIC  PERIPHERAL  NEUROPATHY
BETWEEN  EXPERIMENTAL  AND
CONTROL GROUP 
TABLE 6:    Effectiveness  of  exercises  on  mean  score,
standard  deviation,  mean  difference  and
independent  ‘t’ value of post test level of pain
among  patients  with  diabetic  peripheral
neuropathy between  experimental and control
group
                                                                                           n1 =30    n2 =30
Ex
per
ime
ntal
Gr
oup
Gr
oup
Me
anS
tan
dar
d 
dev
iati
on
Me
an 
diff
ere
nce
Ind
epe
nde
nt‘t
’ 
val
ueT
Group Mean Standar
d
deviation
Mean
difference
Independen
t
‘t’ value
Table
value
I
n
f
e
r
e
n
c
e
abl
e 
val
ueI
nfe
ren
ceS
.  
No
S
2.0
0
8.8
8
13.
5
5.5
6
7.0
3
47.
7
34.
2
Con
trol
Gro
up
1
2
df
=5
8   
S-
sig
nif
ica
nc
e   
( P
<0
.05
)
T
abl
e  6
sho
ws
that
the
mea
n
post
test
scor
es
of
pai
n
am
ong
pati
ents
wit
hdia
beti
c
peri
phe
ral
neu
rop
ath
y in
exp
eri
me
ntal
and
con
trol
gro
up
wer
e
9.6
(SD
±3.
15)
and
15.
9(S
D±
2.9
9)
resp
ecti
vel
y.
The
mea
n
diff
ere
nce
was
6.3.
The
ind
epe
nde
nt
‘t’
val
ue
was
8.5
1w
hic
h
was
sign
ific
ant
at
p<0
.05
leve
l.
The
find
ings
rev
eale
d
that
the
exe
rcis
es
was
effe
ctiv
e  in
dec
reas
ing
pai
n
fro
m
pre
to
post
inte
rve
ntio
n
co
mp
are
d
bet
wee
n
exp
eri
me
ntal
and
con
trol
gro
up
of
pati
ents
wit
h
dia
beti
c
peri
phe
ral
neu
rop
ath
y.
The
refo
re
the
rese
arc
h
hyp
oth
eses
H3
that
,
the
mea
n
post
test
leve
l  of
pai
n
scor
e  in
exp
eri
me
ntal
gro
up
is
sign
ific
antl
y
low
er
tha
n
the
mea
n
post
test
leve
l  of
pai
n
scor
e  in
con
trol
gro
up,
was
acc
epte
d.
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an
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re,
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rd
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on,
me
an
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ere
nce
and
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epe
nde
nt
‘t’
val
ue
of
pos
t
test
leve
l  of
slee
p
am
ong
pati
ent
s
wit
h
dia
beti
c
per
iph
eral
neu
rop
ath
y
bet
wee
nexp
eri
me
ntal
and
con
trol
gro
up
n
=3
n
=3
S.
No
S
2.0
0
8.5
1
6.3
3.1
5
2.9
9
9.6
15.
9
Experimental Groupdf=58                                          S- significance
( P <0.05)
Table 7 shows that the mean post test scores of pain among patients
with diabetic  peripheral  neuropathy in experimental  and control  group were
47.7 (SD±5.56) and 34.2(SD±7.03)  respectively.   The mean difference was
13.5.The independent ‘t’ value was 8.88which was significant at p<0.05 level.
The findings revealed that the exercises was effective in improving level of
sleep level from pre to post intervention compared between experimental and
control group of  patients with diabetic peripheral neuropathy. Therefore the
research  hypothesis  H4  that,  the  mean  post  test  level  of  sleep  score  in
experimental group is significantly higher than the mean post test level of sleep
score in control group,was accepted.
SECTION H: FIND THE RELATIONSHIP BETWEEN THE
POST  TEST  LEVEL OF PAIN  AND  SLEEP
AMONG  PATIENTS  WITH  DIABETIC
PERIPHERAL  NEUROPATHY  IN
EXPERIMENTAL GROUP.
TABLE 8 : Relationship between the post test level of pain
and  sleep  among  patients  with  diabetic
peripheral neuropathy in experimental group.
n=30
Sl.
No
Variable Mean
Standard 
deviation
Mean 
difference
‘r’  value
Table 
value
1
2
Pain 
Sleep 
9.6
47.7
3.15
5.56
38.1 -0.9 0.349
    df=28                                                                                     ( P <0.05)
Table 8 shows that the mean post test scores of pain and sleep among
patients  with  diabetic  peripheral  neuropathy  in  experimental  group  were
9.6(SD±3.15) and 47.7 (SD±5.56) respectively. The mean difference was 38.1.
The ‘r’ value was  -0.9 which shows that negative relationship between pain
and  sleep  scores   among  patients  with  diabetic  peripheral  neuropathy  in
experimental group. It explains that if pain level decreased sleep pattern was
improved.   Therefore  the research hypotheses H5  that,  there  is  a  significant
relationship between post test level of pain score and post test level of sleep
score  among  patients  with  diabetic  peripheral  neuropathy  in  experimental
group was accepted.
SECTION I: ASSOCIATION BETWEEN THE POST TEST
LEVEL OF  PAIN AMONG PATIENTS WITH
DIABETIC  PERIPHERAL  NEUROPATHY
AND  THEIR  SELECTED  DEMOGRAPHIC
VARIABLES IN EXPERIMENTAL GROUP.
Table:9: Association between the post  test  level  of  Pain
among  patients  with  Diabetic  Peripheral
Neuropathy and  their  selected  demographic
variables in experimental group. 
n=30
S. No
Demographic
Variables
Level Of Pain
χ2
Ta
bl
e 
va
lu
e
In
fe
re
nc
e
Non
neuropath
ic pain
Mild
neuropathic
pain
Moderate
neuropath
ic  pain
Severe
neuropat
hic pain
F % F % F % F %
In
fe
re
nc
e

10
a)
b)
c)
Duration of 
Diabetic
Peripheral 
Neuropathy
1-3 years
3-5 years
>5 years 
17
5
2
56.7
16.7
6.6
3
3
-
10
10
-
-
-
-
-
-
-
-
-
-
-
-
-
1.93 5.99
df=2
NS
11
a)
b)
c)
Duration  of
treatment for 
Diabetic
Peripheral
Neuropathy
1-3 years
3-5 years
>5 years
22
1
1
73.4
3.3
3.3
6
-
-
20
-
-
-
-
-
-
-
-
-
-
-
-
-
-
7.66 5.99
df=2
S
NS=nonsignificance         S=significance                         p<0.05
Table  9: Chi  Square  values  were  calculated  to  find  the  association
between post test level of pain scores among patients with diabetic peripheral
neuropathy  in  experimental  group.  The  findings  revealed  that  there  was  a
significant  association  between  marital  status  (χ2 =7.74),  family  monthly
income (χ2 =9.65), duration of treatment for diabetic peripheral neuropathy (χ2
=7.66) in experimental group at  p<0.05 level of significance.  There was no
significant  association  between  age,  sex,  educational  status,  religion,
occupation, types of family, area of residence, duration of diabetic peripheral
neuropathy in experimental group. Therefore the research hypothesis H6 that,
there is a significant association between post test level of pain score among
patients  with  diabetic  peripheral  neuropathy and their  selected demographic
variables in experimental group, was rejected except for marital status, family
monthly income, duration of treatment for diabetic peripheral neuropathy.
SECTION J: ASSOCIATION BETWEEN THE POST TEST
LEVEL OF SLEEP AMONG PATIENTS WITH
DIABETIC  PERIPHERAL  NEUROPATHY
AND  THEIR  SELECTED  DEMOGRAPHIC
VARIABLES IN EXPERIMENTAL GROUP. 
Table:10: Association between the post test level of  sleep
among  patients  with  Diabetic  Peripheral
Neuropathy and  their  selected  demographic
variables in experimental group. 
n=30
S.
No Demographic Variables
Level Of Sleep
χ2
TA
B
L
E
VA
LU
E
IN
FE
R
N
C
E
Goo
d
slee
p
Poor
sleep
Very
poor
sleep
1%F
a)
b)
c)
d)
Age 
30-40 years
41-50 years
51-55 years
Above 55 years
4
6
3
3
13.3
20
10
10
2
6
4
2
6.7
20
13.3
6.7
-
-
-
-
-
-
-
-
0.89 7.82
df=3
NS
2
a)
b)
Sex
Male
Female 
10
6
33.3
20
8
6
26.7
20
-
-
-
-
0.1 3.84
df=1
NS
3
a)
b)
c)
Marital status
Married
Unmarried
Others 
15
-
1
50
-
3.3
12
-
2
40
-
6.7
-
-
-
-
-
-
0.5
5
3.84
df=1
NS
S.
No Demographic Variables
Level Of Sleep
χ2
TA
BL
E 
VA
LU
E
IN
FE
R
N
C
E
Goo
d
slee
p
Poor
slee
p
Ver
y
poo
r
slee
p
4%F
a)
b)
c)
d)
Educational status
No formal education
Primary education
Higher secondary
Graduate 
4
5
5
2
13.3
16.7
16.7
6.7
3
6
2
3
10
20
6.6
10
-
-
-
-
-
-
-
-
4.9 7.82
df=3
NS
5a)
b)
c)
d)
Religion 
Hindu
Muslim
Christian
Others 
7
3
6
-
23.3
10
20
-
9
2
3
-
.
7
10
-
-
-
-
-
-
-
-
-
1.27 5.99
df=2
NS
6
a)
b)
c)
d)
Occupation 
Coolie worker
Private employee
Government employee
Self  employee
3
6
3
4
10
20
10
13.3
7
1
2
4
23.3
3.4
6.7
13.3
-
-
-
-
-
-
-
-
5.17 7.82
df=3
NS
7
a)
b)
c)
d)
Family monthly income
Rs.2000-4000
Rs.4001-6000
Rs.6001-8000
Above Rs. 8001
3
5
6
2
10
16.7
20
6.7
1
5
4
4
3.3
16.7
13.3
13.3
-
-
-
-
-
-
-
-
1.9 7.82
df=3
NS
8
a)
b)
Types of family
Nuclear family
Joint family
11
5
36.7
16.6
11
3
36.7
10
-
-
-
-
0.3
3.84
df=1
NS
S.  
No Demographic Variables
Level Of Sleep
χ2
TA
BL
E 
VA
LU
E
IN
FE
R
N
C
E
Goo
d 
slee
p
Poor
slee
p
Very
poor
slee
p
9%F
a)
b)
Area of residence
Urban
Rural 
10
6
33.3
20
6
8
20
26.7
-
-
-
-
0.65 3.84
df=1
NS
10
a)
b)
c)
Duration of Diabetic 
Peripheral Neuropathy
1-3 years
3-5 years
>5 years
9
5
2
30
16.7
6.6
11
3
-
36.7
10
-
-
-
-
-
-
-
2.56 5.99
df=2
NS
11
a)
b)
c)
Duration of treatment 
for Diabetic  Peripheral 
Neuropathy
1-3 years
3-5 years
>5 years
14
1
1
46.7
3.3
3.3
14
-
-
46.7
-
-
-
-
-
-
-
-
2.12 5.99
df=2
NS
 NS=no significance          p<0.05
Table 10: Chi Square values were calculated to find out the association
between post test level of sleep scores among patients with diabetic peripheral
neuropathy.  The  findings  revealed  that  there  was  no  significant  association
with  demographic  variables  in  experimental  group  at  p<0.05  level  of
significance. Therefore the research hypotheses H7  that, there is a significant
association between post test level of sleep score among patients with diabetic
peripheral neuropathy and their selected demographic variables, was rejected.
 
CHAPTER V
DISCUSSION
This  chapter  deals  with  sample  characteristics  and  objectives  of  the
study. The aim of this present study was to assess the effectiveness of exercises
on  pain  and  sleep  among  patients  with  diabetic  peripheral  neuropathy  in
selected hospitals at Erode.
DISTRIBUTION OF SAMPLE CHARECTERISTICS:
Regarding age in experimental group, majority12(40%) belonged to the
age group of 41-50 years,7(23.3%) belonged to 51-55 years, 6(20%) belonged
to 30-40 years and remaining  5(16.7%) belonged to above 55 years. In control
group majority 14(46.7%) belonged to 41-50 years, 7(23.3%) belonged to 51-
55  years,  5(16.7%)  belonged  to  above  55  years  and  remaining  4  (13.3%)
belonged to 30-40 years. 
With regard to  sex,  in  experimental  group,  18(60%) were males and
12(40%) were females. In control group, 16(53.3%) were males and 14(46.7%)
were females. 
Regarding marital status in experimental group 27(90%) were married
and 3(10%) were widow. In control group 30(100%) were married.
With regard to educational status in experimental group, majority of the
patients 11(36.7%)  had  primary education, 7(23.3%)  had no formal education
and 7(23.3%) had higher secondary education and 5 (16.7%) were graduates. In
control group, majority of the  patients 12(40%)  had  primary education and
10(33.3%)  had higher secondary education,7(23.3%) had no formal education,
and 1(3.4%) were  graduates .
Regarding religion in experimental group, majority 17(56.7%) belonged
to  Hindu  religion,  8(26.6%)  belonged  to  Christian  religion  and  5(16.7%)
belonged to Muslim religion. In control group majority 16(53.3%) belonged to
Hindu religion, 11(36.7%) belonged to Christian religion, and 3(10%) belonged
to Muslim religion.
Regarding occupation in experimental group, majority 10(33.3%) were
coolie workers, 8(26.7%) were self employee, 7(23.3%) were private employee
and 5(16.7%) was government employee. In control group majority 10(33.3%)
were coolie workers, 8(26.7%) were government employee ,7(23,3%) were self
employe,5(16.7%) were private employee.
With regard to family monthly income, in experimental group majority
10(33.3%) were in between Rs 4001-Rs.6000, 10(33.3%) were in between Rs
6001-Rs.8000, 6(20%) were in above Rs.8001 and 4 (13.4%) were Rs.2000-
Rs.4000. In control group majority 9(30%) were in between Rs 2000-Rs.4000,
8(26.7%)  were  in   between  Rs  6001-Rs.8000,  7  (23.3%)  were   Rs.4001-
Rs.6000 and 6(20%) were above Rs.8001. 
With regard to type of family in experimental group 22 (73.3%) were
from nuclear family and 8(26.7%) were from joint family . In control group the
patients 22(73.3%) were from nuclear family and 8(26.7%) were from joint
family.
With  regard  to  area  of  residence  in  experimental  group,  majority
16(53.3%) were in urban area and 14(46.7%) were in rural  area.  In control
group majority 15(50%) were in urban area and 15(50%) were in rural area, 
With  regard  to  duration  of  diabetic  peripheral  neuropathy,  in
experimental group 20(66.7%) had duration of illness for 1-3 years, 8(26.7%)
had duration of 3-5 years and 2(6.6%) had above 5 years.  In control group
majority 13(43.4%) had above 5 years, 11(36.7%) had the illness for 1- 3 years
had, 6(20%) had duration of illness for 3-5 years. 
With regard to duration of treatment, in experimental group 28(93.3%)
had duration of  treatment for  a  period  of  1-3year  ,1(3.3%) had duration of
treatment for a period of 3-5 years,1(3.4%) had a duration of treatment for a
period of above 5 years,. In control group majority 13(43.3%) had duration of
treatment for a period of 1-3 years, 12(40%) had duration of treatment for a
period of 3-5 years, 5(16.7%) had duration of treatment for a period of above 5
years
THE FINDINGS OF THE STUDY ARE DISCUSSED ACCORDING TO
THE OBJECTIVES FOLLOWS:
1. To assess the pretest and post test  level of pain among patients with
diabetic peripheral neuropathy in experimental and control group.
2. To assess the pre test and post test level of sleep among patients with
diabetic peripheral neuropathy in experimental and control group.
3. To compare the  pre  and  post  test  level  of  pain  among patients  with
diabetic peripheral neuropathy in experimental group.
4. To compare the pre and post  test level of sleep among patients with
diabetic peripheral neuropathy in experimental group.
5. To  find  the  effectiveness  of  exercises  on  pain  among  patients  with
diabetic peripheral neuropathy between experimental and control group.
6. To find  the  effectiveness  of  exercises  on  sleep  among  patients  with
diabetic peripheral neuropathy between experimental and control group.
7. To find the relationship between the post test level of pain and sleep
among  patients  with  diabetic  peripheral  neuropathy  in  experimental
group.
8. To find the association between post test level of pain among patients
with  diabetic  peripheral  neuropathy  and  their  selected  demographic
variables in experimental group.
9. To find the association between post test level of sleep among patients
with  diabetic  peripheral  neuropathy  and  their  selected  demographic
variables in experimental group.
OBJECTIVE 1
To  assess  the  pretest  and  post  test  level  of  pain  among  patients  with
diabetic peripheral neuropathy in experimental and control group.
Among  diabetic  peripheral  neuropathy  patients  in  pre  test  of
experimental  group majority  16 (53.3%) had moderate  level  of  neuropathic
pain, 8(26.7) had severe neuropathic pain and 6(20%) had mild neuropathic
pain. In pretest of control group majority 13(43.3%) had moderate neuropathic
pain, 10(33.3%) had mild neuropathic pain, 7(23.4%) had severe neuropathic
pain. In posttest level of pain in experimental group majority 24 (80%) had non
neuropathic pain, 6 (20%) had mild neuropathic pain. In control group majority
14(46.7%) had mild  neuropathic pain,  13(43.3%) had moderate neuropathic
pain, 2(6.7%) had severe neuropathic pain, and 1(3.3%)  had non neuropathic
pain.
This study was consistent with the study findings of  Obrad.W. et.al.,
(2012) reported that diabetic peripheral neuropathy pain in experimental group
was increased in pretest (7.1±2.9) and decreased in post test(4.71±3.4). But in
control  group  there  is  no  marked  changes  of  pain  level  (9.01±4.9  pre/
8.53±3.79 post) (p<0.005)
OBJECTIVE 2
To assess  the  pre  test  and  post  test  level  of  sleep  among patients  with
diabetic peripheral neuropathy in experimental and control group.
Among  diabetic  peripheral  neuropathy  patients  in  pretest  of
experimental group majority 26(86.7%) had very poor sleep and 4(13.3%) had
poor  sleep.  In  control  group  majority  28(93.3%)  had  very  poor  sleep  and
2(6.7%) had poor sleep. In post test of experimental group majority 16(53.3%)
had  good  sleep  and  14(46.7%)  had  poor  sleep.  In  control  group  majority
18(60%) had poor sleep and 12(40%) had very poor sleep. 
This  study  was  consistent  with  the  study findings  of  Alexandra  .D.
et.al.,(2011) who  reported  that  diabetic  peripheral  neuropathy  sleep  in
experimental group was decreased in pretest (48.1±5.9) and increased in post
test (52.09±4..34). But in control group there is no marked changes of sleep
level (34.7±4.9 pre/ 46.65±5.53 post).(p=<0.001)
 
OBJECTIVE 3:
To compare the pre and post test level of pain among patients with diabetic
peripheral neuropathy in experimental group.
The data analysis showed that the mean pretest scores of level of pain in
experimental  group  was  18.3(SD±2.67)  and  post  test  mean  score  was
9.6(SD±3.15)  respectively.  The  mean  difference  was  8.7.  The  post  mean
score(9.6) was lower than the pretest mean score(18.3) . The paired ‘t’ value
was12.82 which was significant at  P<0.05 level.
This study findings consistent with the study findings of Min Yoo.et.al.,
(2013) who reported that posttest score of pain was significantly lower than the
pretest score of pain level (4.95±2.83 pre test, 2.8±2.74 posttest: p=0.0073)
This study concluded that the exercises was effective in reducing the
pain level among patients with diabetic peripheral neuropathy.
Therefore the research hypotheses H1  that, the mean post test level of
pain score is significantly lower than the mean pre test level of pain score in
experimental group, was accepted.
OBJECTIVE 4:
To  compare  the  pre  and  post  test  level  of  sleep  among  patients  with
diabetic peripheral neuropathy in experimental group.
The data analysis showed that the mean pretest and post test scores of
level of sleep in experimental group was 29.1 (SD+ 3.23) and 47.7 (SD+ 5.56)
respectively. The mean difference is 18.6. the ‘t’ value was 16.39 which was
significant at p<0.05 level.
This study was consistent with the study findings of Paul.et.al., [2009]
reported that the level of sleep is significantly higher in post test (56.71±7.43)
than  the  pretest  in  experimental  group  (37.89±5.4)  at  p=  0.001  level  of
significance.
This study concluded that the exercises was effective in improving  the
sleep level among patients with diabetic peripheral neuropathy.
Therefore the research hypotheses H2 that, the mean post test level of
sleep score is significantly higher than the mean pre test level of sleep score in
experimental group , was accepted.
OBJECTIVE 5
To find the effectiveness of exercises on pain among patients with diabetic
peripheral neuropathy between experimental and control group.
The data analysis showed that the mean post test scores of pain among
patients with diabetic peripheral neuropathy in experimental and control group
were 9.6 (SD±3.15) and 15.9(SD±2.99) respectively.  The mean difference was
6.3.The independent ‘t’ value was 8.51which was significant at p<0.05 level.
This  study  was  consistent  with  the  study findings  of  Anil  Bhensal.,
(2009) who reported that the level of pain scores is significantly lower in the
experimental  group(2.56±2.01)  than  the  control  group  (4.50±2.48)  at
(Independent t=5.101) P=0.011 level of significance. 
This study concluded that the exercises was effective in decreasing pain
from  pre  to  post  intervention  compared  between  experimental  and  control
group of  patients with diabetic peripheral neuropathy.
Therefore the research hypotheses H3 that, the mean post test level of
pain score in experimental group is significantly lower than the mean post test
level of pain score in control group, was accepted.
OBJECTIVE 6
To find the effectiveness of exercises on sleep among patients with diabetic
peripheral neuropathy between experimental and control group.
The data analysis showed that the mean post test scores of pain among
patients with diabetic peripheral neuropathy in experimental and control group
were  47.7  (SD±5.56)  and  34.2(SD±7.03)  respectively.  The mean difference
was 13.5.The independent ‘t’ value was 8.88which was significant at p<0.05
level.
This study was consistent with the study findings of  Robin L. kruse.,
(2008)  reported  that  the  level  of  sleep  scores  is  significantly  higher  in  the
experimental  group  (73.45±8.73)  than  the  control  group  (63.75±7.50)  at
(independent t= 9.8) p<0.01 level of significance.
This study concluded that the exercises was effective in improving sleep
level from pre to post intervention compared between control group of  patients
with diabetic peripheral neuropathy.
Therefore the research hypothesis H4 that, the mean post test level of
sleep score in experimental group is significantly higher than the mean post test
level of sleep score in control group, was accepted.
OBJECTIVE 7
To find the relationship between the post test level of pain and sleep among
patients with diabetic peripheral neuropathy in experimental group.
The data analysis showed that  the mean post  test  scores of pain and
sleep  among  patients  with  diabetic  peripheral  neuropathy  in  experimental
group  were  9.6(SD±3.15)  and  47.7  (SD±5.56)  respectively.  The  mean
difference  was  38.1.  The  ‘r’  value  was  -0.9  which  shows  that  negative
relationship  between  pain  and  sleep  scores  among  patients  with  diabetic
peripheral  neuropathy  in  experimental  group.  It  explains  that  if  pain  level
decreased sleep pattern was improved.
This  study  was  consistent  with  the  study  findings  of  Jeffrey  s.
Gonzalez.,(2009) that reported that pain (8.71±3.7) and sleep (53.29±4.3) had
a negative relationship     (r=(-0.9),  p=0.01) it  shows that if  the pain level
decreased the sleep pattern was improved in  diabetic  peripheral  neuropathy
patients. 
Therefore  the  research  hypotheses  H5 that,   there  is  a  significant
relationship between post test level of pain score and post test level of sleep
score  among  patients  with  diabetic  peripheral  neuropathy  in  experimental
group was accepted.
OBJECTIVE 8
To find the association between post test level of pain among patients with
diabetic peripheral neuropathy and their selected demographic variables
in experimental group. 
Chi Square values were calculated to find the association between post
test level of pain scores among patients with diabetic peripheral neuropathy in
experimental  group.  The  findings  revealed  that  there  was  a  significant
association  between  marital  status  (χ2 =7.74),  family  monthly  income  (χ2
=9.65), duration of treatment for diabetic peripheral neuropathy (χ2 =7.66) in
experimental group at  p<0.05 level of significance. There was no significant
association between age, sex, educational status, religion, occupation, types of
family,  area  of  residence,  duration  of  diabetic  peripheral  neuropathy  in
experimental  group. Therefore  the  research  hypothesis  H6 there  will  be  a
significant  association between post  test  level  of  pain score among patients
with diabetic peripheral neuropathy and their selected demographic variables in
experimental group, was rejected except marital status, family monthly income,
duration of treatment for diabetic peripheral neuropathy.
This study was consistent with the study finding of Booya.et.al., (2012)
who  reported  that  there  was  a  significant  association  with  age  (χ2=21.8)  ,
family income (χ2=32.3), duration of treatment (χ2=23.98), height (χ2=19.21)
between level of pain with diabetic peripheral neuropathy.
Therefore  the  research  hypothesis  H6 that,  there  is  a  significant
association between post test level of pain score among patients with diabetic
peripheral neuropathy and their selected demographic variables in experimental
group, was accepted.
OBJECTIVE 9
To find the association between post test level of sleep among patients with
diabetic peripheral neuropathy and their selected demographic variables
in experimental group.
Chi Square values were calculated to find out  association  between the
mean  post  tests  levels  of  pain among  patients  with  diabetic  peripheral
neuropathy  with their selected demographic variables in experimental group.
The findings revealed that  there  was no significant  association  between the
mean  post  tests  levels  of  pain  among  patients  with  diabetic  peripheral
neuropathy with their selected demographic variables for experimental group. 
This study was consistent with the study finding of Benuza.et.al.,(2009)
who  reported  that  there  was  no  significant  association  with  age  (χ2=0.8),
family  income  (χ2=0.02),  duration  of  treatment  (χ2=0.19),  smoking  status
(χ2=1.01),  residence  (χ2=1.13),  low  HDL  cholesterol  level  (χ2=0.9)   at
p<0.001 level of significance between level of sleep with diabetic peripheral
neuropathy. 
Therefore  the  research  hypotheses  H7  that, there  is  a  significant
association between post test level of sleep score among patients with diabetic
peripheral neuropathy and their selected demographic variables, was rejected.
CHAPTER VI
SUMMARY, CONCLUSION, IMPLICATIONS, 
RECOMMENDATION AND LIMITATIONS
This chapter is discussed under 5 headings
 Summary 
 Conclusion
 Implications 
 Recommendation
 Limitation
SUMMARY OF THE STUDY
     The aim of this present study was to assess the effectiveness of exercises
on  pain  and  sleep  among  patients  with  diabetic  peripheral  neuropathy  in
selected Hospitals at Erode.  The design used for the present study was Quasi
experimental non equivalent pre test and post test control group design. The
conceptual  frame  work  was  based  on  modified “Ludwig  Von  Bertlanffy
System  theory  (1968)”.  Sample  size  was  60  out  of  which  30  were  in
experimental group and 30 were in control group.  Non probability purposive
sampling method was used to select the samples of the study. The tool used for
this study was Leeds Assessment of Neuropathic Symptoms and Signs scale to
assess the level of pain and Sleep scale from medical outcomes study was used
to assess the level of sleep among patients with diabetic peripheral neuropathy
before and after intervention.
Every  day  2-3  samples  were  selected  for  experimental  and  control
group by using  purposive sampling technique.                                
On 1st day in experimental  group data pertaining to the demographic
variables was collected  and then pre test was conducted to the participants by
using Leeds Assessment of Neuropathic Symptoms and Signs scale to assess
the level of pain, and sleep scale from medical outcome of study to assess sleep
pattern. Exercises was given to the participants which are carried out as a single
session (30 minutes) per day for 15 days individually to reduce the level of pain
and  improve  the  sleeping  pattern.  After  the  intervention  post  test  was
conducted on the 16th day. For control group the demographic variables was
collected then the pretest was conducted on the 1st day and on the 16th day post
test was conducted by using Leeds Assessment of Neuropathic Symptoms and
Signs scale to assess the level of pain and sleep scale from medical outcome of
study to assess the level of sleep. The same procedure was followed for the
remaining 30 samples and data were collected.
 The  data  was  analyzed  using  descriptive  statistics  and  inferential
statistics.
 MAJOR FINDINGS OF THE STUDY
The major findings were,
¾ Regarding age in experimental group, majority12(40%) belonged to the
age group of  41-50 years,7(23.3%) belonged to  51-55 years,  6(20%)
belonged to 30-40 years and remaining  5(16.7%) belonged to above 55
years.  In  control  group majority  14(46.7%) belonged to  41-50 years,
7(23.3%) belonged to 51-55 years, 5(16.7%) belonged to above 55 years
and remaining 4 (13.3%) belonged to 30-40 years.
¾ Regarding  to  sex,  in  experimental  group,  18(60%)  were  males  and
12(40%) were  females.  In  control  group,  16(53.3%) were males  and
14(46.7%) were females. 
¾ Regarding marital status in experimental group 27(90%) were married
and 3(10%) were widow. In control group 30(100%) were married.
¾ With regard to educational status in experimental group, majority of the
patients 11(36.7%)  had  primary education, 7(23.3%)  had no formal
education and 7(23.3%) had higher secondary education and 5 (16.7%)
were graduates. In control group, majority of the  patients 12(40%)  had
primary  education  and  10(33.3%)   had  higher  secondary
education,7(23.3%)  had  no  formal  education,  and  1(3.4%)  were
graduates.
¾ Regarding religion in experimental group, majority 17(56.7%) belonged
to Hindu religion, 8(26.6%) belonged to Christian religion and 5(16.7%)
belonged  to  Muslim  religion.  In  control  group  majority  16(53.3%)
belonged to Hindu religion, 11(36.7%) belonged to Christian religion,
and 3(10%) belonged to Muslim religion. 
¾ Regarding occupation in experimental group, majority 10(33.3%) were
coolie workers,  8(26.7%) were self  employee,  7(23.3%) were private
employee and 5(16.7%) was government  employee.  In  control  group
majority  10(33.3%) were  coolie  workers,  8(26.7%) were  government
employee  ,7(23,3%)  were  self  employe,5(16.7%)  were  private
employee.
¾ With regard to family monthly income, in experimental group majority
10(33.3%)  were  in  between  Rs  4001-Rs.6000,  10(33.3%)  were  in
between Rs 6001-Rs.8000, 6 (20%) were in between above Rs.8001 and
4  (13.4%)  were  Rs.2000-Rs.4000.  In  control  group  majority  9(30%)
were  in  between  Rs  2000-Rs.4000,   8(26.7%)  were  in   between  Rs
6001-Rs.8000,  7  (23.3%)  were   Rs.4001-Rs.6000  and  6(20%)  were
above Rs.8001. 
¾ With regard to type of family in experimental group 22 (73.3%) were
from nuclear family and 8(26.7%) were from joint family . In control
group the patients 22(73.3%) were from nuclear family and 8(26.7%)
were from joint family.
¾ With  regard  to  area  of  residence  belonged  to  experimental  group,
majority  16(53.3%) were  in  urban area  and 14(46.7%) were in  rural
area. In control group majority15(50%) were in urban area and 15(50%)
were in rural area, 
¾ With  regard  to  duration  of  diabetic  peripheral  neuropathy,  in
experimental  group  20(66.7%)  had  duration  of  illness  for  1-3  years,
8(26.7%) had duration of 3-5 years and 2(6.6%) had above 5 years. In
control group majority 13(43.4%) had above 5 years, 11(36.7%) had the
illness for 1- 3 years had, 6(20%) had duration of illness for 3-5 years. 
¾ With regard to duration of treatment, in experimental group 28(93.3%)
had duration of treatment for a period of 1-3year ,1(3.3%) had duration
of  treatment  for  a  period  of  3-5  years,1(3.4%)  had  a  duration  of
treatment  for  a  period  of  above  5  years,.  In  control  group  majority
13(43.3%) had duration of treatment for a period of 1-3 years, 12(40%)
had  duration  of  treatment  for  a  period  of  3-5  years,  5(16.7%)  had
duration of treatment for a period of above 5 years.
¾ In  experimental  group  pretest  6(20%)  had  mild  neuropathic  pain,
16(53.3%)  had  moderate  neuropathic  pain,  8  (26.7%)  had  severe
neuropathic  pain.  In  control  group  10  (33.3%) had  mild  neuropathic
pain,  13(43.3%)  had  moderate  neuropathic  pain  and  7  (23.4%)  had
severe neuropathic pain. In post test 24(80%) had non neuropathic pain,
6(20%) had  mild  neuropathic  pain  in  experimental  group.  In  control
group,  1(3.3%)  had  non  neuropathic  pain,  14(46.7%)  had  mild
neuropathic  pain,  13(43.3%)  had  moderate  neuropathic  pain  and
2(6.7%) had severe neuropathic pain. 
¾ In experimental group pre test 4(13.3%) had poor sleep, 26(86.7%) had
very poor sleep. In control group 2(6.7%) had poor sleep, 28(93.3%)
had very poor sleep. In post test 16(53.3%) had good sleep, 14(46.7%)
had poor sleep in experimental  group. In control  group 18(60%) had
poor sleep, 12(40%)had very poor sleep. 
¾ The mean pretest and post test scores of level of pain in experimental
group was 18.3 (SD+ 2.67) and 9.6 (SD+3.15) respectively. The mean
difference is 8.7. the paired  ‘t’ value was 12.87 which was significant at
p<0.05 level.
¾ The mean pretest and post test scores of level of sleep in experimental
group was 29.1 (SD+ 3.23) and 47.7 (SD+5.56) respectively. The mean
difference  is  18.6.  the  ‘t’  value  was  16.39  which  was  significant  at
p<0.05 level.
¾ The  mean  post  test  scores  of  pain  among  patients  with  diabetic
peripheral  neuropathy  in  experimental  and  control  group  were  9.6
(SD±3.15) and 15.9(SD±2.99) respectively.  The mean difference was
6.3.The independent ‘t’ value was 8.51which was significant at p<0.05
level.
¾ The  mean  post  test  scores  of  pain  among  patients  with  diabetic
peripheral  neuropathy  in  experimental  and  control  group  were  47.7
(SD±5.56) and 34.2(SD±7.03) respectively.  The mean difference was
13.5.The independent ‘t’ value was 8.88which was significant at p<0.05
level.
¾ The mean post test scores of pain and sleep among patients with diabetic
peripheral  neuropathy  in  experimental  group  were  9.6(SD±3.15)  and
47.7  (SD±5.56)  respectively.  The mean  difference  was  38.1.  The ‘r’
value was      -0.9 which shows that negative relationship between pain
and sleep scores  among patients with diabetic peripheral neuropathy in
experimental group. It explains that if pain level decreased sleep pattern
was improved. 
¾ The association between post test level of pain scores among patients
with  diabetic  peripheral  neuropathy  and  their  selected  demographic
variables  in  experimental  group  using  chi  square  value,  the  findings
revealed that there was a significant association between marital status
(χ2 =7.74), family monthly income (χ2 =9.65), duration of treatment for
diabetic  peripheral  neuropathy  (χ2 =7.66)  in  experimental  group  at
p<0.05  level  of  significance.  There  was  no  significant  association
between  age,  sex,  educational  status,  religion,  occupation,  types  of
family, area of residence, duration of diabetic peripheral neuropathy in
experimental group. 
¾ The  association between post test level of sleep among patients with
diabetic peripheral neuropathy and their selected demographic variable
in experimental group using chi square value, the findings revealed that
there  was  no  significant  association  with  demographic  variables  in
experimental group at p<0.05 level of significance
CONCLUSION:
    The present study was conducted to assess the effectiveness of exercises
on  pain  and  sleep  among  patients  with  diabetic  peripheral  neuropathy  in
selected hospital, Erode. The independent ‘t’ value for pain was 8.51which was
significant at p<0.05 level. The independent ‘t’ value for sleep was 8.88 which
was  significant  at  p<0.05  level.  The  results  of  the  study  concluded  that
exercises was effective in reducing pain and improving sleep among patients
with diabetic peripheral neuropathy.
IMPLICATIONS
       The findings of the study have certain important implication for nursing
service, nursing education, nursing administration, and nursing research.
Nursing Service
♣ The  nurse  must  conduct  in  service  education  about  the  non
pharmacological  measures  used  in  treating  patients  with  diabetic
peripheral neuropathy.
♣ Nurse as the change agent, can introduce the various measures for the
reduction  of  pain  and  improving  sleep  among  patients  with  diabetic
peripheral neuropathy who were admitted in the ward.
♣ Nursing  service  department  can  arrange  health  education  program in
OPD for teaching the patient on exercises.
Nursing Education
♣ The nurse educator can orient the students with alternative therapies in
reducing the level of pain and improving the sleep among patients with
diabetic peripheral neuropathy.
♣ Nurse  educators  should motivate the  students  to  do mini  projects  on
techniques  to  reduce  pain  and  improve  sleep  among  patients  with
diabetic peripheral neuropathy.
♣ Nurse  educators  should  conduct  workshops/  seminars  to  update  the
knowledge of students to promote practicing alternative therapies among
patients with diabetic peripheral neuropathy.
♣ The  nurse  educator  can  include  exercises  as  a  mean  of  non
pharmacological therapy in the curriculum, which can be adopted by the
students and the nursing personnel
Nursing Administration
♣ Nurse  administrator  can  organize  continuing  education  program
regarding promoting optimal wellbeing of patients living with diabetic
peripheral neuropathy.
♣ Nurse  administrator  can  organise  conferences  and  can  enhance  the
knowledge  and  practice  of  alternative  therapies  among  patients  with
diabetic peripheral neuropathy in reducing pain and improving sleep.
♣ Nurse  administrator  can  prepare  and  distribute  information  booklet
about exercises to patients with diabetic peripheral neuropathy.
♣ Nurse administrator should conduct in service education to disseminate
the research findings through continuous nursing education to all nurses.
♣ Pamphlets,  leaflets  about  exercises  can be  made available  to  nursing
staff  in  the  diabetic  clinics  ward  and  to  nurse  educators  in  nursing
educational institution.
Nursing Research:
♣ The study findings can be a baseline for further studies to build upon
for improving the body of knowledge in nursing
♣ The  study  findings  can  be  effectively  utilized  by  the  emerging
researchers   to conduct further studies. 
RECOMMENDATION
Based on the findings the following recommendations are stated
• Similar study can be replicated in a larger samples thereby findings can
be generalized to a large population.
• Comparative  study  can  also  be  done  between  the  effectiveness  of
various non pharmacological measures on reducing pain and improving
sleep among patients with diabetic peripheral neuropathy.
• Comparative  study  can  also  be  done  between  the  effectiveness  of
exercises on level of depression and sleep among patients with diabetic
peripheral neuropathy.
• Longitudinal study can be done between the effectiveness of exercises
on patient with diabetic peripheral neuropathy.
LIMITATIONS
♣ Requested the doctors and convinced the samples in the control group to
come for check up on the 16th day. 
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APPENDIX – C 
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Bishop’s college of nursing,
Dharapuram.
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Respected Madam / Sir,
          Sub: Requisition for content validity of tool.
I am doing M.Sc(Nursing) II year in Bishop’s College of Nursing, Dharapuram under
The Tamil Nadu Dr.M.G.R. Medical university, Guindy, Chennai. As a partial fulfillment of
my M.Sc(nursing) Degree Programme, I am conducting a research on, “A study to assess
the effectiveness of exercises on pain and sleep among patients with diabetic peripheral
neuropathy  at  selected  hospitals,  Erode.”A tool  has  been  developed  for  the  research
study. I am sending the above stated for your expert and valuable opinion. I will be thankful
for your kind consideration. Kindly return it to the undersigned.
                                                  Thanking you,
                                                                                 Yours faithfully,
(V.JENI)
Enclosure:
1) Certificate of content validity
2) Statement of problem, objectives, operational definition, hypothesis
3) Description of the tool and tool for data collection
4) Self addressed envelope
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APPENDIX – H
TOOL
PART -I
ENGLISH
DEMOGRAPHIC VARIABLES
1. Age in years 
a) 30 – 40 years
b) 41 – 50 years
c) 51 – 55 years
d) Above 55 years
2. Sex  
Male
Female
3. Marital status
a) Married
b) Unmarried
c) Others
4. Educational status
a) No formal education
b) Primary education
c) Higher secondary
d) Graduate
5. Religion
a) Hindu
b) Muslim
c) Christian
d) Other
6. Occupation
a)  Coolie worker
b)  Private employee
c)  Government employee
d)  Self employee
7. Income
a)  RS.2000-4000
b)  RS 4001-6000
c)  RS.6001-8000 
d)  RS 8001 and above                                                                                      
8. Types of family
a)  Nuclear family
b)  Joint family
9. Area of Residence
a)  Urban
b)  Rural
10. Duration of  diabetic peripheral neuropathy
a) 1-3 years
b) 3-5 years
c) >5 years
12. Duration of diabetic peripheral neuropathy treatment
a) 1-3 years
b) 3-5years
c) >5years
LEEDS ASSESSMENT OF NEUROPATHIC SYMPTOMS AND SIGNS SCALE
S.No QUESTIONS YES NO
12
3
4
5
6
7
Would you describe your pain as strange unpleasant
sensations in your skin? (e.g. pricking, tingling, pins
and needles).
Does the skin in the painful areas look different to
normal? (e.g. mottled, more red/pink than usual)  .
Is the skin in the affected area abnormally sensitive
to  touch?  (e.g.  unpleasant  sensations  if  lightly
stroked, painful to wear tight clothes).
Does your pain come on suddenly in bursts for no
apparent reason when you are still? (e.g. like electric
shocks, ‘bursting’ or ‘jumping’ sensations).
Do you feel that skin temperature in the painful area
has changed (e.g. hot, burning).
Does stroking the affected area of skin with a piece
of  cotton  wool  produce  an  unpleasant  painful
sensation? 
Does touching the affected area of skin with a sharp
needle feel sharper or duller when compared to an
area of normal skin? 
5
5
3
2
1
5
3
0
0
0
0
0
0
0
 
SLEEP SCALE FROM THE MEDICAL OUTCOMES OF STUDY
1. How long did it usually take for you to fall asleep during the past 
1week? (Circle One)
More than 60 minutes …….1
46-60 minutes……………..2 
31-45 minutes ………..........3
16-30 minutes……………..4 
0-15 minutes…………...…5
2.  On the average, how many hours did you sleep each night during the past 1week?
0-2hours………………1
3-4hours………………2
5-6hours………………3
7-8hours………………4
How often during the past 1 week did you…(Circle One Number On Each Line)
S.
No QUESTIONS
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3 Feel that your sleep was not quiet
(moving restlessly, feeling tense,
speaking, etc., while sleeping)?
1 2 3 4 5 6
4 Get not enough sleep to feel rested
upon waking in the morning?  
1 2 3 4 5 6
5 Awaken with a headache? 1 2 3 4 5 6
6 Feel drowsy or sleepy during the
day?
1 2 3 4 5 6
7 Have trouble falling asleep? 1 2 3 4 5 6
8 Awaken during your sleep time and
have trouble falling asleep again? 
1 2 3 4 5 6
9 Have trouble staying awake during
the day? 
1 2 3 4 5 6
10 Snore during your sleep? 1 2 3 4 5 6
11 Take naps (5 minutes or longer)
during the day? 
1 2 3 4 5 6
12 Did you think that you didn’t slept
well?
1 2 3 4 5 6
APPENDIX – I
PROCEDURE
DIABETIC PERIPHERAL NEUROPATHY FOOT EXERCISES
STEP I:
FOOT MASSAGE :
Inspect the feet before start the massage.  Look for discoloration such as bluish purple spots,
redness, sores, cracks in the skin, fungus on the toe nails , dark spots, cold areas or anything else
that stands out as abnormal. Be sure to look in between the toes and encourage the client to do the
same every day. If they cannot reach their feet, have them place in a mirror on the floor to view
their feet carefully. Experiment with light pressure while you are inspecting the feet.This should
take about two minutes.
Begin with some light compression, using the whole hand. Spend about one minute on each
foot lightly compressing the plantar and dorsal surfaces and all but tissue from the toes to the knee.
STEP II:
FOOT ROLLING EXERCISES:
Sit in a chair with back straight, knees together. Lift right foot off the floor, place a round
thick plastic bottle under the foot. Start to move the bottle front and back. Do this exercise five
times. Lower the right foot to the floor and repeat the exercise with left foot.
STEP III:
STRETCHING THE CALF MUSCLES:
Lean with the palms of the hand against a wall. Keep feet some distance away , the heels
firmly on the floor. Bend arms 10 times, keeping back and legs straight.
STEP IV:
SITTING LEG POINTERS
Sit in a chair with back straight, knees together. Lift right foot off the floor, straightening the
right knee at the same time. Point the toes into the distance. Holding the leg out straight. Circle the
ankle joint clockwise, then counterclockwise five times. Lower the right foot to the floor and repeat
the exercise with the left foot.
 STEP V
TIPTOE EXERCISE:
Hold to a chair and raise and lower the body on the toes of one foot then the other.
STEP VI:
LEG BENDS:
Hold chair. Put one foot forward and lower body straight down, keeping both feet on floor.
Raise and lower 10 times. Change legs.
STEP VII:
HEEL RAISING:
Get up on the toes and then down on heels, about 20 times. Also try putting the whole first
on one leg and then the other. 
STEP VIII:
LEG SWEEPS:
Stand with one leg slightly raised , on a book for  example. While holding to a chair or table
swing the other leg back and forth 10 times. Change to the other leg. Repeat  it.
STEP IX:
WAVE YOUR FEET:
Sit down on the floor and lean backwards. Shake the feet until they are relaxed and warm. 
STEP X:
 MARCH EXERCISE:
Stand straight in a place. March in place lifting the 
knees higher each times.
 Control Group
1
2
